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ABSTRACT 
The present thesis contains two independent parts of research, which are summarised as 
below. 
Part I 
Genome-Wide Association Study (GWAS) has recently been proposed as a powerful 
strategy for detecting the many subtle genetic variants that underlie phenotypic variation 
of complex polygenic traits in population-based samples. One of the main obstacles to 
successfully using the linkage disequilibrium based methods is knowledge of any 
underlying population structure. The presence of subgroups within a population can 
result in spurious association. A robust statistical method is developed to remove the 
population structure interference in GWAS by incorporating single control marker into 
testing for significance of genetic association of a polymorphic marker (SNP) with 
phenotypic variance of a complex trait. The novel approach avoids the need of structure 
prediction which could be infeasible or inadequate in practice and accounts properly for 
a varying effect of population stratification on different regions of the genome under 
study. Both intensive computer simulation study and eQTL analysis in genetically 
divergent human populations show that the new method confers an improved statistical 
power for detecting genuine genetic association in subpopulations and an effective 
control of spurious associations stemmed from population structure. 
Part II 
Regulation of gene transcription (or expression) plays an essential role for viruses, 
prokaryotes and eukaryotes when the genetic information is turned into functional 
products—RNA. It can introduce the variability and adjustability of an organism 
  
 
 
through modulating gene expression levels. Gene expression process may be regulated 
by several aspects, from transcription initiation to methylation-based regulation. In 
epigenetics, the addition of methyl groups to cytosine bases in DNA sequence is 
considered as heritable chemical markers. DNA methylation has been confirmed that it 
plays a fundamental role for regulation of gene expression and is widespread among 
eukaryotic species, particular in vertebrates. In these analyses, two highly conserved but 
distinct methylation-based promoter regulatory patterns have been detected in higher 
vertebrates. These two diverse promoter classifications show distinct features and 
properties in genomic, methylation, expression and function levels. However, they 
present a highly conserved performance among several higher vertebrate species. 
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Chapter Ι 
Overall introduction: association mapping, gene 
transcription process and expression quantitative 
trait loci (eQTLs) analysis 
1. 1 Related publications 
Druka A, Potokina E, Luo Z, Jiang N, Chen X, Kearsey M, Waugh R (2010) 
Expression quantitative trait loci analysis in plants. Plant Biotechnology Journal, 
8(1):10-27. 
Please see AppendixⅠfor a copy of this article as it appeared in print. 
Jiang N, Leach L, Hu X, Potokina E, Jia T, Druka A, Waugh R, Kearsey M, Luo Z 
(2008) Methods for evaluating gene expression from Affymetrix microarray datasets. 
BMC Bioinformatics, 9(1): 284-293. 
Please see Appendix II for a copy of this article as it appeared in print. 
1.2  Overview 
The phenomenon of association between two bi-allelic loci has been initially mentioned 
by Robbins in 1918. He hypothesized that ‘association is the constant allele frequencies 
subject to no pressure except recombination’ (Robbins, 1918). Based on this proposition, 
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association between two loci should ‘continuously debilitate from an initial level to an 
asymptote at zero’ (Collins, 2007). The first statistical models to calculate haplotype 
frequencies and association parameters for two bi-allelic markers were developed by 
Bennett and Hill. In 1965, Bennett introduced a theory for estimating the haplotype 
frequencies between linked gene-pairs in a randomly mating population. And then, Hill 
and Robertson developed a method to calculate the coefficient of association (or linkage 
disequilibrium) in finite population in 1968. During the last 50 years, the genetic 
association between two loci has become a commonly used tool for dissecting the 
genetic architecture of complex traits. The phenotypic differences of complex traits 
among individuals are controlled by multiple genes plus several non-genetic factors. 
Although comprehensive understanding the genetic basis of complex traits is not an 
easy task, association studies have successfully predicted a lot of genes with influences 
on many specific interesting phenotypes, such as drug response, disease susceptibility 
and crop yield. The principle of association mapping is to localize genes that affect the 
complex traits through associating nearby genetic polymorphisms, such as Single 
Nucleotide Polymorphisms (SNPs), Microsatellite polymorphisms and recently 
developed Single feature polymorphisms (SFPs). Currently, with the development of 
sequencing and genotyping technologies, the fast growth database of genetic 
polymorphisms makes development of the linkage disequilibrium based strategy for 
genome-wide mapping complex traits an interesting and useful research topic in 
functional genomics in plants, animals and humans.  
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1.3  Complex traits 
Complex traits have been considered as the ‘unpolished diamonds’ for geneticists and 
medical researchers. Meanwhile, it is also perhaps the largest challenge coming up 
against geneticists. The clustering of phenotypic traits or diseases such as height, yield, 
Body Mass Index (BMI), flower time of plant, type 2 diabetes, Parkinson’s disease and 
cancers, among related individuals show that almost all continuously variable traits (or 
quantitative traits) and common diseases have complicated genetic architectures, which 
opposes to Mendelian diseases or monogenic controlled traits (Weir, 2008). The 
Mendelian trait (or disease), which strictly follows the Mendelian inheritance pattern, 
typically comes from only single gene’s mutation that has extremely high penetrance 
(Collins, 2007). In contrast, complex traits (or complex diseases) are generally affected 
through genetic mutations at multiple loci across the whole genome, and each locus 
only contributes relatively low penetrance. There are also many other factors playing 
very important roles for complex traits, such as epigenetic effect, environmental 
regulation, Epistasis (interactions between genetic mutations at different loci), G× E 
interactions (interactions between genes and environment). Furthermore, complex traits 
are very common in our daily life, and have significant impact for the geneticists to 
improve the medical treatments and increase the economic performance in farming area. 
Two of the most popular methods (or strategies) for dissecting the genetic architecture 
of complex traits are linkage analysis and association study. Linkage analysis is the 
traditional method used to sketchily detect the co-segregation of a small genomic region 
and a trait of interest in families or pedigrees of known ancestry. On the contrary, 
association study is a precision and high-resolution method for mapping the casual 
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genes (or loci) underlying complex traits based on Linkage Disequilibrium (LD) in 
population(s). During last decades, both linkage mapping and association study have 
been widely applied for many complex traits (or diseases); and, of course, some historic 
findings have already been accomplished (Australia and New Zealand Multiple 
Sclerosis Genetics, 2009, Carlson et al., 2004, Easton et al., 2007, Fung et al., 2006, 
Giallourakis, 2003). 
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1.4  Genetic linkage and linkage analysis 
Genetic linkage represents the trend of two (or more than two) genes that are closely 
located with each other on the same chromosome to be co-inherited from one generation 
to another. For typically diploid species, such as human and most vertebrates, the 
meiosis reduces the genome to product haploid gametes through two cell division 
processes. However, the most important events, chromosomal recombinations, can take 
place during prophase I of meiosis. The recombination events exchange sections or 
fragments of chromosomes; hence genes on the same chromosome can be separated into 
different gametes. Therefore, the segregating families or pedigrees can be created. 
Furthermore, the frequency of recombination between two genes on the same 
chromosome relies on their genetic distance: if the two genes are separately located with 
long distance, the greater the chance that a recombination event could take place 
between them; in contrast, if two genes are closely located with each other on the same 
chromosome, the recombination may occur at fewer chance between them, and genes 
are thought to be linked together. The comprehensive understanding of the frequency 
and distribution of recombination events at the chromosomes is essential for linkage 
analysis. 
Linkage analysis is the traditional method used to explore the causal gene of the 
phenotypic trait. The basic principle of linkage analysis depends on the co-inheritance 
of the genetic polymorphisms and phenotypic trait of interest in segregating families or 
pedigrees. Among individuals from segregating families, a phenotypic trait (or disease) 
may occur randomly with some genetic polymorphisms, or correlatively with some 
genetic variants. In the former, the phenotypic trait is considered as be independent of 
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the genetic polymorphisms. However, the latter is identified as ‘genetic linkage’. It 
indicates that the causal gene underlying this phenotypic trait must be closely located to 
the linked genetic polymorphisms. The linkage analysis has been immensely successful 
for identifying the genes that control Mendelian traits (or diseases) (Jimenez-Sanchez et 
al., 2001). Because the Mendelian trait is, by definition, controlled by a single highly 
penetrant gene; genetic polymorphisms within 5-10 cM of the causal gene will be 
highly co-inherited with the phenotypic trait (or disease) status in segregating families 
(Hirschhorn and Daly, 2005). According to the tremendous success in mapping the 
susceptible genes of Mendelian diseases, the linkage analysis has also been applied for 
many complex traits, such as breast and ovarian cancers (Easton et al.), type I diabetes 
(Nistico, 1996) and heart diseases (Hauser and Boehnke, 1998). But, for most of 
complex traits (or diseases), linkage studies have only accomplished limited success 
(Altmuller et al., 2001), the genes which identified by the linkage analysis approaches 
generally explain only a small proportion of the total heritability of the complex traits. 
The lack of success can be contributed to several factors. Most importantly, linkage 
study needs the family-based samples, and the low penetrance of complex disease 
means that vast amounts of information are required during the analysing. However, the 
adequate size of family-based samples is not available in reality of many applications. 
Second, even if the candidate regions can be identified, the resolution of linkage studies 
is typically on the order of a few cM (usually 5-10 cM), which in terms of the organism 
genome may correspond to hundreds or thousands of genes. It is very difficult to 
precisely identify the causal gene from such large of candidate genes’ group. 
Furthermore, the linkage studies are also much less powerful for detecting the 
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susceptible genes that have modest effects on phenotypic traits (or diseases) (Risch and 
Merikangas, 1996, Risch, 2000).  
1.5  Linkage disequilibrium and association studies 
Recently, Linkage Disequilibrium (LD) has been considered as one of the most 
important topics in population genetics. Linkage disequilibrium generally refers to the 
‘non-random association of alleles’ at two (or more) linked and unlinked genes (or loci) 
in a population. The estimation of LD coefficient between genetic markers can offer 
useful information for identifying the alternative evolutionary patterns of genomic 
variations within or between populations (Lewontin and Kojima, 1960). The current 
stage of Linkage Disequilibrium (LD) based association mapping focuses on 
exploration of causal genetic polymorphisms (or mutants) of complex traits (or diseases) 
in plants, animals and human beings (Easton et al., 2007, Remington et al., 2001, Valdar 
et al., 2006). The key point of these analyses is the estimation or inference of LD 
between genetic polymorphisms and functional genes (or loci) that are genetically 
linked in short distance.  
1.5.1 Definition of LD 
Linkage Disequilibrium (LD) is not the same as genetic linkage, which represents the 
combination of two (or more) loci on the chromosome(s). In population genetics, LD 
represents the observed haplotype frequencies of alleles at two (or more) genetic 
markers less often or more often than would be expected based on their allele 
frequencies in a random mating population. Let us consider a simple two bi-allelic loci 
model: one locus affect a quantitative trait (QTL), and the other one is polymorphic 
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markers completely lacking of effect on this particular trait. These two alleles are 
represented by A and
 
a at QTL, by M and m  at genetic marker locus. The allelic 
frequencies for each allele at each locus are listed in table I.1 respectively.   
Table I.1: Allele frequencies of QTL and genetic marker 
Locus QTL Genetic marker 
Alleles A a M m 
Frequencies Af  af  Mf  mf  
Accordingly, the observed and expected haplotype frequencies of each combined alleles 
between QTL and genetic marker in a random mating population are shown in table I.2. 
Table I.2: Observed and expected haplotype frequencies for QTL and genetic marker 
Gamete M A  M a  m A  ma
 
Observed 
frequencies MA
f  Maf  mAf  maf  
Expected 
frequencies 
M Af f⋅  M af f⋅  m Af f⋅  m af f⋅  
Discrepancy M A M Af f f− ⋅
 
M a M af f f− ⋅  m A m Af f f− ⋅  m a m af f f−  
The discrepancy between the observed and expected frequencies of a haplotype is 
defined as Linkage Disequilibrium and generally abbreviated to ‘ D ’, 
i.e.
M A M AD f f f= − ⋅ , where M Af , Mf and Af are frequencies of gamete MA, alleles M 
and A in this population. This LD measurement indicates that: if the two loci (QTL and 
marker) are independently segregating in the population, the observed haplotype 
frequency of MA would equal to
M Af f⋅  hence 0D = ; on the contrary, if the alleles at 
QTL and marker are not independently segregating, the observed frequency of MA 
would not equal to
M Af f⋅  hence 0D ≠ . Although the linkage disequilibrium parameter 
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D  is easy to be estimated, the scale range of D  varies depending on the allele 
frequencies in the population. The theoretical maximum of D  can be given by:  
max
min( , (1 )(1 ))       when 0
min( (1 ),(1 ) )       when 0
MM A A
M A M A
f f f f D
D f f f f D
⋅ − − <
= 
− − >
. (I-5.1) 
The equation I-5.1 shows that the range of D  can be maximal (=0.25), only when the 
allele frequencies are 0.5 at both QTL and genetic marker loci. Thus, it is not easy to 
directly compare the linkage disequilibrium degrees across different loci due to the 
variation in scale. In 1964, Lewontin introduced a normalization method to divide the 
standard estimation D
 
by the theoretical maximum
m a xD : 
max
'
D
D
D
=         (I-5.2) 
After the normalization, the adjusted 'D  always varies from 0 to 1 irrespective of the 
different allele frequencies. 
Furthermore, the LD between two genetic loci in a population changes across different 
generations. In the random mating population without any evolutionary disturbance, 
such as selection, mutation, migration and genetic drift, the LD between two loci will 
progressively converge to 0 along the generations at a rate depending on recombination 
frequency r  between these two loci, 
1(1 )n nD r D −= −       (I-5.3) 
where 
nD
 
and 1nD −
 
are the LD at the thn  and ( 1)thn − generation, r denotes frequency 
of recombination between the two loci. After a large number of generations, only those 
closely linked loci, with small magnitude of r , can maintain a significantD. Based on 
this fact, the Linkage Disequilibrium (LD) is an ideal parameter to detect the genetic 
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association between markers and casual genes (or loci) of complex traits with high 
resolution. 
1.5.2 Genetic association studies 
Genetic association study is a statistical approach of identifying causal genes (or loci) 
regulating complex traits that employs the historic association (or LD) to link the 
phenotypic traits to genetic polymorphisms. As mentioned above, the association study 
is based on the idea that only the causal gene that is physically close to a genetic marker 
will still be retained in a relatively significant LD after a number of generations. In the 
last decade, there were many LD based studies attempted to map the genes that 
underlies complex traits (diseases). All of the mapping methods broadly fall into two 
classes: ‘candidate-gene studies’ and ‘whole genome studies’. 
The ‘candidate-gene’ based association study is hypothesis-based analysis. The 
‘candidate genes’ are selected for association mapping, either by their location in a 
genomic region that has been roughly identified via linkage analysis, or on the prior 
information that they might be related to the complex trait. And then, in a group of 
population-based samples, one can search and genotype one or several common genetic 
polymorphism(s) that are located within the candidate genes. Finally, the association 
study is applied to each of the genetic markers and complex trait. In the simplest form, 
association mappings contrast the allele frequencies of a particular genetic marker 
between case and control sampling groups to identify the gene that affects complex trait 
(Weir, 2008). Since then, many different statistical methods have been developed for 
association studies, such as Pearson 2χ test, Armitage’s trend test, linear regression 
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model and likelihood-based strategies for association mapping. Until now, the 
candidate-gene association mappings have confirmed a lot of genes which are already 
annotated to contribute to susceptibility of complex traits (diseases) (Hirschhorn and 
Altshuler, 2002, Lohmueller et al., 2003). But, candidate-gene association studies 
depend heavily on prior information, usually on particular biological assumptions or the 
location of the candidate genes within a previously identified region of linkage. So, if 
the prior information of complex traits (diseases) is unknown, the candidate-gene 
studies will obviously be unable to explore the genetic architectures of complex traits 
(diseases). 
Alternatively, whole-genome association study, also called as genome-wide association 
study, is an approach for examining genome-wide genetic polymorphisms in a group of 
population-based samples to identify whether any genetic marker is associated with a 
given phenotypic trait. Due to no assumptions have to be made about the location of the 
candidate genes, this strategy has to survey the whole genome or most of genome for 
causal genetic variants (or loci). Hence, the genome-wide association study provides a 
comprehensive option that can be attempted even in the absence of prior information 
regarding the genomic location of the causal genes.  
1.5.3 Advantages of association studies 
Compared with traditional linkage analysis, the association studies have several 
advantages (table I.3). First, linkage studies capture the co-inheritance of causal genes 
and adjacent genetic polymorphisms within family-based samples or pedigrees of 
clearly known ancestry. However, association study uses diagnosis of existing natural 
populations versus the need to generate a segregating population. So, it is feasible to 
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collect much larger samples for association mapping. Second, population-based samples 
in association study include historical recombination events and evolutionary 
segregations at the population level. The ancestry might extend to over thousands of 
generations. Therefore, the association study is more powerful for identifying causal 
genes (or loci) that have modest effect on complex trait. Third, in association studies, 
the mapping resolution is dramatically increased by use of high density genetic markers 
(e.g. SNPs); association analysis can offer a fine mapping resolution <1cM so that the 
candidate gene can be directly identified in small DNA sequence regions. It is an 
enormous improvement over the linkage studies where the candidate gene can hardly be 
narrowed down to such a resolution. Overall, the LD-based association study is a more 
precise and higher-resolution approach than traditional linkage analysis in dissecting the 
genetic architectures of complex traits. 
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Table I.3: Comparison between linkage and linkage disequilibrium based approaches to 
explore the causal genes for complex traits  
 Candidate-gene studies Genome-wide studies 
Potential advantages Linkage 
analysis 
Association 
mapping 
Linkage 
analysis 
Association 
mapping 
No prior information required     
location to small region  
(high resolution )     
Inexpensive   /  
Pedigree not required     
Power to detect common alleles of 
modest effect a / 
 /  
Ability to detect rare allele     
Tools for analysis available     
a
 Common allele: minor allele frequency >5%  
Symbols indicate whether the potential advantage in the left column applies complete 
(), weakly (/), not at all (). 
1.5.4  Population structure: A big challenge in association study 
However, the primary hindrance to successfully using association approach is 
underlying population structure among the collected samples. The significant 
association may be detected between two genetic markers that have no physical linkage 
with each other, when samples are collected from different populations.  
Population structure, also known as population stratification, represents the systematic 
variation in allele frequencies across subpopulations, due to different evolutionary 
histories and varied ancestry backgrounds. In 1988, Chakraborty and Smouse 
formulated the coefficient of linkage disequilibrium between two loci in admixed 
populations. Consider a structured population generated from instant admixture of two 
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genetically divergent random mating populations, the proportion of subpopulation 1 in 
the mixed population is denoted by m. There are two bi-allelic markers with alleles A, a 
and M, m respectively. In subpopulation i (i=1 or 2), the allele frequencies are denoted 
by ( )i
Af , ( )iaf  and ( )iMf , ( )imf
 
respectively. The linkage disequilibrium (LD) in each 
subpopulation can be expressed as:  
(1) (1) (1) (1)( ) A MD f AM f f= −      (I-5.4) 
(2) (2) (2) (2)( ) A MD f AM f f= −      (I-5.5) 
where (1) ( )f A M  and ( 2 ) ( )f A M are the haplotype frequencies of AM in subpopulation 1 
and 2. However, the LD between two genetic markers in the admixed population is 
given by: 
(1) ( 2 )
( )
(1 ) (1 )
adm ixed adm ixed A M
A M
D f AM f f
m D m D m m δ δ
= −
= + − + −
 (I-5.6) 
where (1) ( 2 )
A A Af fδ = −  and (1 ) ( 2 )M M Mf fδ = −  (Chakraborty, 1988). Equation I-5.6 shows that 
the coefficient of LD in admixed population is the summation of (a) a linear 
combination of the LD between the two loci in each of the subpopulations (i.e. the 
genuine LD between the two loci in each of the subpopulations), and (b) a nonlinear 
component of the difference in allele frequencies between the two subpopulations (the 
spurious LD). When these two genetic markers are actually in linkage equilibrium (LE) 
within each subpopulation ( (1) 0D =
 
and ( 2) 0D = ), LD in admixed population may still 
be observed due to the spurious term. And the magnitude of spurious LD is the product 
of the subpopulation proportions and the allelic frequency differences. During 
association studies, the spurious term in equation I-5.6 can seriously lead to both false-
positive and false-negative results if not correctly addressed. 
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To avoid this, one apparent way is to get some non-substructure samples, but 
unfortunately it is very hard for most of the time, especially when the sample used is 
fairly large. So how to remove the confound effect of population structure in association 
mapping is essential for an appropriate setting of GWAS. In chapter II, I will introduce 
a novel approach to control the confound effect in association studies. 
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1.6  Genetic markers and high-throughput genotyping technologies 
A genetic marker is a short section of DNA sequence with a known genomic location 
that can be used to describe polymorphisms and segregating individuals at the molecular 
level. The length of genetic marker can vary from single nucleotide base-pair (such as 
Single Nucleotide Polymorphisms) to several hundred nucleotide bases (Microsatellite 
polymorphisms), even as long as over thousand nucleotides for Minisatellite 
Polymorphic markers. No matter how long it is, the ideal genetic maker should have 
two characters. First, the genotyping process is very easy to be implemented and have as 
low an experiment cost as possible. Second, the genetic markers should be high-density 
and independently distributed across the whole genome. Due to the various molecular 
biology techniques, and to various biological information can be obtained, a series of 
genetic markers have been discovered. According to the types of information can be 
provided, genetic markers can be divided into three main categories: the bi-allelic 
dominant markers, such as Amplified Fragment Length Polymorphisms (AFLPs); the 
bi-allelic co-dominant markers, such as Single Nucleotide Polymorphisms (SNPs), 
Single Stranded Conformation Polymorphisms (SSCPs), Restriction Fragment Length 
Polymorphisms (RFLPs) and the multi-allelic co-dominant, such as Microsatellite 
Polymorphisms, Minisatellite Polymorphisms. Here, I briefly listed the biological and 
technical characters of these different types of genetic markers in table I. 4.  
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Table I.4: Main biological and technical characters of genetic markers 
Genetic 
marker Variants Density 
Genotyping 
accuracy 
AFLPs bi-allelic 
dominant Very Low Medium 
RAPDs bi-allelic 
dominant Very Low Very Low 
RFLPs bi-allelic co-
dominant High Very High 
SSCPs bi-allelic co-
dominant Medium Medium 
SNPs bi-allelic co-
dominant Very high Very High 
Microsatellite multi-allelic 
co-dominant Low High 
Minisatellite multi-allelic 
co-dominant Low High 
During last 20 years, the use of genetic markers has played a more and more important 
part in genetics researches. Among all available genetic markers, SNPs marker is the 
most popular. The great interest in SNPs has basically come from the recent 
requirement of very high-density genetic markers for genome-wide association studies 
to detect the casual variants of complex traits. As indicated by the acronym, a SNPs 
(Single Nucleotide Polymorphism) marker is only a single nucleotide base-pair 
mutation (or variant) in DNA sequence. This type of bi-allelic co-dominant markers 
widely and abundantly spreads across the complete genome. For example, in 
International HapMap Project, there are over 3.1 million SNPs markers identified in the 
human genome, when combining Phase I and II releases. In average, one SNP can be 
genotyped at every 1,000 nucleotide base-pairs. Furthermore, the recent development of 
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high-throughput SNPs genotyping technologies is another reason for the increasing 
popularity of SNPs. Compared with traditional genotyping procedure which involves 
PCR and denatured gel electrophoresis, the high-throughput SNP genotyping 
technology enables the genotyping procedure to be simultaneously implemented for 
hundreds of thousands of candidate SNPs, which has made the whole genome-wide 
association mapping in complex traits to be practised for the first time. 
1.6.1 Genotyping SNP markers using microarray platforms 
During the last decade, there is a revolution occurring in SNPs genotyping technology: 
the microarray is able to accurately genotype hundreds of thousands of SNPs in large 
cohort studies. Currently, this type of high-throughput genotyping technology has been 
commercially developed by many biotech companies (table I.6). All of the different 
commercial microarrays can detect as many genetic polymorphisms as can be designed 
on the array and are easily applied to automatic running (Grant and Hakonarson, 2008). 
In this section, I focus on the Affymetrix technology and briefly review how the 
microarray accurately genotypes a large number of SNPs at once (other different 
commercial microarray genotyping technologies are not discussed here but has been 
listed in table I.5).  
In Affymetrix platform, the input DNA sequences are cut by the restriction enzymes 
StyI and NspI and bound to adaptors that recognize the 4-bps overhangs. All DNA 
segments represent substrates for adaptor ligation; a generic primer that can tie to the 
adaptor sequence is used to amplify these DNA segments. PCR technique has been used 
to preferentially amplify fragments in the 200 bps to 1100 bps size range. And then, the 
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amplified DNA fragments are fluorescently labelled, and hybridized to an Affymetrix 
DNA genotyping microarray. The chips are washed and scanned automatically; the 
genotypes are analyzed using standard algorithm GeneChip Genotyping Analysis 
Software (GTYPE) which developed by the Affymetrix company 
(http://www.affymetrix.com/support/technical/index.affx). The more detailed 
information can be learned from www.affymetrix.com.  
Table I.5: Commercially available high-throughput genotyping platforms 
Company Detection method No. SNPs detected 
simultaneously 
Affymetrix Fluorescence; hybridization to array 10,000~100,000 
Illumina Fluorescence; tags on bead-array 100,000+ 
ABI Fluorescence; gel electrophoresis 200,000 
Parallele Fluorescence; tags on array 10,000 
Sequenom Mass spectrometry 1,000 
Perlegen Fluorescence; hybridization to array 100,000+ 
Third Wave Fluorescence; plate reader few 
 
1.6.2 Discovering and genotyping SNPs based on NGS technologies 
Over the past decade, several advanced ‘high-throughput’ sequencing technologies, 
called Next Generation Sequencing (NGS), have been developed and applied for a 
variety of applications (Metzker, 2010). These new sequencing methods are able to 
sequence large and complex genomes much faster, cheaper and more accurate than 
previous methods, for example Sanger sequencing. A common theme of these NGS 
platforms is that the whole-genome wide sequences are sheared into small pieces (200-
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300 bps), and then the fragments are fixed or attached to a solid support. The fixation of 
independent fragments into different sites allows more than millions of sequencing 
reactions to be carried out simultaneously. The resulting data of these new methods 
consists of millions of short-piece reads (30-200 bps) from unknown locations in the 
genome. Analysis of these datasets brings an unprecedented computational and 
informatics challenge, both because of the large amounts of short-reads that the new 
platforms can generate, and because the length of reads is significantly shorter than 
previously generated from traditional methods. The statistical methods for assembling 
(or aligning) short-reads have been developed over the last 4 years, and while some of 
the short-read mapping problems are now available in form of computer software. 
Meanwhile, it has seen an accelerating flurry of publications in which the NGS platform 
is widely applied for a variety of studies. One of the most important applications is the 
whole genome-wide sequencing, and then identifying mutations or genetic 
polymorphisms, such as SNPs. 
From 2008, a series of programs have been developed for identifying SNPs based on 
NGS sequencing data, such as SOAPsnp (Li et. al, 2009), MAQ (Li et. al, 2008), 
SAMtools (the most widely used) (Li et. al, 2009). The most serious challenge for SNP 
identification lies in inferring the likelihood that a nucleotide position is a homozygous 
or heterozygous variant given the error ratios of the differential platforms, the 
probability of incorrect read alignment, and the depth of coverage. The SNP discovery 
analysis after the alignment generally has a standard procedure in which it filters the 
mapped short-reads and re-scores the nucleotide base quality values, then followed by a 
consensus genotype calling step through a Bayesian model. The Bayesian model is to 
compute the conditional probabilities of the genotype at each nucleotide position: 
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( ) ( )( ) ( )
P R G P G
P G R
P R
= . This equation shows that one can infer the probability of a 
particular genotype G given the observation data R (posterior) given the overall 
probability of that genotype (prior probability) and the probability of observation data R 
from this genotype. The details of Bayesian approach have been implemented in MAQ 
consensus genotype calling section (Li et. al, 2008). Although all of the SOAPsnp, 
MAQ and SAMtools methods use the same Bayesian model to detect SNPs, they are 
widely diverse in the details and use different interpretations of statistics. For assigning 
a posterior probability of a certain genotype, MAQ and SAMtools calculate a 
probability of observing the given read and base quality values for each genotype prior 
via a binomial distribution; meanwhile, SOAPsnp computes the probability based on 
various characters of the reads. Finally, the SNPs are identified through comparing the 
consensus genotype calling results with reference sequence. It is believed that NGS 
technology will be widely applied to this purpose in the near future. 
1.6.3 Prediction of genetic polymorphisms from expression microarray dataset 
With the development of the microarray technology, the markers’ genotyping and their 
chromosomal locations can be simultaneously implemented with the expression data in 
expression microarray experiments. The ability to identify sequence polymorphisms 
from gene expression microarray data has useful implications in at least two aspects. 
First, it improves both accuracy and precision in calculating gene expression indices by 
excluding probes containing genetic polymorphisms, while in turn, improving the 
statistical power of eQTL analysis (Alberts et al., 2007). Second, it enables the 
concomitant generation of an abundant collection of reliable genetic markers that can be 
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used as the framework for subsequent eQTL genetic analysis (Luo et al., 2007, Borevitz 
et al., 2003).  In 2003, a type of marker called ‘Single Feature Polymorphism (SFP)’ has 
been derived from Affymetrix expression microarray experiments (Borevitz et al., 2003). 
To distinguish hybridization signals associated with any molecular alteration from 
background, the signals generally need to be collected from the sequences where 
mutation occurs. The probe-set design of Affymetrix microarrays perfectly meets this 
need. Statistical methods have been developed to detect polymorphisms between target 
sequences and probes by testing for non-uniformity of hybridization intensity among 
every feature in a probe-set for a given gene. The principle for RNA based templates is 
an extension of that described by Winzeler et al. (1998) who pioneered in the 
development of a high-throughput genotyping platform by hybridization of labelled 
total genomic DNA to oligonucleotide arrays.  
By attempting to integrate genetic polymorphism screening and gene expression 
analysis, (Wang et al., 2009)proposed a Bayesian statistical approach for detecting 
SFP’s in transcript sequences and for predicting SFP genotypes when tested in a 
segregating population derived from genetically divergent parental lines.  This was 
achieved by modelling a perfect match value from Affymetrix cRNA hybridization 
experiments as a product of the binding affinity between the transcript and probe 
sequences and the abundance of the transcript. They analyzed two independent 
microarray datasets (RNA hybridisations from barley and yeast) and demonstrated that 
their method provided significantly improved robustness and accuracy for predicting 
SFPs reflecting genuine sequence polymorphism, when compared to five other 
statistical methods. Their method was appropriate for predicting SFPs from expression 
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microarray data and from genomic DNA microarray data.  By comparing predicted 
SFPs to those where sequence information was available, they showed that all the 
methods applied stringent selection criteria to call SFPs and thus only a small fraction of 
probes were called as SFPs. The approach effectively maintained both false positive and 
false negative rates at a low level.  
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1.7 Gene expression process 
Gene expression is a complicated biological process in which the heritable information 
units stored in the genome, called genes, are used to synthesize the functional products 
(Khaitovich et al., 2006, Hegde and Kang, 2008, Kuznetsov et al., 2002, Schwanhausser 
et al., 2011, Tomilin, 2008, Xu et al., 2007). In genetics, gene expression process plays 
an essential role through which the genotype leads to the phenotype: the genetic 
information conserved in the DNA sequence can be exported through expression 
process, and then the products of gene expression will guide the phenotype of organisms 
(Brawand et al., 2011, Robertson, 2010, Tuch et al., 2008). Briefly, gene expression has 
two major steps (figure I.1): a) from DNA sequence to mature RNA molecule—
Transcription process; b) from mature RNA to protein product—Protein Synthesis. 
In the transcription process, each gene is separately transcribed to create a primary RNA 
molecule with essentially the complementary copy of the original DNA sequence (Gnatt 
et al., 2001, Clancy, 2008a). In most eukaryotes, the gene usually contains both exons 
and introns, and only the exons store the functional information for further biological 
processes. Thus, the primary RNA sequences need to be modified by several RNA 
processes, such as splicing, to remove the introns and produce mature RNA molecules 
or messenger RNAs (mRNAs) which only contain exons (Nilsen and Graveley, 2010). 
The mature transcription product can be directly used as micromolecular machinery for 
life, such as ribosomal RNA (rRNA), transfer RNA (tRNA), microRNA and siRNA; or, 
it is considered as intermediate, messenger RNA (mRNA), to be further translated into 
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protein product (Yusupova et al., 2001, Smith and Shaw, 2008, Clancy and Brown, 
2008). 
The second step of gene expression is protein biosynthesis. As there is no direct 
commensurateness (or correspondence) between the nucleotide sequence of RNA 
molecule and the amino acid sequence of protein, the messenger RNA has to be 
translated into amino acids (Clancy and Brown, 2008, Laursen et al., 2005). During 
translation, each three nucleotide bases of an RNA sequence generated by transcription 
is deciphered by the ribosome to yield a specific amino acid; hence a complete 
messenger RNA molecule can be decrypted into an amino acid chain, also called a 
polypeptide chain (Watson, 1963). And then, the amino acids in a linear chain will 
interact with each other to fold into a three dimensional (3D) structure (Steitz, 2008). 
The appropriate 3D structure is essential for the protein to preserve its biological 
function and activity (Panse and Johnson, 2010). Finally, the structured proteins need to 
be transported to some parts of cells (or tissues, organs) where they are supposed to be 
(Yusupova et al., 2001, Clancy and Brown, 2008). 
The gene expression process is an efficient system for interpreting the genetic 
information into functional products. Furthermore, the expression of a gene can be 
regulated in every step, from primary transcription, RNA processing, to translation and 
post-translation modification (Robertson, 2010, Mattick et al., 2009, Hegde and Kang, 
2008). The regulation of gene expression allows organisms to control how the genetic 
information is used. Overall, gene expression and its regulation are fundamental 
processes for organisms to maintain their biological behaviours and life (Khaitovich et 
al., 2006). 
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Figure I.1: Diagrammatic illustration for the process of gene expression 
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1.8 Gene transcription 
Transcription is the first fundamental step of the gene expression process, which can 
produce an RNA copy based on the genetic information of a functional gene 
(Khaitovich et al., 2006, Gnatt et al., 2001, Clancy, 2008a, Clancy, 2008b, Bell and 
Jackson, 1998). Since both RNA and DNA molecules are nucleic acid sequences, the 
DNA sequence can be directly read by appropriate RNA polymerases, and then 
converted into an exactly anti-parallel nucleotide sequence. During transcription, DNA 
sequence is read and transcribed from 3’ to 5’ direction; whereas, the RNA sequence is 
produced from 5’ to 3’ end (Clancy, 2008a). Although DNA molecule is structured as 
two anti-strands in double helix format, only one strand, referred to as the ‘template 
strand’, can be transcribed. Meanwhile, the other unused strand is referred as the 
‘coding strand’, because its nucleotide codes are the same as the produced RNA 
sequence (Clancy, 2008c). The transcription process is very highly similar with DNA 
replication. The most obvious difference is that the nucleotide sequence in RNA 
molecule uses uracil (U) to substitute all thymine (T) during transcription.  
The primary transcription products can be divided into two groups for further processes 
(Watson, 1963, Clancy, 2008b, Ralston and Kenna, 2008). If genes encode for some 
non-coding functional RNAs, the primary transcripts need to be converted into mature 
RNAs via several RNA processes. Alternatively, the majority of genes in the genome 
are protein-coding genes. The transcripts from these genes will then produce proteins 
through the translation processes. However, the primary transcription products includes 
not only the coding sequences that will be decoded into proteins (exons) but also some 
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other sequences, such as the untranslated regions at both 5’ and 3’ends (termed as 
5’UTR and 3’UTR), introns and poly-A end. The untranslated regions at both 5’ and 
3’ends have been identified as regulatory sequences that do not translate into protein but 
play important roles for regulating both transcription and protein synthesis (McCarthy, 
1998). And the introns need to be removed from messenger RNAs via a process of 
splicing (Nilsen and Graveley, 2010). Therefore, gene transcription is a complex but 
accurately regulated process. Briefly, the transcription procedure can be summarized in 
6 stages: pre-initiation, initiation, promoter clearance, elongation, termination and RNA 
processing (splicing). 
1) Pre-initiation: in both prokaryote and eukaryote organisms, each gene contain a 
small but essential element— ‘promoter’. The promoter region is a stretch of 
DNA sequence that will facilitate the transcription for this particular gene. 
Typically, the promoter is located at upstream of the gene which it controls. 
Furthermore, the core region of a promoter is the minimal section of the 
promoter required to precisely start the transcription process, which is usually 
found at around 100 nucleotide bps upstream from the transcription start site of 
the gene (Kim et al., 1997, Smale and Kadonaga, 2003). At the beginning of 
transcription, the appropriate RNA polymerase needs to bind with the core 
promoter region to start transcription process (Kornberg, 2007). However, in 
eukaryote species, the RNA polymerase cannot directly identify the core 
promoter regions (Lee and Young, 2000). Alternatively, several proteins, termed 
as transcription factors, will assist the binding of RNA polymerases. The core 
promoter regions in eukaryotes usually contain signal boxes, such as TATA box 
(Maston et al., 2006). The TATA box is the binding site of a particular 
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transcription factor (TATA-binding protein) (Ouhammouch et al., 2003). The 
TATA-binding protein is also a medium of another transcription factor 
(transcription factor IID). After the transcription factor IID binds to TATA box 
through TATA-binding protein, the appropriate RNA polymerase can recognize 
and bind with the core promoter to generate a Pre-initiation Complex. While, in 
prokaryotes, the RNA polymerase can directly recognize and bind with the 
signal box (Pribnow box) in core promoter regions to initiate the transcription 
(Schaller et al., 1975). 
2) Initiation: after the RNA polymerase binding to the core promoter region, the 
transcription process can be initiated immediately (Clancy, 2008c). For 
eukaryotes, there have three different types of RNA polymerases, and each of 
them can only bind to the core promoter regions of particular genes: RNA 
polymerase I only recognizes the core promoter region of ribosomal RNA genes; 
the RNA polymerase II can bind with both protein–coding genes and some non-
coding RNA genes, including snRNA, snoRNA and long non-coding RNA; 
RNA polymerase III is responsible for 5S rRNA and transfer RNA genes (Lee et 
al., 2004, Hurwitz, 2005, Grummt and Kivie, 1998, Willis, 1993). However, in 
prokaryotes, it has only one type of RNA polymerase, which can initiate the 
transcription process for all types of genes (Ebright, 2000).  
3) Promoter clearance: when the first nucleic acid of transcription sequence is 
synthesized, the RNA polymerase may be cleaved from the promoter region (Pal 
et al., 2001). At this time, the RNA transcript is possibly to be slipped, hence 
creates a truncated transcripts. This phenomenon is referred as abortive initiation, 
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which may take place in both prokaryote and eukaryote species. An enzyme, 
called σ factor, can keep off the abortive initiation and result in the transcription 
elongation complex. When the transcript sequence is synthesized over 30 
nucleotide base pairs, it will not ever slip and elongation process will continue. 
4) Elongation: at this step, the corresponding RNA polymerase covers the template 
strand of DNA sequence and follows the complementary roles 
( , ,  a n d  A U C G G C T A⇒ ⇒ ⇒ ⇒ ) to produce a copy of RNA 
sequence (Reines et al., 1999, Nudler, 1999). Unlike DNA replication process, 
the RNA transcription can be engaged by more than one RNA polymerase on a 
single template strand, hence several rounds of transcription can occur 
simultaneously and a large amount of RNA molecule products can be rapidly 
generated from a particular gene. Furthermore, the elongation also has a ‘proof-
reading’ mechanism which can check and substitute the incorrectly transcribed 
nucleotide bases (Yan et al., 1999). 
5) Termination: the transcription process stops when the RNA polymerases reach 
the terminator region (Richardson, 2002). The transcription terminator is a 
stretch of DNA sequence that labels the end of gene for transcription process. 
The transcription termination is a complex step in eukaryote organisms, and so 
far little is known about this process. However, at the end of termination, it 
commonly involves a process called polyadenylation, which adds a 
polyadenylation signal sequence (5’-AAUAAA-3’) at the 3’ end of the newly 
created transcription product (Connelly and Manley, 1988). 
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6) RNA processing: in prokaryotes, the transcripts produced via above steps are 
ready for directly being translated into protein. However, the primary transcripts 
in eukaryotes have to experience a series of RNA processes or modifications to 
become stable and mature RNA molecules, including splicing, 3’ cleavage 
(Proudfoot et al., 2002, Guhaniyogi and Brewer, 2001). The most important 
RNA process for primary transcripts is RNA splicing. Nearly all of the primary 
transcripts in eukaryotes consist of both exons and introns DNA sections. During 
RNA splicing process, a protein complex, called as spliceosome, can cut the 
introns and joint the neighbouring exons together (Black, 2003, Matlin et al., 
2005). In some situations, some exons segments can also be removed from 
transcription sequence. It is referred as ‘alternative splicing’, which can create 
different protein products from only a single gene. Thus, the ‘alternative 
splicing’ extends the variant and complexity of gene transcriptions. Another 
RNA process is 3’ end cleavage. It takes place when the polyadenylation signal 
sequence presents at the 3’end. In this process, the primary transcripts are 
cleaved the polyadenylation signal sequence and then added poly A (around 200 
adenines) tails at 3’ end to protect the RNA molecules from degradation. 
Moreover, the poly A tail can be bound by several poly A-binding proteins for 
assisting the RNA export and translation re-initiation. Finally, the mature RNA 
molecules have to be transported from the nucleus into cytoplasm for the 
following protein synthesis.  
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1.9  Expression quantitative trait loci (eQTLs) analysis   
Expression quantitative trait loci (eQTLs) are those genetic loci detected by 
implementing the traditional quantitative trait loci (QTL) analysis to data on the 
expression level of genes in samples taken from different individuals (tissues or cell 
lines) in a random mating population or populations with other different segregation 
structures. Transcript abundance can be analyzed as a complex trait just like other 
traditional phenotypes such as weight or height. Usually, gene expression information 
could be simultaneously extracted for most (or all) of genes over the whole genome, and 
hence there are normally over thousands of gene expression traits recorded in a typical 
gene expression profile using microarray or sequencing techniques. 
Similar to the traditional phenotypic quantitative trait loci (pQTL) analyses, eQTL 
analysis needs high-density genetic markers which can be genotyped in all collected 
samples and constructed the whole genome (or genome wide) genetic variation profile 
for each sample. These markers’ genotyping and their chromosomal locations can be 
investigated in the selected samples before the eQTL study or can be simultaneously 
developed with the expression data in expression microarray experiments. High quality 
genetic marker information is one of the key components of such studies, determining 
the quality of eQTL analyses, and allows exploring the impact of genetic variation on 
physiological processes through transcriptional regulation networks (Sieberts and 
Schadt, 2007). The eQTL studies are ultimately to test for genetic association between a 
specific genetic markers and the expression level of the interested gene. The 
significance of the genetic association can be reported as the probability values (P-value) 
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of a null hypothesis test, the Log Odds (LOD) score or Likelihood-Ratio (LR) of a 
likelihood function. The values of the test statistic (P-value, LOD score or LR) need to 
reach a prior given significance level depending on the sample size, population structure 
and the proportion of non genetic variation for the trait. The significant eQTLs indicate 
the genetic polymorphisms in these candidate genetic loci (or genes) have a high 
confidence to cause the observed variation in gene expression level across samples.   
Generally, eQTL can be classified into two groups: cis-acting eQTL and trans-acting 
eQTL. In the former, the DNA sequence polymorphism regulating expression level is 
assumed to be regulated by the genetic polymorphism that locate within or in the close 
proximity of the gene. In term of classical molecular genetics, such DNA sequence 
polymorphisms are called cis-elements; hence a cis-acting eQTL is in harmony with the 
location of the gene under question. In the case of trans-acting eQTL, the location of the 
identified eQTL does not coincide with the location of the corresponding target gene. 
Genes underlying trans-eQTL are assumed to encode trans-acting factors – typically the 
proteins, by binding to cis-elements of other genes, which regulate their mRNA 
expression levels. Such trans-acting eQTL could, for example, represent the location of 
a transcription factor that regulates the expression of the binding target alone or, 
potentially, several functionally related genes. In reality, the expression level of a 
particular gene can be regulated by a combination of both cis- and trans-acting elements. 
It must be punctuated that all eQTL studies rely on the genetic association between 
markers and gene expression trait in these particular samples under study. Different 
samples (or populations) may involve different eQTLs; hence the absence of eQTL for a 
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gene expression trait in a group of collected samples does not indicate that eQTL for 
that particular gene’s expression trait does not exist in other samples (or populations). 
1.9.1 A frame work of eQTL analysis 
A high quality of eQTL analysis should precisely dissect the genetic architecture of the 
gene expression variation as a phenotypic trait in a relatively high-resolution. It can 
have three origins as follows: the gene expression profile accurately extracted for each 
sample, the high density genetic markers to comprehensively describe the genome-wide 
genetic polymorphisms for corresponding individuals and appropriate genetic 
association strategy to integrate these two sources of information into eQTL analysis. 
First, gene expression levels are assayed as the steady-state abundance of mRNA 
transcripts that have been extracted in a specific sample (tissue or cell line) and at a 
specific time point. The transcript abundance can be measured using a variety of 
techniques from quantitative Reverse Transcription Polymerase Chain Reaction (RT-
PCR) (Czechowski et al., 2004), through gene expression microarrays (Schena et al., 
1995) to Next Generation Sequencing (NGS) technology (Wall et al., 2009). When 
expression levels of a particular gene are identified for all collected samples, the 
observed variation in expression level for this gene may be recognized as a heritable 
quantitative trait that can be applied to association mapping for dissecting the genetic 
architecture at the molecular level. Meanwhile, the accuracy of mapping eQTL also 
depends on the high density and precisely genotyped genetic polymorphisms. Until 
now, there are many different types of genetic markers have been developed, such as 
Simple sequence length polymorphism (SSLP), Restriction fragment length 
  
36 
 
polymorphism (RFLP), Amplified fragment length polymorphism (AFLP), 
Microsatellite polymorphism and Single nucleotide polymorphism (SNP). Among these 
genetic markers, Single Nucleotide Polymorphism (SNP) has obtained the most 
widespread interest. Because SNPs are highly abundant, and are generally estimated to 
occur at one out of every 1000 bases in the human genome (Sachidanandam, 2001, 
Venter, 2001). Currently, with the development of biological techniques, several high-
throughput DNA genotyping platforms enable quick and efficient generation of high 
quality and density SNP markers over the genome under study. 
The major challenge of eQTL analysis is how to model and identify the regulators of 
genome-wide gene expression using such high-dimensionality and complex dataset. 
Virtually, eQTL analysis shares the same statistical principles and approaches as 
conventional QTL analysis (Lan et al., 2003). 
1.9.2 Extracting genome wide gene expression profile for eQTL mapping. 
Rather than focus on a single gene, an eQTL analysis typically involves high-
dimensional expression profile of genes in the whole genome (Jansen and Nap, 2001). 
Although many platforms are suitable for simultaneously measuring the genome wide 
(or whole genome) gene expression abundances, microarray technology is the most 
popular choice nowadays. Despite the Next Generation Sequencing technology reveals 
several improvements for constructing transcriptome, the expensive cost limits the 
application of NGS technology to small sample size. I tabulated in table I.6 the 
commercially available expression microarray platforms, where the Affymetrix 
GeneChip microarray and custom Agilent microarrays are commonly used (Close et al., 
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2004). The basic detection units of Affymetrix expression microarrays are 25-base long 
oligodeoxy-nucleotide probes that are synthesized at specific locations on a coated 
quartz surface by photolithography 
(http://www.affymetrix.com/about_affymetrix/outreach/educator/microarray_curricula.a
ffx#1_1).  Each unique 25-mer probes’ group is called a feature. Over a million features 
per microarray are usually available for synthesis, allowing multiple (typically from 11 
to 22) probe-pairs per gene (the probe set).  Generally, a typical Affymetrix GeneChip 
microarray enables to simultaneously measure ~20, 000 genes’ expression levels.   
In contrast, the basic detection units of Agilent expression microarrays have 60-base 
long oligodeoxyribo-nucleotides that are printed on glass slides using Agilent’s 
proprietary SurePrint™ technology. Currently, the Agilent’s commercially available 
chips generally contain either 1 x 244K, 2 x 105K, 4 x 44K or 8 x 15K probes. The 
Agilent gene expression platform is fully customizable; ready-to-go probes can be 
ordered to be synthesized on the slide, or alternatively custom sequences can be used to 
design probes by ‘eArray’, an online probe design tool 
(http://www.chem.agilent.com/enUS/products/instruments/dnamicroarrays/pages/gp506
60.aspx). An extensive pool of pre-designed probes is also available from the eArray 
depository.  Experimental design using Agilent microarrays can incorporate either a 
two-dye labelling protocol or single-dye labelling. Currently, the typical Agilent 44K 
microarray enables measure over 40,000 genes’ expression levels at the same time. 
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Table I.6: Commercially available parallel, high-throughput gene expression analysis platforms. 
Company Detection method No. of probes per gene Probe length 
No. of 
channels 
No. of genes detected 
simultaneously 
Affymetrix 
 
Fluorescence; 
hybridization to array 
Multiple 
(10-20 pairs) 25 mer 1 10,000~100,000 
Agilent Fluorescence; hybridization to array Single 60 mer 1 or 2 15,000~244,000 
Nimblegen Fluorescence; hybridization to array 
Multiple 
(up to 20) 45-60 mer 1 or 2 10,000~100,000 
Illumina Fluorescence; tags on beads Single 50 mer 1 10,000+ 
ABI Fluorescence; gel electrophoresis Single 60 mer 1 10,000+ 
Sequenom Mass spectrometry Single 60-90 mer 2 Up to 1000 
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When choosing a microarray platform, one has to consider the genome presentation, 
analysis performance and experiment at costs. Usually, Affymetrix arrays are in 
principle more reliable than the Agilent platform because every gene on Affymetrix 
arrays represented by a multiple probes-set. However, relatively lower genome coverage 
and higher product cost can counterbalance its detection advantage. Agilent’s flexible 
customization could also, of course, be used to design a cheap multi-probe array. 
Similar microarray platforms are either commercially available for most model species 
or can be easily produced for any species with available EST database using the 
flexibility of the Agilent (or other vendors) approach. 
Recently, Next Generation Sequencing platforms, such as Roche/454, Illumina’s Solexa, 
Life/APG SOLiD, Polonator and Helicos/BioSciences, offer an increasingly attractive 
alternative for digital gene expression measurement (Wall et al., 2009).  Despite the 
relatively expensive cost at the moment, these platforms offer the opportunity to analyze 
any species – with or without a genome reference sequence – using a high-throughput 
strategy that enables measure the abundance of all transcripts in a given sample. 
Although there are only a few eQTL analysis published to date using this approach, it is 
highly likely that NGS application in RNA level (RNA-seq) will be widely utilized for 
this purpose in the near future.   
If the researchers extract the gene expression profiles from several different platforms, 
an important question subsequently rises up that how consistently gene expression can 
be achieved from different technical platforms. It has been documented that commercial 
microarrays are more technically consistent than non-commercial microarrays (Chen et 
al., 2007, Coughlan et al., 2004) and that one-dye platforms are typically more 
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consistent than two-dye platforms (Kuo et al., 2006). I compared the expression of 
15,208 barley ‘unigenes’ profiled using Agilent one-dye and two-dye microarrays with 
that of the same group of genes from Affymetrix microarrays (unpublished results). I 
observed a significant discrepancy between the expression levels evaluated from the 
two types of microarray. Correlation coefficients in estimated expression indices were 
as low as 65% among the different platforms and the one-dye system generated a higher 
level of concordance than the two-dye system. The poor performance of consistently 
gene expression measurement was not only observed across different microarray 
platforms, but also found in the same platform using different statistical methods to 
extract expression levels. In 2008, I explored seven main stream methods developed for 
extracting gene expression levels from Affymetrix microarray datasets in both yeast and 
barley and found that these methods can be divided into two clusters (Jiang et. al, 2008). 
The methods within each cluster show correlation coefficients of ≥95%, but the 
correlation is reduced to ~70% between the two clusters. Furthermore, the number of 
genes identified to be ‘significantly differentially expressed’ between the same group of 
genes varies substantially among the different extraction methods when subject to the 
same significant threshold or rate of false positives (Storey and Tibshirani, 2003).  
1.9.3 eQTL Hotspots 
Almost all eQTL analyses reveal that eQTL are not evenly distributed across the whole 
genome (Breitling et al., 2008, West et al., 2007, Gilad et al., 2008, Wei et al., 2007).  
When eQTLs are enriched in a specific genomic region more than expected by chance, 
this genomic region can be considered as ‘an eQTL hotspot’. This type of eQTL hotspot 
is generally of functional interest. A biologically meaningful eQTL hotspot would 
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represent, for example, the location of a master transcriptional regulator that controls the 
expression of a group of genes that may link each other in the same biological process 
or pathway.  
When eQTL studies are implemented in different samples using same treatments or 
tissues (cell lines), the expectation is that consistent eQTL hotspots should be observed. 
They would reveal the same biological pathways.  eQTL studies applied in the same 
samples but using different treatments or tissues (cell lines) should however yield 
complementary results, reflecting the dynamic nature of the transcription process.  For 
example, Potokina et al. (2008) observed several regions on chromosomes 2H, 5H and 
7H which had many more eQTL than expected by chance alone based on a uniform 
distribution of genes per cM, using microarray profiles of genome-wide gene expression 
from germinating embryos of barley species. Interestingly, in the same population using 
Puccinia hordei infected seedling leaves 18 hours post infection, eQTL hotspots on two 
different chromosomes 1H and 3H, were observed. In the former, some eQTL hotspots 
did however correlate with the known location of ‘malting quality’ QTL (a trait 
expressed and measured in this tissue), while in pathogen challenged tissues at least 2 of 
the 3 hotspots were enriched for mRNAs related to general ‘pathogen responsive 
genes’. While such observations provide a potential opportunity to unravel the genetic 
regulation mechanisms of important phenotypic traits, in general, these types of study 
are currently at a very early stage.  
1.9.4 An important application of eQTL studies 
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The long-term objective of eQTL association mapping is to explore how genotypic 
variation underlies morphological or physiological consequences by using gene 
expression levels as intermediate information in molecular level. It means eQTL studies 
can offer useful information to identify the causal loci for conventional complex traits, 
particularly when the biologists try to understanding the molecular mechanism of the 
aetiology and provide new therapeutic targets for complex diseases. For most complex 
diseases, both morphological and physiological phenotypes which used to represent the 
characters of diseases in association studies are usually the outcomes of many different 
genes, which may interact with each other and with environmental factors. On the other 
hand, there might be many other unanticipated covert phenotypes that are also 
segregating. But, this wealth of information would be missed without additional specific 
phenotype assays. 
A typical gene expression profile dataset contains the transcription abundance for whole 
genome or genome-wide genes. The enormous gene expression abundance information 
can be used as intermediate molecular phenotypes to explore the genetic basis of 
complex traits in association studies. First, one needs to identify several ‘candidate 
genes’ that correctly represent the complex traits under question. Then, these candidate 
genes would be quickly applied for eQTL studies and easily further analysed for 
understanding the genetic basis of relative complex traits (diseases). 
A straightforward strategy to determining a ‘candidate gene’ for a given phenotypic trait 
of interest is to correlate this phenotypic trait values with expression levels of all 
detectable genes. The analysis constraint is that the same genetically fixed samples have 
been used to obtain both the trait and gene expression levels. A correlation study returns 
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a list of correlates (genes) and their respective correlation coefficients. Correlates with 
the highest absolute correlation coefficient can be potentially used as intermediate 
molecular traits to dissect the genetic architecture of phenotypic trait. Logically, most 
highly correlated eQTL should fall into the region containing the phenotypic QTL. 
Correlation analysis is of course only the first step, and offers an overview of potential 
genes related to a trait. Further analysis involves the putative functions of the correlated 
genes and whether there are multiple coinciding eQTL, or hotspots, that may indicate 
that the causal gene is a trans-acting ‘master regulator’.  If such eQTL hotspots 
predominantly consists of trans-eQTL that have annotations from previous studies 
suggesting some form of functional relatedness, then a master regulatory locus may be 
inferred. Such a locus has been hypothesized on barley chromosome 2H where a 
putative regulatory ‘master locus’ affecting the expression of other genes associated 
with programmed cell death (PCD) has been proposed (Druka et al., 2008). When 
making such inferences, particularly in small sample size, it is important to exclude the 
possibility that chance co-segregation is responsible for the correlation. 
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Chapter II 
Developing a robust statistical method  
for association-based  
expression quantitative trait analysis 
2.1 Related publication 
Jiang N, Wang M, Jia T, Wang L, Leach L, Hackett C, Marshall D, Luo Z. (2011) A 
robust statistical method for association-based eQTL analysis. PLoS One, 6(8): e23192. 
Please see Appendix III for a copy of this article as it appeared in print. 
2.2 Overview 
It has been well established that theoretical kernel for recently surging genome-wide 
association study (GWAS) is statistical inference of linkage disequilibrium (LD) 
between a tested genetic polymorphism and a putative locus affecting a complex trait. 
However, a fundamental problem in such studies is the existence of population structure 
because it can lead to artificial associations, even within relatively homogeneous 
populations. Whilst many methods have been proposed to correct for the influence 
either through predicting the structure parameters or correcting inflation in the test 
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statistic due to the stratification, these may not be feasible or may impose further 
statistical problems in practical implementation. I propose here a novel statistical 
method to control spurious LD in GWAS from population structure by incorporating a 
control marker into testing for significance of genetic association of a polymorphic 
marker with phenotypic variation of a complex trait. The method avoids the need of 
population structure prediction which may be infeasible or inadequate in practice and 
accounts properly for varying effects of population stratification on different regions of 
the genome under study. Utility and statistical properties of the new method were tested 
through an intensive computer simulation study and an association-based genome-wide 
mapping of expression quantitative trait loci in genetically divergent human populations. 
The analyses show that the new method confers an improved statistical power for 
detecting genuine genetic association in subpopulations and an effective control of 
spurious associations stemmed from population structure when compared with other 
two popularly implemented methods in the literature of GWAS. 
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2.3 Introduction 
Linkage disequilibrium (LD) based association mapping has received increasing 
attention in the recent literature (Ardlie et al., 2002, Couzin and Kaiser, 2007, Iles, 2008, 
McCarthy et al., 2008, Slatkin, 2008, Weiss and Clark, 2002) for its potential power and 
precision in detecting subtle phenotypic associated genetic variants when compared 
with traditional family-based linkage studies. Association mapping methods for the 
genetic dissection of complex traits utilize the decay of LD, the rate of which is 
determined by genetic distance between loci and the generation time since LD arose 
(Mackay and Powell, 2007). Over multiple generations of segregation, only loci 
physically close to the quantitative trait loci (QTL) are likely to be significantly 
associated with the trait of interest in a randomly mating population, providing great 
efficiency at distinguishing between small recombination fractions (Remington et al., 
2001). Despite this potential power, many reported association studies have not been 
replicated or have resulted in false positives (Cardon and Bell, 2001, Risch, 2000), 
commonly caused by ‘cryptic’ structure in population-based samples. Population 
structure, or population stratification (Balding, 2006), arises from systematic variation 
in allele frequencies across subpopulations, which can result in statistical association 
between a disease phenotype and marker(s) that have no physical linkage to causative 
loci (Ewens and Spielman, 1995, Lander and Schork, 1994), i.e. false positive or 
spurious associations. This gives rise to an urgent need for methods of adjusting for 
both population structure and cryptic relatedness occurring due to distant relatedness 
among samples with no known family relationships. 
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2.3.1 Family-based association studies 
To avoid the problems raised from population stratification, family-based association 
studies have been proposed, such as the transmission-disequilibrium test (TDT), which 
is an exact application of McNemar’s Test in genetics (Spielman et al., 1993). In this 
test, the samples are collected from nuclear families which consist of two parents and 
one affected offspring (family trios). The TDT test is designed to compare the 
frequencies of marker alleles transmitted from heterozygous parents to affected 
offspring against those that are not transmitted. For example, there are two alleles 
1M
 
and 
2M at a genetic locus. In total n trios’ families, there are 2n parents and n affected 
offspring. The transmissions and non-transmissions of alleles 
1M
 
and 
2M from parents 
to offspring can be summarised in a 2× 2 table (table II.1):  
Table II.1: Transmitted and nontransmitted marker alleles 1M and 2M from 2n 
parents to n affected offspring 
Non-transmitted allele 
Transmitted allele 
1M  2M  
Total 
a b 
1M  
1 1 1P M M M= →  1 2 1P M M M= →  
a+b 
c d 
2M  
1 2 2P M M M= →  2 2 2P M M M= →  
c+d 
Total a+c b+d 2n 
The TDT only uses information from heterozygous parents (b and c in table II.1). The 
null hypothesis of TDT test states that the observed ratios of / ( )b b c+ and 
/ ( )c b c+  have equal proportions (0.5, 0.5). It means this locus does not genetically 
  
55 
 
associate with the phenotypic trait. This hypothesis can be inspected via an 
asymptotically Chi-square test with 1 degree of freedom: 
2 2
2
2
[ ( ) / 2] [ ( ) / 2]
( ) / 2 ( ) / 2
( )
b b c c b c
b c b c
b c
b c
χ − + − += +
+ +
−
=
+
  (II-3.1) 
In TDT design, the ethnic background of cases and controls needs to be necessarily 
matched, conferring robustness to the presence of population structure. However, TDT 
design can detect the presence of linkage between trait and genetic marker only if 
genetic association (results from linkage-disequilibrium) is present. And, it also requires 
samples from family trios, which are difficult to obtain compared to population based 
designs where a large sample is feasibly obtained. Moreover, increased genotyping 
efforts are required for TDT design to achieve the same power as population based 
design (Cardon and Palmer, 2003, McGinnis et al., 2002). 
2.3.2 Genomic control (GC) method and the structure association (SA) analysis 
Numerous methods have been proposed to overcome the problems caused by population 
structure without the need for family based samples. Among the most widely used 
approaches are the genomic control (GC) method (Devlin and Roeder, 1999, Bacanu et 
al., 2002) and the structure association (SA) analysis (Pritchard et al., 2000a, Pritchard 
et al., 2000b). In the former, the genomic control method was initially designed for 
case-control studies but has been extended to quantitative traits (Bacanu et al., 2002). 
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For example, in a case-control study, the genotype distribution of two alleles 
1M and 
2M at a bi-allelic locus can be summarised in a 2× 3 table (table II.2): 
Table II.2: genotype distribution of allele 1M
 
in case-control samples 
1M alleles  
0 1 2 
Total 
Case 
0r  1r  2r  R 
Control 
0s  1s  2s  S 
Total 
0n  1n  2n  N  
Devlin and Roeder (1999) employed the Armitage’s trend test to examine the 
association between genetic marker and phenotypic trait: 
2
2 1 2 1 2
2
1 2 1 2
( ( 2 ) ( 2 ))
( )( ( 4 ) ( 2 ) )
N N r r R n nY
R N R N n n n n
+ − +
=
− + − +
 (II-3.2) 
where the trend test statistic 2Y  is asymptotic -square distribution with 1 degree of 
freedom. If there is no population structure in the collected samples, the test statistic can 
be directly used to evaluate the significant level of genetic association. However, when 
the population structure is present in samples, the trend test 2Y
 
will be inflated by a 
factor λ  where the inflation λ  depends on the confounding effect of population 
structure. In genomic control method, Devlin and Roeder assumed that the confounding 
effects of population stratification can cause a constant inflation factor λ  of the test 
statistic across the whole genome. It uses statistical inference approaches (both of 
frequentist statistics and Bayesian inference) to estimate this constant inflation factor λ  
from a group of unlinked genetic markers. And then, the test statistic will be adjusted 
from the estimate before being applied to infer the significance of association. The 
genomic control is an efficient method because it does not require knowledge of the 
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population structure information. However, the genomic control method considers an 
ideal but unrealistic situation of constant inflation factor λ  for all markers, while in 
reality the influence of population structure on statistical inference of marker-trait 
association varies over genome locations (Astle and Balding, 2010). It is due to the fact 
that the divergences of allele frequencies across ancestral populations vary around the 
whole genome. 
The main alternative approach to adjust population structure effect in association studies 
is the structure association (SA) analysis (Pritchard et al., 2000a, Pritchard et al., 2000b). 
Briefly, the structure association (SA) method is a Bayesian-based clustering strategy to 
infer the population structure information using genotypic data. Pritchard assume that 
there are K subpopulations from which the samples are collected, and each of 
subpopulation is distinguished by frequencies of a set of characterised alleles. In this 
method, each sample is assigned into subpopulation based on the genotypes of a group 
of selected markers. The SA method is widely suitable for many different types of 
genetic markers, such as Restriction fragment length polymorphisms (RFLPs), Single 
feature polymorphisms (SFPs) and Single nucleotide polymorphisms (SNPs). However, 
it requires that these selected markers should be unlinked with each other and also 
segregated under Hardy-Weinberg equilibrium within subpopulations. In SA method, it 
does not give a clear guide to select such genetic markers. In practice, it is a challenge 
to obtain a group of markers matched those requirements without the knowledge of 
population structure information. Moreover, for the SA method, it is computationally 
intensive to obtain accurate and reliable values for both the number of subpopulations in 
real datasets and to assign any individual into a population membership.  
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2.3.3 Principal component analysis (PCA) based method— EIGENSTRAT 
Recently, several methods have been adopted to infer the subpopulation number, 
including Latent-Class model (Satten et al., 2001), mixture model (Zhu et al., 2002), a 
Bayesian model — AdmixMap (Hoggart et al., 2003) and a Principal Component 
Analysis (PCA) based strategy — EIGENSTRAT (Price et al., 2006). These methods 
share the common assumption that associations among unlinked markers are the result 
of population structure and subpopulations are allocated to minimize these associations. 
This step depends critically upon the correct selection of a panel of markers to reflect 
population structure information, because using different groups of genetic markers can 
lead to distinct inference results. For example, Price et al. (2006) proposed a principal 
component analysis (PCA) based method, EIGENSTRAT, to explicitly model the 
ancestral divergences in allele frequency and correct for population stratification by 
adjusting genotypes through linear regression. Briefly, this simple and efficient 
approach consists of three steps. At first, principal component analysis (PCA) is applied 
to genotype information to obtain the continuous axes of genetic variance. In this step, 
principal component analysis (PCA) successfully reduces the high-throughput genetic 
information into a few dimensions, keeping as much variance as possible. And then, it 
adjusts both phenotype and genotype data by the amounts of attribution to ancestry 
along the axes of variance. Finally, it tests the association statistics based on the 
ancestry adjusted genotype data and phenotype trait. While EIGENSTRAT provides 
specific correction for candidate markers, how to choose appropriate markers to infer 
population structure remains in question. In fact, prediction of the population structure 
may fail whenever the key assumption behind the structure prediction methods is 
violated.  
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2.3.4 Correcting the confound effect of population structure using only one 
genetic marker 
Rather than using a panel of unlinked markers to exploit the cryptic population structure, 
a single null marker can be used to correct for bias of the test statistic in association 
studies. Wang et al. (2005) suggested using only one well-selected null marker to 
correct biases from population stratification on association test for a candidate gene. At 
first, Wang et al. (2005) has assessed how the confounding effect of population 
structure in association studies could be corrected by a single genetic marker. When the 
selected null marker has greatly varied distribution patterns across subpopulations, 
spurious association can be partially corrected in a logistic regression model. 
Furthermore, when the null marker has the same genotype distribution as the candidate 
gene across subpopulations, the confounding effect of population structure can be 
completely removed from the logistic regression model. Compared with above models 
and methods, this method better defines a clear guide to select a type of null maker for 
correcting the bias (or spurious) due to population structure. However, for this method, 
they assumed a simplistic situation that the null marker had the same genotypic 
distribution as the candidate gene, which was unknown in practice. Furthermore, they 
did not statistically model the power assessment of bias reduction when using null 
marker distributed un-identically to the candidate gene. 
Proposed that the confounding effect of population structure in association studies may 
be corrected by only one well-selected genetic marker, I develop a novel linear 
regression model for association-based eQTL analysis. The variation of transcript 
abundance is widely reported in all organisms’ studies to date (Gilad, 2008). It has 
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already proved that gene expressed variation may be responsible for many kinds of the 
phenotypic traits in natural populations e.g. branching structure in maize (Clark, 2006), 
bristle number in fruit flies (McGregor, 2007), beak morphology in Darwin finches 
(Abzhanov, 2004). Moreover, gene expression variation has been genetically associated 
with more than hundreds of human complex traits including diverse aspects of 
behaviour, physiology and disease (Kleinjan, 2005, Wray, 2007). Despite accumulating 
evidence that transcription variation contributes to many important complex traits, it 
still know little about the genetic architectures for variation in gene expression levels. 
Gene expression quantitative trait loci (eQTL) analysis is the main approach to identify 
which genomic regions control transcription and to explore the effect of variation in 
these DNA sequence regions. In such studies, the gene transcription abundances are 
considered as the quantitative traits, and the genetic basis to regulate the variation in 
transcription level can be identified using genome-wide association study. The 
expression quantitative trait locus (eQTL) analyses have recently proved that variation 
in human gene expression levels among individuals and also populations is influenced 
by polymorphic genetic variants (Campino et al., 2008, Cheung et al., 2003, Spielman et 
al., 2007). The use of structured populations has meant that to detect the genetic variants 
accounting for differences in gene expression between subpopulations, Genome-wide 
association studies (GWAS) had to be carried out separately for each subpopulation and 
the results subsequently compared. I present here a simple linear regression model of 
utilizing only one ‘control’ marker to remove the population structure effect in detecting 
linkage disequilibrium (LD) between a marker and a putative quantitative trait locus 
(QTL). I first established the theoretical basis for selection and use of a control marker 
to correct for population structure and established a regression-based method for 
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detecting the LD which is integrated with information of the control marker. I  
investigated the method for its efficiency to test the LD and to reduce false positives 
stemmed from population structure through intensive computer simulation studies and 
re-analysis of the gene expression and SNP datasets collected from genetically 
divergent populations. The new method (Method 1) was compared with two alternative 
methods: single marker regression without population structure correction (Method 2) 
and multiple regression analysis with incorporation of known individual ancestry 
information (Method 3).  
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2.4 Statistical models and methods 
2.4.1 Method 1: a novel regression analysis with correcting population structure 
Here, the model is designed to analyze a structured randomly mating population 
produced through instant admixture of two genetically divergent subpopulations. The 
proportion of subpopulation 1 in the mixed population is denoted by m; meanwhile the 
proportion of subpopulation 2 can be represented by 1-m. Let us consider three bi-
allelic loci: one affects a quantitative trait (Q) while another two are polymorphic co-
dominant markers devoid of direct effect on the phenotypic trait. They are called, for 
convenience, one of the markers the test marker (T) which is used to be tested for 
genetic association with the QTL, and the other considered as control marker (C), 
assumed to be not associated with both the QTL and the test marker (i.e. the linkage 
disequilibrium D equal 0). Two alleles are denoted by A and a at the putative QTL, T 
and t at the test marker, and C and c
 
at the control marker. Three genotypes at the QTL, 
AA, Aa and aa, are assumed to affect the quantitative trait by d, h and –d respectively. 
Trait phenotype of an individual (Y ) is assumed to be normally distributed with mean 
depending on its genotype effect at the QTL and residual variance 2
eσ . Genotypic values 
at the test marker and control marker are denoted by X and Z, which are the number of 
alleles T and C respectively. In subpopulation i (i=1 or 2), the allelic frequencies of the 
QTL, test marker and control marker are denoted by ( )iQP , ( )iTP and ( )iCP respectively, 
while the coefficients of linkage disequilibrium between any pair of the loci are denoted 
by ( )iTCD , 
( )i
TQD  and 
( )i
CQD .  
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Table II.3 explicitly illustrates probability distribution of joint genotypes at a test 
marker and a putative QTL in randomly mating populations together with genotypic 
values at the QTL and the original work for drawing this table was implemented by Luo 
in 1998. In table II.3, the conditional probabilities Q (or R) are represented the 
frequency of marker allele T simultaneously carrying allele A (or a) at the QTL, which 
can be formulated by allele frequencies at marker loci (p) and putative QLT (q) and the 
coefficient of linkage disequilibrium between the marker and QTL (D). It is clear from 
Table II.3 that the joint distribution of marker-QTL can be fully characterized by the 
parameters defining population allele frequencies at the two loci and the coefficient of 
linkage disequilibrium between them. This provides the theoretical basis for statistical 
analyses developed below. 
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Table II.3: Probability distribution of joint genotypes at a test marker and a putative QTL and genotypic values at the QTL 
 
Genotypes at QTL AA Aa aa 
Marker genotypes TT Tt tt TT Tt tt TT Tt tt 
Probabilities (qQ)2 2q2Q(1-
Q) 
 q2(1-
Q)2
 2 q(1-
q)QR 
2 q(1-q) 
(Q+R-2QR) 
2 q(1-q) (1-
Q)(1-R) 
(1-q)2R2
 
2(1-q)2 
R(1-R) 
 (1-q)2(1-
R)2 
Genotypic values 
at QTL 
µ + d µ + h µ - d 
  
where A and a are segregating alleles at a putative QTL, T and t are alleles at the test marker locus. Allele frequency of A is q, 
allele frequency of T is p. Q and R are conditional probabilities of marker allele T given QTL allele A and a respectively, 
which are formulated as DQ p q= + and (1 )DR p q= − −  where D is the coefficient of linkage disequilibrium between the 
marker and QTL. µ, d and h are population mean, additive and dominance genic effects at the QTL.  
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2.4.1.1 The novel linear regression model and theoretical analysis 
In 1990, Land and Thompson have introduced the usage of regression of quantitative 
trait on the number of common alleles of genetic marker as a marker score in marker-
assisted selection (MAS) analysis of a quantitative trait. Here, for phenotypic value of a 
quantitative trait and each of the genetically polymorphic markers, I fit the following 
form: the genotype
ijX of individual i at the given marker locus j  may be classified as 
one of three states: 0 , 1 , 2i jX o r=  for homozygous rare, heterozygous and 
homozygous common alleles, respectively; while
iY
 
is the phenotypic value for 
individual 1, , ,i n= ⋅ ⋅ ⋅ ⋅ ⋅ ⋅ . In the present model, I fit a linear regression of the form for 
each genetic marker: 
             0 1i ij iY b b X ε= + +        (II-4.1) 
where 
0b is the mean of phenotypic value of quantitative trait in total samples, 1b  is the 
regression coefficient between X and Y , and iε is an independent normally distributed 
random variable with mean 0 and variance 2eσ . In statistics, the simple linear regression 
model is to estimate the relationship between Y and one explanatory variable X . In the 
least-square approach, the best fitted model should minimize the sum of squared 
residuals 2iε  in the regression analysis: 
 
0 1
0 1 0 1
2
1
1
2
0
, 1
( , ),   ( , ) ( )min
n
i
b
n
i
b
i
ii
YQ b b where Q b b b b Xε
==
= −= −∑∑ (II-4.2) 
According to the least-square approach, the best fitted regression coefficient 
1b is given 
by: 
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=
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=
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−
=
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∑
∑ ∑ ∑
∑ ∑ .     (II-4.3) 
In association studies, it has been clearly demonstrated that significance of the 
regression coefficient can be used to infer significance of LD between a polymorphic 
marker locus and a QTL in a single randomly mating population since the regression 
coefficient has a form of 
            
,
1 2 2 2
2 [ (1 2 ) ]( ) ( ) ( )
( ) ( ) 2 (1 )
TQ QX Y
X T T
D d p hE XY E X E Yb
E X E X p p
σ
σ
+ −
−
= = =
− −
 (II-4.4) 
(Luo, 1998). In equation II-4.4, it is clear that the magnitude of linear regression 
coefficient 
1b  directly depends on the level of association between test marker and 
putative QTL (
TQD ). However, in a structured population, it clearly shows that the LD 
between a marker and a QTL is given by 
           
(1) (2)(1 ) (1 )TQ TQ TQ T QD mD m D m m δ δ= + − + − ,  (II-4.5) 
(Chakraborty and Smouse, 1988), where m is the proportion of subpopulation 1 in this 
mixed samples, the superscripts (1) and (2) refer to the subpopulations, (1) ( 2 )
T T Tp pδ = −  
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and (1 ) ( 2 )
Q Q Qp pδ = − . The covariance between the QTL and the test marker can be worked 
out as 
           
(1) (1)
,
(2) (2)
(1) (2)
2 ( 2 )
2(1 ) ( 2 )
4 (1 ) [ (1 )]
X Y TQ Q
TQ Q
T Q Q Q
mD d h hp
m D d h hp
m m d h p p
σ
δ δ
= + −
+ − + −
+ − + − −
.   (II-4.6)  
Equations II-4.5and II-4.6 show that the association between the QTL and test marker 
in a mixed population is the summation of (i) a linear combination of the associations 
between the two loci in each of the subpopulations (i.e. the genuine association due to 
LD between the two loci in each of the subpopulations), and (ii) a nonlinear component 
of the differences in allele frequencies between the two subpopulations (i.e. a spurious 
term of association). The objective of this analysis is to remove the spurious term by 
using a control marker ‘C’.  
Consistent with above analysis, the covariance between control marker and QTL (or test 
marker) in the admixture population are given by 
(1) (1)
,
(2) (2)
(1) (2)
2 ( 2 )
2(1 ) ( 2 )
4 (1 ) [ (1 )]
Y Z CQ Q
CQ Q
C Q Q Q
mD d h hp
m D d h hp
m m d h p p
σ
δ δ
= + −
+ − + −
+ − + − −
  (II-4.7) 
(1) (2)
,
2 2(1 ) 4 (1 )X Z TC TC T CmD m D m mσ δ δ= + − + −  (II-4.8) 
where (1 ) ( 2 )
C C Cp pδ = − . If the control marker is neither in association with the QTL 
(i.e. (1 ) ( 2 ) 0C Q C QD D= = ) nor with the test marker ( (1 ) ( 2 ) 0T C T CD D= = ), then the covariance between 
control marker and QTL (or test marker) can be simplified as 
           
(1) (2 )
,
4 (1 ) [ (1 )]Y Z C Q Q Qm m d h p pσ δ δ= − + − −  (II-4.9) 
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           ,
4 (1 )X Z T Cm mσ δ δ= −      (II-4.10) 
In an admixed population, the control marker’s allelic frequency 
is (1 ) ( 2 )(1 )C C Cp m p m p= + − . In a population with allelic frequency Cp  at the control marker 
locus, the expected and observed variances at the control marker are  
           
2 ( 1 ) ( 2 ) ( 1 ) ( 2 )[ ] 2 [ (1 ) ] [1 (1 ) ] 2 (1 )Z C C C C C CE m p m p m p m p p pσ = + − − − − = − (II-4.11) 
           
2 (1) (2) (1) (2 ) 22[ (1 ) ][1 (1 ) ] (1 )2Z C C C C Cmp m p mp m p m mσ δ= + − − − − + − (II-4.12) 
Thus, the difference between the expected and observed variances at the control marker 
indicates the existence of population structure, 
           
2 2 2[ ] 2 (1 )Z Z CE m mσ σ δ− = −      (II-4.13) 
The spurious term in the covariance in equation (II-4.6) can be completely corrected 
using a single control marker, as follows: 
           
, ,
, , 2 2
(1) (1) (2) (2)
2{ [ ]}
2 ( 2 ) 2(1 ) ( 2 )
X Z Y Z
X Y X Y
Z Z
TQ Q TQ Q
E
mD d h hp m D d h hp
σ σ
σ σ
σ σ
= −
−
= + − + − + −

 (II-4.14) 
Therefore, the regression coefficient calculated from 
            
, ,
, 2 2
,
1 2 2
2{ [ ]}
X Z Y Z
X Y
ZX
X X
ZY Eb
σ σ
σ
σ
σ
σ σ
σ
−
−
= =

    (II-4.15) 
would reflect correction for the population structure.  
2.4.1.2 Significant test of the regression coefficient 
1b  
In this novel model, the standard Student’s t-test can be used to test for significance of 
the regression coefficient
1b . In t-test, the statistic has the form  
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test=
Z
t
S
−
       (II-4.16) 
where Z and S represent statistic to be tested and standard error of Z, respectively.  In 
the present setting, Z is the regression coefficient 
1b in the analysis and Standard error of 
1b is given by  
           
1
2 2 2
,
2
X Y X Y
b
X
S
n
σ σ σ
σ
−
=

      (II-4.17) 
Given the regression coefficient and the standard deviation, the power of the regression 
analysis can be predicted from the probability (Johnson and Kotz, 1970) 
            /2;Pr{ ( ) }t v t vt tαρ δ= >      (II-4.18) 
where ( )v tt δ represents a random variable with non-central t-distribution with v degrees 
of freedom and non-centrality parameter 
tδ  and / 2;vtα is the upper 2
α point of a central 
t-variable with the same degrees of freedom. The value of v equals n-3 and the non-
centrality parameter is given by (Johnson and Kotz, 1970) as     
1
1[ / 2]
/ 2 [( 1) / 2]t b
v b
v v S
δ Γ=
Γ −      (II-4.19) 
where ( )Γ i stands for a gamma function. 
2.4.1.3 Selection of the control marker 
In practice, I propose the following procedure to select the control marker for a given 
test marker. Firstly, any marker but the test marker would be candidate for the control 
marker if it has or is 
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• autosomal location 
• locates on different chromosomes from the test marker, 
• less missing genotype data than a prior given proportion 
For each marker passing the above screening, one calculates the expected and observed 
variances from 
                  
2[ ] 2 (1 )Z C CE p pσ = −      (II-4.20) 
                  
2 2
1
( ) / ( 1)
n
Z i
i
Z nσ µ
=
= − −∑
     (II-4.21) 
where iZ is the genotypic value of the candidate control marker (0, 1, 2) for individual 
1 , ,i n=   , and µ  and Cp  are the mean genotypic value across all 
individuals (
1
/
n
i
i
Z n
=
∑  ) and the allelic frequency of this marker, respectively. It 
should be noted that equations (II-4.11) and (II-4.20) are the same and that equation 
(II-4.21) stands for the sampling variance of the control marker whose expectation is 
given by equation (II-4.12) in the presence of population structure. The control marker 
is the one with the maximum difference between observed and expected variances, 
which has the maximum ability to remove the spurious term in mixed populations and 
does not introduce bias in single population. 
2.4.2 Method 2 (Regression analysis without correcting population structure) 
The traditional method fits a simple regression model for detecting LD between the trait 
phenotype and a test marker as it has been proposed previously (Spielman et al., 2007) 
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and implemented in a recent population based eQTL analysis in (Luo, 1998), in which 
the regression coefficient has a form of  
             
*
,
1 2
X Y
X
b
σ
σ
=
        (II-4.22) 
with a standard error equal to 
             1
2 2 * 2
,
2
( )X Y X Y
b
X
S
n
σ σ σ
σ
−
=
      (II-4.23) 
where *
,X Yσ
is the non-corrected covariance between test marker locus and the 
quantitative trait.                                                                                     
2.4.3 Method 3 (multiple regression analysis) 
The method regresses the trait phenotype on genotypic value of a test marker (
ijX = 0, 1, 
2) and the probability of membership to each constituent population Pi (i =1, 2 here) as 
described in the following multiple regression model  
            0 1 2i ij i iY b b X b P ε= + + +      (II-4.24) 
where the 
2 ib P term reflects the population structure effect in mixed populations. 
The regression coefficients are given by 
           
2
, , ,
1 2 2 2
,
P X Y X P P Y
X P X P
b
σ σ σ σ
σ σ σ
−
=
−
     (II-4.25) 
           
2
, , ,
2 2 2 2
,
X P Y X P X Y
X P X P
b
σ σ σ σ
σ σ σ
−
=
−
     (II-4.26) 
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where 
,X Yσ is the covariance between test marker and phenotypic trait, ,P Yσ is the 
covariance between subpopulation information and phenotypic trait, and 
,X Pσ  is the 
covariance between test marker and subpopulation information. Furthermore, the 
standard errors of the regression coefficients are formulated as  
           
1
2 2
2 2 2
,
P Y
b
X P X P
S
n
σ σ
σ σ σ
=
−
 
     (II-4.27) 
           
2
2 2
2 2 2
,
X Y
b
X P X P
S
n
σ σ
σ σ σ
=
−
      (II-4.28) 
according to (Snedecor and Cochran, 1967). Significance of association of the test 
marker with the quantitative trait can be tested through testing for significance of the 
regression coefficient b1 by the Student t-test. 
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2.5 Simulation study 
The novel method that only uses one control marker to correct the confound effect of 
population structure is very important for linkage-disequilibrium based association 
studies. This part presents the efficient performance of the novel method for association 
studies in admixed populations based on simulated samples. In order to 
comprehensively explore statistical properties and limitations of the methods described 
above, I developed and conducted a series of computation simulation studies. All of the 
simulation studies were implemented in FORTRAN program. 
2.5.1 Simulations of admixed populations 
A multiple-locus simulation program was developed to simulate diploid population. The 
simulation program mimics segregation pattern of genes at multiple marker loci and 
QTL in randomly mating natural populations in terms of simulation parameters defining 
allele frequencies, linkage disequilibria and population structure as illustrated in Table 
II.4. The methods were detailed for simulating a population characterized by the joint 
genotypic distribution at two loci and for sampling individuals from the simulated 
population. Although the distribution involves only two loci, it is easy to extend to 
multiple loci because the two locus joint distribution can be easily converted into 
conditional (or transition) probability distribution of genotypes at one locus on that at 
another, and genotypes at multiple loci can be simulated as a Markov process governed 
by the conditional probability distribution. Of course, this will not undermine flexibility 
to specify any required linkage disequilibrium pattern among any loci. Subpopulations 
were independently generated and merged to produce the admixed population. For each 
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subpopulation, the simulation started by randomly sampling genotypes at both QTL and 
control marker locus for an individual based on the pre-specified allele frequencies, 
respectively. Given a haplotype genotype at the QTL, the haplotype genotype at the test 
marker locus was sampled from a probability distribution as given in Table II.3. 
Phenotype of the trait was generated for each individual according to its genotype at the 
QTL and prior defined quantitative genetic model and parameters characterizing genetic 
effects at the QTL (Table II.3 and Table II.4), plus a random number sampled from a 
normal distribution of mean zero and variance 2
eσ . For simplicity, the QTL genotypic 
effects were expressed in terms of the QTL heritability defined as in an equilibrium 
population with QTL allelic frequency q=0.5. The phenotypic variance of the trait was 
assigned a constant value of 100. In the present study, I was focused on 20 simulated 
populations defined by simulation parameters listed in Table II.4.  
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Table II.4: Parameters defining two subpopulations that are merged to produce admixed  
populations. 
 
n is the sample size, m is the proportion of subpopulation 1 in the admixture,  h2 is QTL 
heritability defined in an equilibrium population with QTL allelic frequency p=0.5, Φ is 
the dominance ratio at the QTL, ( )i
Qp , 
( )i
Tp and ( )iCp are respectively the allelic frequencies at 
QTL, test marker and control marker in the i-th subpopulation (i=1,2), and ( )i
TQD is the 
coefficient of linkage disequilibrium between QTL and test marker in i-th subpopulation. 
 
 
Pop. n m h2 Φ (1)Qp
 
(1)
Tp  
(1)
Cp
 
(1)
TQD  
(2)
Qp
 
(2)
Tp  
(2)
Cp
 
( 2 )
T QD  
1 1000 0.3 0.1 1 0.8 0.4 0.8 0.0 0.5 0.7 0.4 0.0 
2 500 0.5 0.1 0 0.8 0.4 0.3 0.0 0.5 0.7 0.6 0.0 
3 500 0.5 0.1 0 0.8 0.4 0.8 0.0 0.5 0.7 0.4 0.0 
4 500 0.5 0.1 0.5 0.7 0.7 0.3 0.00 0.3 0.3 0.7 0.00 
5 500 0.5 0.1 0 0.2 0.8 0.2 0.00 0.8 0.2 0.8 0.00 
6 500 0.5 0.2 0.5 0.2 0.8 0.2 0.00 0.8 0.2 0.8 0.00 
7 1000 0.7 0.1 0 0.7 0.7 0.2 0.0 0.3 0.3 0.6 0.0 
8 500 0.5 0.2 1 0.2 0.8 0.2 0.0 0.8 0.2 0.8 0.0 
9 1000 0.5 0.2 1 0.2 0.8 0.2 0.0 0.8 0.2 0.8 0.0 
10 500 0.5 0.1 0 0.3 0.7 0.3 0.08 0.7 0.3 0.8 -0.08 
11 1000 0.5 0.1 0 0.6 0.6 0.6 0.1 0.4 0.4 0.4 0.1 
12 500 0.5 0.1 0 0.6 0.6 0.6 0.1 0.4 0.4 0.4 0.1 
13 500 0.7 0.1 0.5 0.4 0.4 0.4 0.05 0.6 0.6 0.6 0.05 
14 500 0.5 0.1 0 0.6 0.4 0.6 0.1 0.4 0.4 0.4 0.1 
15 500 0.5 0.2 0 0.4 0.5 0.4 0.1 0.6 0.5 0.6 0.1 
16 500 0.5 0.1 1 0.4 0.5 0.4 0.05 0.6 0.5 0.6 0.05 
17 500 0.4 0.1 0 0.3 0.7 0.5 0.05 0.7 0.4 0.8 0.05 
18 500 0.4 0.1 0 0.3 0.7 0.4 0.05 0.7 0.4 0.8 0.05 
19 500 0.4 0.1 0 0.3 0.7 0.3 0.05 0.7 0.4 0.8 0.05 
20 500 0.4 0.1 0 0.3 0.7 0.2 0.05 0.7 0.3 0.8 0.05 
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2.5.2 Comparisons of three approaches based on simulation data 
The association studies between QTL and test marker in simulation data were 
implemented by Method 1 (the novel method), Method 2 (original simple linear 
regression) and Method 3 (multiple regression including known population ancestry). 
For each method, the simulated observation of the risk/power to predict 
spurious/genuine association at the test marker was calculated as the frequency of 
significant statistical tests (significance threshold α = 0.0001) over 100 repeated 
simulations, implying an overall type I error of 1%.  
2.5.2.1 Probability of statistical power and false positive inference 
I tabulated in Table II.5 means and standard errors of 100 repeated regression 
coefficients and proportions of significant tests of the regression coefficients. It can be 
seen that simulations showed good agreement with the theoretical predictions for all 
three methods.  
Listed in Table II.5 were proportions of significant tests of the regression in repeated 
simulations. In populations 1-9, LD between test marker and QTL was equal to zero in 
both of two subpopulations, thus there were no genuine LD in admixed populations. 
Furthermore, in population 10, LD between test marker and QTL had the opposite sign 
in two subpopulations, and thus completely counterbalanced the genuine LD in admixed 
populations (genuine LD=0 in admixed populations). It should be stressed that 
populations 1-10 have no LD between QTL and test marker; the differences in allelic 
frequency distribution between subpopulations led to spurious prediction of LD in the 
  
77 
 
structured populations, therefore the ‘proportions of statistical tests for significance of 
the regression coefficients’ here is equivalent to the risk of claiming false positives. It is 
clear that the rate of false positive is properly controlled in association analysis with 
Method 1, and Method 3. However, the Method 3 (multiple regression method) is 
completely effective in avoiding false positives when the population structure 
information is fully known. While, Method 1 predicted the regression coefficients and 
power to zero at the test marker without the requirement of population structure 
information. In contrast, Method 2 did not correct for the population structure, and 
hence had the highest false positive rates in both simulation and theoretical prediction, 
performing particularly poorly in populations 4 -10, where the false positive rate 
reached approximately 100%. 
When populations 11-20 have QTL and test marker in true LD, the proportion measures 
rate provides evaluation of an empirical statistical power for detecting the genetic 
association. In populations 11-13 the spurious LD from population structure had the 
same sign as the genuine LD, thus increasing the absolute value of the LD coefficient 
between QTL and test marker; in this situation, Method 2 had the highest power to 
detect the true associations, while Methods 1 and 3 performed similarly. But both 
Methods 1 and 3 could also detect truly existing LD with a high statistical power. In 
populations 14-16 the test marker had constant frequency between the two 
subpopulations, so there was no spurious LD between the QTL and test marker. The 
three methods performed similarly, as expected. In populations 17-20 the spurious LD 
from population structure had the opposite sign, and thus partially counterbalanced the 
genuine LD. The observed LD were less than half of the true LD values in the original 
subpopulations, and Method 2 completely lost power to predict true associations. By 
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contrast, both Methods 1 and 3 were able to correct for population structure, with 
empirical powers of around 50% and more than 80% respectively. 
According to these extensive simulation studies, the Method 2 is thus inappropriate to 
be used for genetic association analysis when population structure was present. 
Although Method 3 (multiple regression analysis incorporated membership of 
individuals to constituent populations as a covariate) can precisely correct the spurious 
association and detect the genuine LD, it seriously depends on the prior population 
structure information. I have investigated how the knowledge of population structure 
information could influence the association studies in subsequent analysis. Overall, 
these results show that the novel method (Method 1) provides a powerful test for 
linkage disequilibrium between polymorphic markers and QTL and an effective control 
of population structure in the test.  
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Table II.5: Means and standard errors of regression coefficients (b±se) and proportions ( ρ or ρˆ ) of statistical tests for significance 
of the regression coefficients from three methods. 
Method 1 (the novel method) Method 2 (simple regression) Method 3 (Multiple regression) 
Simulated Predicted Simulated Predicted Simulated Predicted 
Pop 
TQD  
'
TQD  
b ± se ρˆ  b ρ  b ± se ρˆ  b ρ  b ± sea ρˆ
a
 b ± seb ρˆ
b
 
1 -0.019 0.00 0.01±0.00 0.01 0.00 0.00 -0.38±0.01 0.13 -0.38 0.19 0.00±0.01 0.00 0.00 0.00 
2 -0.022 0.00 0.13±0.02 0.10 0.00 0.00 -0.75±0.01 0.44 -0.75 0.50 -0.00±0.01 0.00 0.00 0.00 
3 -0.022 0.00 0.05±0.01 0.03 0.00 0.00 -0.75±0.01 0.43 -0.75 0.50 -0.01±0.01 0.00 0.00 0.00 
4 0.04 0.00 -0.087±0.015 0.07 0.00 0.00 1.162±0.006 0.97 1.163 0.98 -0.00±0.007 0.00 0.00 0.00 
5 -0.09 0.00 0.015±0.008 0.00 0.00 0.00 -2.371±0.005 1.00 -2.368 1.00 0.006±0.007 0.00 0.00 0.00 
6 -0.09 0.00 0.005±0.011 0.00 0.00 0.00 -3.157±0.007 1.00 -3.157 1.00 -0.00±0.009 0.00 0.00 0.00 
7 0.034 0.00 0.04±0.01 0.06 0.00 0.00 1.08±0.01 1.00 1.08 1.00 -0.01±0.01 0.00 0.00 0.00 
8 -0.090 0.00 0.03±0.01 0.00 0.00 0.00 -2.74±0.01 1.00 -2.74 1.00 0.02±0.01 0.00 0.00 0.00 
9 -0.090 0.00 0.01±0.01 0.00 0.00 0.00 -2.74±0.01 1.00 -2.74 1.00 -0.00±0.01 0.00 0.00 0.00 
10 -0.04 0.00 0.008±0.009 0.01 0.00 0.00 -1.233±0.006 0.99 -1.234 0.99 -0.00±0.007 0.00 0.00 0.00 
11 0.110 0.10 1.61±0.02 0.96 1.72 1.00 2.07±0.01 1.00 2.06 1.00 1.76±0.01 0.99 1.86 1.00 
12 0.110 0.10 1.62±0.02 0.95 1.72 1.00 2.06±0.01 1.00 2.06 1.00 1.75±0.01 0.98 1.86 1.00 
13 0.058 0.05 0.80±0.03 0.64 0.85 0.61 1.14±0.01 0.94 1.13 0.96 0.92±0.01 0.64 0.91 0.71 
14 0.100 0.10 1.78±0.02 0.98 1.86 1.00 1.86±0.01 1.00 1.86 1.00 1.86±0.01 1.00 1.86 1.00 
15 0.100 0.10 2.37±0.03 0.97 2.53 1.00 2.52±0.01 1.00 2.53 1.00 2.52±0.01 1.00 2.53 1.00 
16 0.050 0.05 0.71±0.02 0.36 0.73 0.39 0.72±0.01 0.33 0.73 0.39 0.72±0.01 0.36 0.73 0.43 
17 0.021 0.05 0.97±0.02 0.49 0.83 0.56 -0.12±0.01 0.00 -0.13 0.00 0.99±0.01 0.85 0.98 0.90 
18 0.021 0.05 0.88±0.01 0.48 0.83 0.56 -0.13±0.01 0.00 -0.13 0.00 0.97±0.01 0.84 0.98 0.90 
19 0.021 0.05 0.84±0.01 0.50 0.83 0.56 -0.11±0.01 0.00 -0.13 0.00 0.99±0.01 0.88 0.98 0.90 
20 0.012 0.05 0.79±0.01 0.45 0.78 0.51 -0.42±0.01 0.03 -0.42 0.04 1.06±0.01 0.89 1.07 0.94 
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TQD  and 'TQD  are the coefficients of LD between the marker and QTL in the simulated mixed population before and after correction 
for population structure respectively. apredicted when all individuals were allocated to their correct subpopulations; The 
predicted values were estimated from theoretical analysis, while the simulated values were estimated from the simulation studies. 
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2.5.2.2 The performance of Method 3 when the population structure information is 
unknown 
Method 3 (multiple regression analysis with prior population structure information) 
apparently had the well performance both in correcting for spurious associations and in 
predicting genuine associations, but its prerequisite for the correct assignment of 
individuals to subpopulations is a serious shortcoming. To investigate how this could 
influence the association studies, I further simulated three scenarios in which only a 
proportion r of the individuals was correctly assigned to subpopulations, while (1-r) 
were assigned population membership either incorrectly (scenario 1, Table II.6), 
randomly (scenario 2, Table II.7), or partially with 60% correctly assigned (scenario 3, 
Table II.8).  
In all scenarios, Method 3 can correct spurious associations (populations 1–10) and 
detect genuine associations (populations 11–20) when 95% individuals are correctly 
assigned to subpopulations (r = 0.95). However, when r is reduced then the power to 
detect genuine associations and the ability to remove the spurious associations both 
decrease correspondingly; when r = 0.50 then the false positive rate could rise to 100% 
and the power declined to zero in some situations. Generally, the Method 3 could lose 
its statistical power to detect the truly existing LD (populations 11–20) or make false 
positive inference of genetic association (populations 1–10) when on average a quarter 
of individuals under analysis were wrongly allocated to subpopulations. Thus, 
performance of Method 3 serious depends on the extent by which individuals are 
correctly allocated to their belonging populations. In reality, Method 3 could be 
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impractical for association studies due to the computational difficulty of correctly 
assigning individuals to subpopulations. However, Method 1 that I have developed here 
addresses this limitation, because it successfully controls the false positive rate to a low 
level, and has sufficient power to detect genuine associations in admixed populations, 
while not requiring any individual ancestral information. 
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Table II.6: The values of regression coefficient (b) and empirical statistical power estimated from Method 3 when a proportion of 
individuals r was correctly assigned to subpopulations while (1- r) were incorrectly assigned. 
r = 0.5 r = 0.6 r = 0.7 r = 0.8 r = 0.9 r = 0.95 
Pop. 
b ± se Power b ± se Power b ± se Power b ± se Power b ± se Power b ± se Power 
1 -0.375±0.004 0.15 -0.364±0.004 0.14 -0.330±0.004 0.07 -0.267±0.004 0.03 -0.163±0.004 0.01 -0.089±0.005 0.00 
2 -0.748±0.006 0.41 -0.723±0.006 0.36 -0.646±0.006 0.25 -0.508±0.006 0.10 -0.301±0.006 0.01 -0.162±0.006 0.00 
3 -0.751±0.006 0.44 -0.726±0.006 0.40 -0.649±0.006 0.26 -0.511±0.007 0.09 -0.301±0.007 0.01 -0.166±0.007 0.00 
4 1.236±0.006 0.98 1.201±0.006 0.98 1.086±0.007 0.92 0.879±0.007 0.63 0.542±0.007 0.10 0.303±0.007 0.01 
5 
-2.362±0.005 1.00 -2.315±0.005 1.00 -2.164±0.006 1.00 -1.866±0.006 1.00 -1.280±0.007 0.98 -0.781±0.008 0.44 
6 
-3.348±0.007 1.00 -3.284±0.007 1.00 -3.066±0.008 1.00 -2.637±0.009 1.00 -1.817±0.010 0.98 -1.112±0.010 0.49 
7 1.084±0.004 1.00 1.056±0.005 1.00 0.967±0.005 1.00 0.798±0.005 0.93 0.508±0.005 0.35 0.295±0.005 0.03 
8 -2.744±0.007 1.00 -2.693±0.007 1.00 -2.516±0.007 1.00 -2.182±0.008 1.00 -1.492±0.010 0.87 -0.919±0.010 0.24 
9 -2.749±0.005 1.00 -2.696±0.005 1.00 -2.521±0.005 1.00 -2.177±0.006 1.00 -1.503±0.007 1.00 -0.920±0.007 0.68 
10 
-1.236±0.006 0.99 -1.200±0.006 0.98 -1.083±0.007 0.91 -0.878±0.007 0.62 -0.535±0.007 0.11 -0.299±0.007 0.01 
11 2.066±0.004 1.00 2.058±0.004 1.00 2.036±0.004 1.00 1.997±0.004 1.00 1.941±0.004 1.00 1.906±0.004 1.00 
12 2.061±0.006 1.00 2.055±0.006 1.00 2.032±0.006 1.00 1.993±0.006 1.00 1.936±0.006 1.00 1.899±0.006 1.00 
13 1.143±0.006 0.94 1.136±0.006 0.94 1.114±0.006 0.92 1.076±0.006 0.89 1.020±0.006 0.81 0.976±0.006 0.75 
14 1.860±0.007 1.00 1.861±0.007 1.00 1.860±0.007 1.00 1.861±0.007 1.00 1.862±0.006 1.00 1.861±0.006 1.00 
15 2.528±0.009 1.00 2.528±0.009 1.00 2.527±0.009 1.00 2.526±0.009 1.00 2.526±0.009 1.00 2.525±0.009 1.00 
16 0.728±0.007 0.34 0.728±0.007 0.34 0.726±0.007 0.33 0.727±0.007 0.34 0.728±0.007 0.36 0.727±0.007 0.36 
17 -0.133±0.007 0.00 -0.095±0.007 0.00 0.015±0.007 0.00 0.213±0.007 0.00 0.523±0.007 0.08 0.728±0.006 0.36 
18 -0.109±0.007 0.00 -0.072±0.007 0.00 0.038±0.007 0.00 0.239±0.007 0.00 0.540±0.007 0.09 0.743±0.007 0.40 
19 -0.134±0.007 0.00 -0.099±0.007 0.00 0.014±0.007 0.00 0.212±0.007 0.00 0.520±0.007 0.08 0.727±0.006 0.36 
20 -0.432±0.006 0.03 -0.388±0.006 0.02 -0.256±0.007 0.01 -0.012±0.007 0.00 0.392±0.007 0.02 0.690±0.007 0.28 
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Table II.7: The values of regression coefficient (b) and empirical statistical power estimated from Method 3 when a proportion of 
individuals r was correctly assigned to subpopulations while (1- r) were randomly assigned (50% probability to each 
subpopulation). 
r = 0.5 r = 0.6 r = 0.7 r = 0.8 r = 0.9 r = 0.95 
Pop. 
b ± se Power b ± se Power b ± se Power b ± se Power b ± se Power b ± se Power 
1 
-0.312±0.004 0.05 -0.278±0.004 0.02 -0.229±0.004 0.01 -0.173±0.004 0.00 -0.098±0.004 0.00 -0.055±0.004 0.00 
2 
-0.601±0.006 0.18 -0.527±0.006 0.09 -0.430±0.006 0.04 -0.316±0.006 0.01 -0.179±0.006 0.00 -0.100±0.006 0.00 
3 
-0.592±0.006 0.17 -0.516±0.006 0.10 -0.422±0.006 0.04 -0.307±0.006 0.01 -0.167±0.007 0.00 -0.092±0.006 0.00 
4 0.997±0.007 0.81 0.885±0.007 0.64 0.731±0.007 0.36 0.544±0.007 0.10 0.308±0.007 0.01 0.160±0.007 0.00 
5 
-2.038±0.006 1.00 -1.865±0.006 1.00 -1.616±0.007 1.00 -1.282±0.007 0.98 -0.776±0.008 0.43 -0.434±0.008 0.05 
6 
-2.891±0.008 1.00 -2.647±0.008 1.00 -2.293±0.009 1.00 -1.806±0.010 0.98 -1.101±0.010 0.47 -0.625±0.010 0.05 
7 0.889±0.005 0.98 0.789±0.005 0.93 0.665±0.005 0.72 0.503±0.005 0.32 0.282±0.005 0.02 0.148±0.005 0.00 
8 
-2.362±0.008 1.00 -2.164±0.009 1.00 -1.878±0.009 0.99 -1.486±0.010 0.89 -0.906±0.010 0.23 -0.508±0.011 0.03 
9 
-2.363±0.006 1.00 -2.164±0.006 1.00 -1.885±0.006 1.00 -1.481±0.007 1.00 -0.912±0.007 0.66 -0.510±0.007 0.08 
10 
-0.995±0.007 0.80 -0.878±0.007 0.62 -0.721±0.007 0.33 -0.542±0.007 0.11 -0.297±0.007 0.01 -0.160±0.007 0.00 
11 2.021±0.004 1.00 2.000±0.004 1.00 1.974±0.004 1.00 1.944±0.004 1.00 1.909±0.004 1.00 1.889±0.004 1.00 
12 2.019±0.006 1.00 1.996±0.006 1.00 1.972±0.006 1.00 1.943±0.006 1.00 1.907±0.006 1.00 1.887±0.006 1.00 
13 1.084±0.007 0.89 1.062±0.007 0.86 1.035±0.007 0.83 1.004±0.007 0.79 0.959±0.007 0.72 0.938±0.007 0.68 
14 1.864±0.006 1.00 1.864±0.006 1.00 1.865±0.006 1.00 1.864±0.006 1.00 1.865±0.006 1.00 1.865±0.006 1.00 
15 2.524±0.009 1.00 2.524±0.009 1.00 2.519±0.009 1.00 2.521±0.009 1.00 2.519±0.009 1.00 2.521±0.009 1.00 
16 0.729±0.007 0.33 0.728±0.007 0.34 0.728±0.007 0.34 0.729±0.007 0.35 0.729±0.007 0.34 0.728±0.007 0.35 
17 0.093±0.007 0.00 0.205±0.007 0.00 0.346±0.006 0.01 0.513±0.006 0.08 0.717±0.006 0.33 0.837±0.006 0.6 
18 0.107±0.007 0.00 0.215±0.007 0.00 0.353±0.007 0.02 0.523±0.007 0.09 0.726±0.007 0.36 0.849±0.006 0.61 
19 0.098±0.007 0.00 0.212±0.007 0.00 0.349±0.007 0.02 0.512±0.007 0.08 0.723±0.007 0.35 0.847±0.006 0.61 
20 
-0.130±0.007 0.00 0.015±0.007 0.00 0.196±0.007 0.00 0.421±0.007 0.02 0.701±0.007 0.28 0.875±0.006 0.62 
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Table II.8: The values of regression coefficient (b) and empirical statistical power estimated from Method 3 when a proportion of 
individuals r was correctly assigned to subpopulations while for (1- r) population membership information was partially known 
(60%). 
r = 0.5 r = 0.6 r = 0.7 r = 0.8 r = 0.9 r = 0.95 
Pop. 
b ± se Power b ± se Power b ± se Power b ± se Power b ± se Power b ± se Power 
1 
-0.151±0.004 0.00 -0.127±0.004 0.00 -0.097±0.004 0.00 -0.070±0.004 0.00 -0.038±0.004 0.00 -0.022±0.004 0.00 
2 
-0.277±0.006 0.01 -0.228±0.006 0.00 -0.177±0.006 0.00 -0.124±0.006 0.00 -0.073±0.006 0.00 -0.043±0.006 0.00 
3 
-0.267±0.006 0.01 -0.220±0.006 0.00 -0.172±0.007 0.00 -0.117±0.006 0.00 -0.061±0.006 0.00 -0.034±0.006 0.00 
4 0.472±0.007 0.05 0.396±0.007 0.02 0.304±0.007 0.01 0.210±0.007 0.00 0.109±0.007 0.00 0.057±0.007 0.00 
5 
-1.143±0.006 0.95 -0.973±0.006 0.78 -0.778±0.007 0.41 -0.556±0.007 0.10 -0.296±0.007 0.01 -0.152±0.007 0.00 
6 
-1.626±0.009 0.96 -1.389±0.009 0.83 -1.100±0.009 0.45 -0.781±0.009 0.12 -0.420±0.009 0.01 -0.218±0.009 0.01 
7 0.439±0.005 0.17 0.363±0.005 0.07 0.281±0.005 0.02 0.194±0.005 0.01 0.096±0.005 0.00 0.043±0.005 0.00 
8 
-1.328±0.009 0.75 -1.135±0.009 0.49 -0.906±0.010 0.20 -0.647±0.010 0.05 -0.346±0.010 0.00 -0.177±0.010 0.00 
9 
-1.325±0.006 0.99 -1.137±0.006 0.95 -0.909±0.006 0.67 -0.642±0.007 0.19 -0.347±0.007 0.01 -0.181±0.007 0.00 
10 
-0.469±0.007 0.06 -0.389±0.007 0.02 -0.297±0.007 0.01 -0.204±0.007 0.00 -0.102±0.007 0.00 -0.051±0.007 0.00 
11 1.933±0.004 1.00 1.921±0.004 1.00 1.909±0.004 1.00 1.895±0.004 1.00 1.882±0.004 1.00 1.875±0.004 1.00 
12 1.932±0.006 1.00 1.918±0.006 1.00 1.908±0.006 1.00 1.894±0.006 1.00 1.880±0.006 1.00 1.873±0.006 1.00 
13 0.991±0.007 0.77 0.977±0.007 0.76 0.961±0.007 0.74 0.947±0.007 0.69 0.927±0.007 0.66 0.920±0.007 0.65 
14 1.866±0.006 1.00 1.864±0.006 1.00 1.865±0.006 1.00 1.865±0.006 1.00 1.865±0.006 1.00 1.865±0.006 1.00 
15 2.523±0.009 1.00 2.521±0.009 1.00 2.517±0.009 1.00 2.521±0.008 1.00 2.519±0.008 1.00 2.520±0.008 1.00 
16 0.730±0.007 0.34 0.729±0.007 0.35 0.728±0.007 0.34 0.728±0.007 0.35 0.728±0.007 0.35 0.728±0.007 0.36 
17 0.573±0.006 0.11 0.646±0.006 0.22 0.722±0.006 0.35 0.802±0.006 0.50 0.881±0.006 0.69 0.924±0.006 0.77 
18 0.582±0.007 0.14 0.652±0.007 0.23 0.731±0.006 0.37 0.809±0.006 0.52 0.890±0.006 0.70 0.936±0.006 0.78 
19 0.582±0.007 0.14 0.651±0.007 0.23 0.727±0.006 0.38 0.806±0.006 0.52 0.889±0.006 0.70 0.934±0.006 0.78 
20 0.492±0.006 0.05 0.599±0.006 0.14 0.706±0.006 0.28 0.821±0.006 0.51 0.942±0.006 0.75 1.005±0.006 0.84 
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2.5.2.3 Performance of the novel method (Method 1) using varied control markers 
Use of control markers in Method 1 is the key underpinning for the method to be able 
to control influence of population structure in the genetic association test. To investigate 
effect of the control marker on efficiency of the association test, I explored performance 
of the novel method when different control markers are used in the presence of 
population structure. Table II.9 shows predicted and observed proportions of significant 
tests of the disequilibrium between a test marker and a putative QTL in 10 simulation 
populations with various population structures. Here, all of the 10 simulation 
populations were generated by same parameter set (simulation population 11 from table 
II.4), except the allele frequencies of control marker.  The proportions were calculated 
from analyses with Method 1 by using the control marker with varying allele 
frequencies. When population structure is present in samples, the method bears a high 
chance to make a false positive inference and to lose its detecting power if the control 
marker selected to be implemented in the analysis has a small difference in allele 
frequency between the subpopulations. However, the risk can be effectively controlled 
and the reduced power can be recovered when using the control marker with a large 
allele frequency difference.  
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Table II.9: Investigating the ability of control marker that can remove ‘spurious association’ between two subpopulations 
(Here, the parameters defining the two simulated subpopulations come from simulation population 11.) 
 
 
( )i
Cp is respectively the allelic frequencies at control marker in the i-th subpopulation (i=1,2), and ( )iM QD is the coefficient of linkage 
disequilibrium between QTL and test marker in i-th subpopulation.
M QD  and 'M QD  are simulated coefficients of LD before and 
after correction for population structure respectively. 
Method 1 (the novel method) 
Simulated Predicted Pop (1)Cp
 
(2)
Cp
 
(1) (2)
C Cp p−  (1 )M QD  
( 2 )
M QD  M QD  
'
M QD  
b ± se Power b Power 
1 0.50 0.50 0.00 0.00 0.00 -0.03 0.00 -0.924±0.028 0.71 0.000 0.00 
2 0.60 0.40 0.20 0.00 0.00 -0.03 0.00 0.066±0.035 0.25 0.000 0.00 
3 0.70 0.30 0.40 0.00 0.00 -0.03 0.00 0.049±0.014 0.04 0.000 0.00 
4 0.80 0.20 0.60 0.00 0.00 -0.03 0.00 -0.005±0.010 0.00 0.000 0.00 
5 0.90 0.10 0.80 0.00 0.00 -0.03 0.00 0.006±0.006 0.00 0.000 0.00 
6 0.50 0.50 0.00 0.08 0.08 0.05 0.08 0.384±0.027 0.10 1.325 1.00 
7 0.60 0.40 0.20 0.08 0.08 0.05 0.08 1.292±0.029 0.70 1.325 1.00 
8 0.70 0.30 0.40 0.08 0.08 0.05 0.08 1.385±0.013 0.94 1.325 1.00 
9 0.80 0.20 0.60 0.08 0.08 0.05 0.08 1.325±0.006 1.00 1.325 1.00 
10 0.90 0.10 0.80 0.08 0.08 0.05 0.08 1.321±0.005 1.00 1.325 1.00 
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Furthermore, I also explored the performance of Method 1 (the novel method) when 
population structure is actually absent. Table II.10 presents the simulated and predicted 
proportions of significant test of association studies when there is no population 
structure or the diversity of allelic frequencies at QTL and test marker between the two 
subpopulations is equal. It demonstrates that the type I error is well controlled and the 
disequilibrium is efficiently detected by the method using a control marker even when 
population structure does not actually exist. In addition, all these suggest that 
implementation of control markers with a non-trial difference in allele frequency will 
not cause any significant problem of false positive/negative inference when population 
stratification is actually not existent. In presence of population structure, I propose 
selection of a marker with largely divergent allele frequencies as the control marker.  
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Table II.10: Predicted and observed proportions of significant tests of linkage 
disequilibrium between a test marker and a putative QTL in different simulation 
populations without population stratification from Method 1 in which the control 
marker implemented into the analyses had a constant allele frequency difference of 0.4. 
Simulated  Predicted  
Pop 
(1) (2)
Q Qp p=  
(1 ) ( 2 )
T Tp p=  (1) (2)C Cp p−  
'
TQD  
ˆb se±  ρˆ  b ρ  
1 
0.50 0.50 0.40 0.00 0.003±0.007 0.00 0.00 0.00 
2 
0.55 0.50 0.40 0.00 0.001±0.007 0.00 0.00 0.00 
3 
0.55 0.45 0.40 0.00 -0.001±0.007 0.00 0.00 0.00 
4 
0.60 0.45 0.40 0.00 0.019±0.008 0.00 0.00 0.00 
5 
0.60 0.40 0.40 0.00 0.024±0.009 0.01 0.00 0.00 
6 0.50 0.50 0.40 0.05 0.894±0.007 0.66 0.894 0.74 
7 
0.55 0.50 0.40 0.05 0.899±0.007 0.67 0.894 0.74 
8 
0.55 0.45 0.40 0.05 0.878±0.007 0.65 0.886 0.72 
9 
0.60 0.45 0.40 0.06 1.058±0.007 0.87 1.052 0.93 
10 
0.60 0.40 0.40 0.06 1.475±0.011 0.85 1.46 0.91 
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2.6 Real data analysis  
From previous simulation studies, I have demonstrated that the novel method using only 
one control marker could efficiently and precisely remove the spurious associations and 
detect the genuine associations. This part will compare the performance of Method 1 
(the novel method) with Method 2 and 3 in genome wide association studies based on 
real data analysis — genome wide expression quantitative trait loci (eQTL) analysis.  
2.6.1 Data resources and pretreatment 
The genome-wide eQTL analysis requires the information of genome-wide genetic 
variants in a large collected sample group and the whole genome expression levels for 
each corresponding individual. Due to the expense and labour involved, the genome-
wide approach to investigate the genetic architecture of gene expression variation has 
not been feasible until the last few years (genotyping technique has considerably 
improved and become much cheaper). The microarray, which considers as the first 
high-throughput method for genotyping the genetic variants, has moved the genome-
wide association mapping from the futuristic to the realistic. Furthermore, microarray 
may not only be used for genotyping the genome-wide genetic polymorphisms, but also 
for high-throughput profiling the expression levels of whole genome-wide. Here, two 
publicly microarray datasets collected from the International HapMap Project 
(http://www.hapmap.org) and NCBI Gene Expression Omnibus Database 
(http://www.ncbi.nlm.nih.gov/geo) were used in real data analysis.  
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2.6.1.1 Gene expression data 
The gene expression datasets were collected from Epstein-Barr virus (EBV) 
transformed lymphoblastoid cell lines of unrelated individuals of European-derived 
(CEU, 60 Europeans), and Asia-derived (CHB+JPT, 41 Chinese and 41 Japanese). The 
datasets were originally developed by Spielman et al (2007) to explore population 
specified gene expression and genetic control of the population specified gene 
expression, and were downloaded from National Center for Biotechnology Information, 
Gene Expression Omnibus Database under the accession number GSE5859 
(http://www.ncbi.nlm.nih.gov/geo).  
For this dataset, the expression profiles were measured by Affymetrix Human Genome 
Focus Target Array, which provides relatively comprehensive coverage of the human 
genome. In this commercial expression array, it targets over 8,400 well-characterized 
human genes. The unique DNA sequences used to represent the genes are selected from 
GeneBank Database (http://www.ncbi.nlm.nih.gov/genbank/), dbEST 
(http://www.ncbi.nlm.nih.gov/dbEST/) and RefSeq 
(http://www.ncbi.nlm.nih.gov/RefSeq/). The oligonucleotide probes complementary to 
each selected DNA sequence are synthesized and fixed on the array. A total 11 pairs of 
oligonucleotide probe sets are used to present each gene. Table II.11 briefly 
summarized the basic features of Affymetrix HG Focus array. More technical details of 
this microarray please refer to the AFFYMETRIX company official website 
(http://www.affymetrix.com/). The raw hybridized signals from expression microarrays 
were analyzed using the Affymetrix standard strategy MAS 5.0 and the hybridization 
intensity was log2-transformed into expression phenotype. The study focused on 4,197 
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genes that are expressed at least 80% of the samples in lymphoblastoid cell lines. Of the 
4,197 genes, 1,097 were detected significantly differentially expressed between the 
CEU and CHB+JPT samples (t-test, 51 0P −< ; 0 .0 5
c
P < , Sidak correction) 
(Westfall and Young, 1993).  
Table II.11: Basic features of Affymetrix Human Genome Focus Target Array 
                              Array 
   Features 
Human Genome 
Focus Array 
Number of probe sets ~8,700 
Number of transcripts ~8,500 
Number of genes ~8,400 
Number of control probe sets ~200 
Oligonucleotide probe length 25 bps 
Probe pairs 11 
 
2.6.1.2 Genome-wide genotype datasets for 142 human individuals 
Genotype data for the corresponding 60 CEU, 41 CHB and 41 JPT samples were 
obtained from the International HapMap Project (release 19, http://www.hapmap.org). 
The International HapMap Project, which was officially established in 2002, primarily 
aimed to provide a genome wide database of common genetic variation in human 
genome for guiding the design and analysis of clinical studies. Recently, this project has 
become a crucial resource for geneticists to implement the genetic studies of complex 
traits in human genome. Furthermore, the genotyping data created by this project is 
freely available to geneticists all over the world.  
The initial version (phase 1) of International HapMap Project has successfully 
genotyped at least one common SNP marker in every 5 kilobases (KBs) interval across 
the whole human genome. The genotyping assay was implemented by five different 
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platforms under 9 research institutes (table II.12). The common marker meant that the 
project only focused on the SNP markers with minor allele frequency (MAF) equal or 
greater than 5%. In total, more than 1 million common SNP markers have been 
genotyped for each individual. 
Table II.12: Genotyping platforms and research institutes in HapMap Project 
Research institute Genotyping platforms 
Welcome Trust Sanger Institute in UK Illumina BeadArray 
McGill University and Genome Quebec innovation center Illumina BeadArray 
Illumina Inc. Illumina BeadArray 
Chinese HapMap Consortium Illumina BeadArray 
Broad Institute of Harvard and MIT in USA Illumina BeadArray 
RIKEN in Japan Third Wave Invader 
Baylor College of Medicine with ParAllele Bioscience ParAelle MIP 
University of California and Washington University in 
USA 
PerkinElmer Acycolprime-
FP 
Perlegene Sciences Inc. Affymetrix Microarray 
Here, I downloaded the genotyping dataset (released at the 19th version) for the present 
genome wide eQTL analysis. Compared with initial (phase 1) dataset, additional million 
common SNP markers were genotyped for the same samples. Most of the additional 
genotype data for Release 19 version were generated from the Affymetrix GeneChip 
Mapping Array 500K set, the Illumina HumanHap100 and HumanHap 300 SNP assays. 
Overall, there were more than 2.2 million and 2.0 million common SNP markers for the 
CEU samples and CHB+JPT samples respectively. Comparison between the CEU and 
CHB+JPT samples provided genotype data of 1,606,182 unique SNP markers among all 
142 individuals (60 CUE and 82 CHB+JPT samples). 
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I selected and re-analysed the gene expression and SNP datasets in the present study for 
several reasons. Firstly, these samples were collected from the populations whose 
genetic diversification was well verified (Consortium, 2003, Consortium, 2005, 
Consortium, 2007), and make a typical example which the method is designed for. 
Secondly, gene expression phenotype bears a wide spectrum of genetic controls from 
cis to trans regulation and different levels of heritability. Some of these quantitative 
phenotypes show population specified expression or heterogeneity of underlying 
genetics. These enable the method to be tested under different genetic backgrounds. 
Finally, re-analysis of the same datasets recently published allows a direct comparison 
of analysis with the method developed in the present study with that implemented in the 
published analysis.  
2.6.2 Validation of population structure 
In 2005, The International HapMap Project reported that the CHB and JPT samples’ 
allele frequencies were generally very similar, but different to the allele frequencies of 
CEU samples (Figure II.1). I first explored deviation in genotypic distribution at each of 
nearly 2 million SNP markers from the Hardy-Weinberg equilibrium (HWE) within 
CEU and CHB+JPT samples separately and in mixed of the two samples by using both 
Pearson's chi-squared test and Fisher’s exact test. To account for the multiple tests, I set 
the significant different level at p < 2.5x10-8 ( 0 .0 5
c
P =  after Sidak correction). The 
analyses did not detect any of the SNP markers whose genotypic distribution showed 
significant deviation from HWE in either of the two samples. However, when all CEU 
and CHB+JPT samples were merged together there were approximately 3,000 markers 
scattered across all autosomes deviating significantly from the HWE expectation (2911 
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markers from Pearson's chi-squared test, consistent with 3011 markers from Fisher’s 
exact test). These analyses show that the CEU and CHB+JPT samples can be 
recognized to be collected from genetically divergent random mating populations and 
that a mixed of them represents an example of samples from these populations. 
Population structure in the mixed sample was visualized as a score plot of the first two 
principal components built on the 2911 SNP markers, which explained a total of 62% of 
variability of the marker data (Figure II.2).  
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Figure II.1: Comparison of allele frequencies between populations for all SNP markers 
genotyped in the International HapMap Project. 
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Figure II.2: The first 2 Principal Components from PCA of 142 mixed HapMap Project 
human samples. 
 
The first and second principal components explained 60.77% and 1.34% of total 
variability respectively. 
2.6.3 Genome-wide association eQTL analysis 
I implemented the three methods described above to perform association mapping of 
expression quantitative trait loci (eQTL) using the gene expression and SNP marker 
datasets. The analysis was carried out on the CEU and CHB+JPT samples separately or 
jointly. An eQTL in the present analysis was defined as an independent peak in the p-
value profile across a given chromosome. Peaks occurring within 5 Mb of adjacent 
peaks were taken as a single eQTL peak because of insufficient evidence to declare the 
existence of multiple eQTL peaks over such narrow intervals (Morley et al., 2004). The 
eQTL location was defined as the location within the peak with the smallest p-value. To 
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account for the large number of tests, I set the significance level at nominal 
82 . 5 1 0P −< × ( 0 .0 5
c
P < after Sidak correction), a conservative level also used 
previously (Spielman et al., 2007, Westfall and Young, 1993).  A cis-regulated eQTL 
was operationally defined by the presence of significant association with a SNP in the 
region 500 kb upstream of the start of the transcript to 500 kb downstream of the 3’ end; 
otherwise, the eQTL was classified as trans-acting. Table II.13 summarizes the number 
of eQTL detected by the three methods (Method 1 developed in the present study, 
Method 2 the simple regression analysis employed by Spielman et al in 2007, and 
Method 3 the multiple regression analysis) from the Europe derived, Asia derived 
samples and their mixed respectively.  
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Table II.13: The number of eQTLs detected by three different methods (Methods 1, 2, 3 or M1, 2, 3 accordingly) or detected 
common between two of these methods from the CEU, CHB+JPT and their mixed samples.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
M3a is for Method 3 when individuals were randomly assigned to the Europe derived sample (CEU) with probability of 58% or 
to the Asia derived sample (CHB+JPT) otherwise.   
 
The CEU samples The CHB+JPT samples The mixed CEU and  CHB+JPT samples The number of eQTLs 
per expression trait M1 M2 M1+2 M1 M2 M1+2 M1 M3 M1+3 M3a M3+3a 
1 280 312 225 263 255 209 206 251 145 398 89 
2 58 57 33 43 41 25 16 13 5 136 1 
3 20 21 10 13 16 7 2 7 2 97 0 
4 10 16 6 8 6 4 2 2 1 72 0 
5 4 4 1 5 6 2 0 0 0 48 0 
6 3 1 1 1 3 1 0 0 0 37 0 
7 3 3 1 0 2 0 0 0 0 22 0 
8 0 2 0 1 0 0 1 0 0 22 0 
9 2 1 1 0 0 0 0 1 0 14 0 
>=10 19 22 5 6 7 1 2 2 1 1,111 1 
Total eQTLs 1,009 1,149 912 633 670 554 296 354 226 1,975 240 
        cis-eQTLs 21 22 21 48 49 48 51 58 51 618 53 
          trans-eQTLs 988 1127 891 585 621 506 245 296 175 1,339 187 
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It can be seen that the eQTL analysis results from the CEU and CHB+JPT samples are 
quite comparable between Method 1 and 2 in terms of the number of detected eQTLs 
and their map locations, suggesting a comparable predictability of the two methods in 
the absence of population structure. In the mixed sample, 64% of eQTL detected by the 
multiple regression analysis (Method 3) with use of full population membership 
information can be recovered by the method developed in the present study (Method 1), 
confirming the predictability of the latter in the presence of the population structure. I 
explored the predictability of Method 3 when individuals were randomly assigned to 
the Europe derived sample (CEU) with probability of 58% or to the Asia derived sample 
(CHB+JPT) otherwise. The analysis showed that only 12% (240/1,975) of eQTL 
detected by the method with the partial population membership information was 
consistent with those detected by the same method with the full membership 
information, suggesting that the predictability of the method depends heavily on 
certainty of the membership information and that the method may generate a large 
proportion of false positives when the information is not complete.  
The POMZP3 and HSD17B12 (on the human chromosome 7 q11.23 and chromosome 
11 q11.2 respectively) are two well-characterized and cis-regulated genes (Campino et 
al., 2008, Cheung et al., 2005, Morley et al., 2004, Ouyang et al., 2008, Peng et al., 
2007, Spielman et al., 2007). Although all the three methods considered here were able 
to detect the previously identified cis-regulators from the three samples, there were a 
large number of spurious association signals predicted from the simple regression 
analysis (Method 2) with the mixed sample (Figure II.3: A and B, respectively). It is 
clear that these spurious associations were effectively removed in the analysis with 
Method 1, reflecting the effectiveness of the latter in controlling the false positives 
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(Figure II.3: C and D, respectively).  In the mixed samples, Method 1 was able to reveal 
296 significant eQTL, 51 of which were cis-regulators (Table II.13). Firstly, the cis- 
eQTL predicted here include all the 11 cis-acting regulators reported by Spielman et al. 
(Spielman et al., 2007) who performed the simple regression analysis (Method 2) in the 
CEU and CHB+JPT samples separately. In addition to 16 previously detected cis- 
acting factors, Method 1 detected 35 novel cis- eQTL and all the eQTL explained 
20~70% of variability in expression of the genes regulated (Table II.14). I compared the 
245 trans-regulators detected by the novel method from the mixed sample against the 
Gene Ontology (GO) Molecular Function annotation database 
(http://www.geneontology.org/) and found that 101 (42%) trans-eQTLs predicted were 
mapped into the category of transcriptional factors, 82 (33%) trans-regulators played a 
role in signal pathway activity. In total, 75% trans-regulators predicted by the present 
method were previously known to play a role in gene regulation. All these reveal a 
significantly improved statistical power of the present method in detecting the true 
genetic associations.  
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Figure II.3: Manhattan plots for the genome-wide eQTL analysis of two genes POMZP3 
and HSD17B12; Quantile-quantile (QQ) plots to compare the distributions between 
expected and observed p-values. 
 
Plots show score (-log10 p-value) for all SNPs by physical position for POMZP3 and 
HSD17B12 respectively based on simple linear regression (Method 2, a and b) and 
corrected linear regression (Method 1, c and d) in 142 mixed population samples. 
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Table II.14: The 51 cis-eQTLs predicted by Method 1 from the mixed sample  
 
NUM Gene cis-SNP ID SNP position P-value 
 
2R  Reference 
1 UGT2B17 rs3100645 Chr4:69806739 2.22E-16 0.38 [a] 
2 POMZP3 rs2005354 Chr7:75856016 3.87E-28 0.58 [a] , [b] 
3 PEX6 rs2395943 Chr6:42987528 3.13E-17 0.40 [a] 
4 PSPHL rs10243293 Chr7:55583849 2.25E-10 0.25 [a] , [b] 
5 CSTB rs2838386 Chr21:44080386 4.95E-12 0.29 [a] , [b] 
6 DNAJD1 rs2281778 Chr13:41395977 2.64E-13 0.32 [a] 
7 AP3S2 rs4932265 Chr15:88153061 1.24E-11 0.28 [a] 
8 HSD17B12 rs1061810 Chr11:43842243 4.77E-16 0.37 [a], [b] 
9 NUBP2 rs1065663 Chr16:1779024 2.02E-09 0.22 [a] 
10 B4GALT1 rs10124479 Chr9:33126233 5.94E-10 0.24 [a] 
11 TPP2 rs1887355 Chr13:100933170 1.09E-08 0.21 [a] 
12 IRF5 rs12155080 Chr7:128212697 7.33E-18 0.41 [b] 
13 CHI3L2 rs942694 Chr1:111082865 1.20E-09 0.23 [b] 
14 CPNE1 rs12480408 Chr20:34950229 1.56E-19 0.44 [b] 
15 CTSH rs10400902 Chr15:76947435 6.90E-15 0.35 [b] 
16 GSTM2 rs366631 Chr1:109551199 8.83E-26 0.54 [b] 
17 DFNA5 rs12700538 Chr7:24379328 1.35E-09 0.23 - 
18 HEBP2 rs2076273 Chr6:138684210 5.80E-09 0.21 - 
19 EVI2A rs2107359 Chr17:29842786 1.29E-08 0.20 - 
20 CRYZ rs10890142 Chr1:74549064 5.40E-09 0.21 - 
21 PARP4 rs7317850 Chr13:22792037 1.59E-09 0.23 - 
22 RRM1 rs10767857 Chr11:4132198 4.92E-13 0.31 - 
23 RPL31 rs12472882 Chr2:101267759 3.70E-23 0.50 - 
24 HLA-DPB1 rs9277463 Chr6:33100194 5.46E-30 0.60 - 
25 TSG101 rs1395320 Chr11:18512504 4.37E-12 0.29 - 
26 DDX42 rs1043127 Chr17:62264581 4.50E-17 0.39 - 
27 MEST rs12672246 Chr7:129671295 6.04E-09 0.21 - 
28 AMFR rs2440468 Chr16:56196080 9.57E-15 0.35 - 
29 GSTM3 rs1332018 Chr1:109581699 1.24E-08 0.21 - 
30 ECD rs6480700 Chr10:74446293 7.26E-10 0.24 - 
31 MTRR rs326123 Chr5:7929599 2.17E-13 0.32 - 
32 RABGGTA rs3940231 Chr14:22738491 7.23E-16 0.37 - 
33 BACH1 rs733610 Chr21:29576646 2.66E-15 0.36 - 
34 GSTM1 rs366631 Chr1:109551199 2.72E-27 0.57 - 
35 SLC7A7 rs12884337 Chr14:21263242 1.15E-11 0.28 - 
36 TAP2 rs241448 Chr6:32843645 2.11E-16 0.38 - 
37 APOBEC3B rs17000581 Chr22:37608815 2.47E-09 0.22 - 
  
104 
 
38 NT5C2 rs10883824 Chr10:104477484 4.01E-16 0.38 - 
39 HBS1L rs12663447 Chr6:135297596 2.08E-24 0.52 - 
40 HLA-DQB1 rs9275141 Chr6:32697538 5.55E-15 0.35 - 
41 BTN3A2 rs9366653 Chr6:26462226 1.06E-16 0.39 - 
42 TLR1 rs3924112 Chr4:38692990 1.03E-13 0.32 - 
43 MXRA7 rs1014390 Chr17:75310009 1.29E-13 0.32 - 
44 CD47 rs6768207 Chr3:109345802 2.88E-11 0.27 - 
45 GLT8D1 rs736408 Chr3:52792702 5.38E-09 0.21 - 
46 TIMM13 rs3848633 Chr19:2360880 1.47E-17 0.40 - 
47 POLR1D rs9512760 Chr13:25971662 1.23E-08 0.21 - 
48 SMUG1 rs3136375 Chr12:52867203 8.83E-13 0.30 - 
49 POLR1E rs10758432 Chr9:37478009 7.49E-11 0.26 - 
50 ERAP2 rs2548540 Chr5:96304251 4.95E-39 0.70 - 
51 IPP rs12091503 Chr1:45521162 6.67E-17 0.39 - 
 
a for ‘Spielman RS, Bastone LA, Burdick JT, Morley M, Ewens WJ, et al. (2007) 
Common genetic variants account for differences in gene expression among ethnic 
groups. Nature Genetics 39: 226–231.’ 
b for ‘Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, et al. (2004) Genetic 
analysis of genome-wide variation in human gene expression. Nature 430: 743–747.’ 
 
It is interesting to note that the number of cis- eQTL detected from the mixed samples is 
larger than that from the component samples separately whilst a much larger number of 
trans- eQTL are detected in the component samples than in their mixed. This 
observation may reflect the fact that an increase in size of the mixed sample has 
enhanced the statistical power to detect cis- eQTL and thus led to an increased number 
of cis- eQTL detected. However, if linkage disequilibria between genes regulated and 
their trans- regulators are in opposite directions between different populations, the LD 
may be counter-balanced in the merged population, and thus decrease the number of the 
trans- eQTL to be detected. Despite a relatively small number of cis eQTLs detected, 
the cis-regulated effects were generally stronger than those in trans, with the most 
coefficients of determination 2 5 0 %R > regulators in cis (Figure II.4), consistent with 
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findings in human and mice (Dixon et al., 2007, Hubner et al., 2005, Morley et al., 2004, 
Schadt et al., 2003). 
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Figure II.4: Histograms of coefficient of determination for eQTLs from 142 mixed sample set.  
a for Method 1 and b for Method 3 
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2.7 Discussion 
Linkage disequilibrium (LD) based association mapping has been advocated as the 
method of choice for identifying chromosomal regions containing disease-susceptibility 
loci or loci affecting other complex quantitative traits of interest (Risch and Merikangas, 
1996). However, it is well known that the presence of population structure can result in 
false positive inference of genetic association between a test marker and trait loci. 
Various methods have been proposed in the literature to tackle this problem (Pritchard 
et al., 2000a, Pritchard et al., 2000b, Satten et al., 2001, Zhu et al., 2002, Hoggart et al., 
2003, Risch and Merikangas, 1996) and many of them have heavily depended on 
adequate prediction of the population structure (Pritchard et al., 2000a, Price et al., 
2006). Efficiency of the methods is thus largely affected by adequacy of population 
structure prediction. It has been shown that adequate prediction of population structure 
is in fact not a feasible task (Yu et al., 2006). On the other hand, it is obvious that effect 
of the population stratification on association tests may vary across different regions of 
the genome (Weiss and Clark, 2002, Mackay and Powell, 2007, Remington et al., 2001). 
Thus, the methods designed to correct for the stratification caused spurious associations 
through adjusting the test statistic by subtracting a constant inflation in the statistic may 
not perfectly reflect this observation (Risch, 2000, Wang et al., 2005). To address these 
problems, I have proposed here a statistical method for correcting for stratification 
confounding effect in LD-based QTL mapping. The method extends the idea of using 
control markers to correct for background effect on a statistical test for significance of 
QTL at any given genome position in linkage-based QTL mapping analysis (Alexander 
et al., 2009) and enables the effect of population stratification in the LD-based QTL 
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analysis to be adjusted at a local basis (Wang et al., 2005). I presented here a simple but 
effective method to determine the control marker and demonstrated that incorporation 
of control markers would not cause any significant statistical problem even though 
population structure does actually not exist.  
The new method developed in this study is tested and compared with other most 
popularly implemented methods in the literature of genetic association studies through 
intensive computer simulation studies and analysis of large scale and high quality gene 
expression and SNP datasets for mapping expression QTL. These analyses strongly 
support outperformance of the new method for its significantly improved statistical 
power to detect genuine LD between any polymorphic markers and putative trait loci 
and its effectiveness in controlling spurious association due to population stratification. 
Worthwhile, although the multiple regression analysis based on a mixed linear model 
does also provide a control of the influence of population stratifications, its efficiency 
depends heavily on accuracy of prediction of the population structure and on accurate 
allocation of individuals’ membership to the constituent populations. Any bias in the 
structure prediction and uncertainty in the membership allocation may lead to severe 
consequence on its analytical efficiency. It has been argued that several factors may 
substantially influence or even disable the prediction of population structure (Zeng, 
1994, Patterson et al., 2006). Therefore, the method virtually avoids the need for 
sophisticated prediction of population ancestry of individuals and, in turn, effectively 
controls any bias embedded with the prediction. The method was designed for 
modelling and analyzing samples collected from different ethnical (or ecological) 
cohorts (or populations) with or without a clear clue about their genetic diversity. This 
is a very popular practice in many GWAS analyses, particularly with human samples 
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(Spielman et al., 2007, Kang et al., 2008, Fung et al., 2006, Satake et al., 2009, Simon-
Sanchez et al., 2009, Cockram et al.).  
Wang et al has proposed use of a single null marker to correct for population structure 
in a candidate gene based association analysis using case and control samples (Wang et 
al., 2005). In their settings, the null marker was fitted as a dichotomous variable in 
parallel to the test candidate gene in a logistic regression model, and the influence of 
population structure on the association test at the candidate gene was adjusted by 
subtracting the regression coefficient associated with the null marker from the 
coefficient associated with the gene. Question rises to the parallel formulation: which is 
the major effect to be tested in the model? In contrast, the novel method was developed 
upon a rigorous population genetics model in which contributions of three different loci 
(i.e. the test marker, QTL and control marker) to the linkage disequilibrium pattern are 
properly formulated. The method is thus more appropriate for population based 
association studies. Although theoretical analysis was built on a single marker test, the 
idea and principle of the method could be extendable to the haplotype-based association 
mapping which uses information from multiple marker loci (Schaid et al., 2002, Schaid, 
2004). This is because the population confounding term is linearly attached to the main 
disequilibrium terms in the covariance between the test polymorphism and trait effect 
(seeing equation II-4.6). My goal is to remove the confounding term from the 
covariance and, thus form of the main disequilibrium terms either in genotype at an 
individual marker locus or in haplotypes at multiple marker loci will not affect the way 
to correct for the confounding term. Although the method was presented for two 
genetically divergent populations, the overall pattern of LD between any test marker 
and trait locus in their admixed population may become theoretically more complicated 
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when the admixture involves more than two populations. Before having invested more 
theoretical investigation to the problem, I would suggest to merge those genetically less 
divergent objects together as I did in the present analysis with the Chinese and Japanese 
samples and to correct for the stratification raised from between the most divergent 
populations such as the European derived and the Asia derived samples. 
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Chapter III 
General introduction: regulation of gene 
transcription 
3.1 Overview 
Transcription is the first essential procedure leading to gene expression. In this step, 
DNA sequence of a particular gene is copied to create a RNA molecule. The 
transcription process for gene expression is common to all known organisms, including 
viruses, prokaryotes and eukaryotes. However, all genes in the genome are not equally 
transcribed (or expressed). Only a few genes in the genome are transcribed in all tissues 
and at all of the time. For example, a typical human cell has only about 3% to 5% of its 
total genes transcribed at any time, which are considered as ‘house-keeping’ genes to 
maintain the basic biological process for life (Hsiao et al., 2001). Meanwhile, most 
genes in the genome are differentially transcribed in different tissues (or cells) and at 
different development stages. The different transcription levels can be modulated by 
several regulation mechanisms, such as transcription factor, microRNA, DNA 
methylation and histone protein binding. In genetics, the regulation of gene 
transcription can drive organisms to produce the RNA in particular tissues (or cells), at 
particular times and even at particular abundances; in order to make the organisms to 
flexibly adapt different stages of development, variable environments and external 
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signals. Thus, understanding the transcriptional regulation mechanism will be important 
for both biological and medical research.  
3.2 Regulation of gene transcription 
As mentioned above, all of genes in the whole genome are not uniformly transcribed 
and expressed in all cells (or tissues) and at any times. The transcription process must be 
controlled to allow the cell to produce some particular transcriptions when and where 
they are needed, and even how much the particular transcription products are needed 
(Moore, 2005, Chen and Rajewsky, 2007, Levine and Tjian, 2003). Thus, the regulation 
of gene transcription is vital to give organisms the ability to drive the cell differentiation 
and morphogenesis processes, to adjust to environmental changes, to response to both 
internal and external signals, etc (Cornell et al., 2010). Moreover, regulation of 
transcription may also have the function of a substrate for evolutionary change, since 
modulation of the location, timing and abundance of gene transcriptions can have an 
esoteric effect on the roles (or functions) of the gene in different cells or tissues, even in 
different species (Brawand et al., 2011, Khaitovich et al., 2006, Robertson, 2010, Tuch 
et al., 2008).  
The regulation can take place at two possible stages during synthesizing of the matured 
RNA (Fenton, 1992). First, any step of gene transcription can be regulated, from pre-
initiation to RNA processing. Second, the transcription can be regulated after they are 
completely produced via post-transcription regulation mechanisms (Halbeisen et al., 
2008). For the post-transcription regulation, the stableness of the transcription products 
mainly participates in the regulation of transcription: the unstable RNA molecules can 
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be easily degraded; hence it results in low transcription abundances. Briefly, the 
regulation of transcription is a complicated process, which simultaneously combines 
multiple mechanisms to dynamically control the transcription of gene. According to the 
sources of influence, regulation of gene transcription can be divided into three main 
routes: a) by regulatory proteins, such as transcription factors, repressors and activators; 
b) by non-coding RNA molecules, including microRNAs, small interfering RNAs 
(siRNAs) and long non-coding RNAs (lncRNAs); 3) by epigenetic regulations, for 
example, the structure changes of chromatins and DNA methylation. 
3.2.1 Regulatory proteins 
Regulatory proteins are a group of proteins that involve in regulating gene transcription 
process. Generally, the typical regulatory proteins must be bound to particular DNA 
binding sites to touch off the up or down regulation functions (Johnson and McKnight, 
1989). The DNA binding sites are usually located at the promoter region or around the 
transcription start site (TSS), and can be divided into multiple groups, such as enhancers, 
operators, insulators and silencers (Berg et al., 1982). The mechanisms of regulatory 
proteins may also vary, from prohibiting the RNA polymerases binding to core 
promoters, to encouraging the transcription as activators. Briefly, the regulatory proteins 
can be divided into at least 4 different mechanisms: 1) general transcription factors, 2) 
specificity factors, 3) repressors and 4) activators.  
1) General Transcription Factors (GTFs), also referred as the basal transcription 
factors, are a group of proteins which can bind to the specific sites on DNA 
sequence to initially switch on the transcription process (Orphanides et al., 
1996, Lee and Young, 2000). Generally, the GTFs guide and place the 
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appropriate RNA polymerase at the start site of a coding sequence and then 
conduct the polymerase to transcribe it into RNA. In bacteria, it has only one 
general transcription factor, called as sigma factor. In eukaryotes, transcription 
initiation involves several GTFs, including TFIIA, TFIIB, TFIID, TFIIE and 
TFIIF (Latchman, 1997). 
2) Specificity Factors are a set of proteins which can only bind to a few specific 
promoters, and make these promoters more or less likely to bind with RNA 
polymerase (Mitchell and Tjian, 1989).  
3) Repressors are a set of proteins that can attach to the operator regions 
(Herschbach and Johnson, 1993, Rojo, 2001). The operator is a segment of 
coding sequences which are overlapped with or closed to the promoter region. 
By binding to the operator, the repressor can physically block the RNA 
polymerase to bind to the promoter region, and further prevent the 
transcription of the genes. 
4) Activators are also typical DNA-binding proteins, which can obviously 
encourage the transcription levels of the targeted genes (Busby and Ebright, 
1999). The activators are functioned by binding to a specific site of DNA 
sequence (activator site) located at or very near a promoter and making 
interactions with the subunits of RNA polymerase.  
3.2.2 RNA based transcriptional regulation 
Furthermore, the RNA based transcriptional regulation is also widespread in most 
eukaryotes (Barrandon et al., 2008, Kurokawa et al., 2009). Recently, the biological 
functions of non-coding RNA molecule in modulating gene transcription have become a 
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topic of intense interests (Mattick, 2009). A typical RNA based mechanism is often 
through non-coding RNAs as media to control the transcriptions, including microRNA, 
small interference RNA and long non-coding RNA.   
1) microRNA are a set of short (about 22 nucleotides) non-coding RNA 
molecules which can bind to their complementary sequences in the 3’ end of 
target mRNAs, and repress the transcription synthesize (Bartel, 2004, Bartel 
and Chen, 2004). microRNA was first identified during research on 
development in C. elegans regarding the Lin-14 gene (Lee et al., 1993). This 
study found that the transcription level of Lin-14 gene could be regulated by 
presence of a short RNA sequence that contains only 22 nucleotides and is 
completely complementary to the 3’ UTR of target gene. After that around 
20,000 microRNAs have been identified in over 168 eukaryotic species 
including human, mouse, rat and Arabidopsis (Lagos-Quintana et al., 2003, 
Lim et al., 2003). Furthermore, these microRNAs can bind to more than 60% 
of all annotated genes and result in the negative regulation of the transcription 
level for target genes (Wightman et al., 1993, Enright, 2003, Ambros, 2004, 
Lewis et al., 2005, Friedman et al., 2009). It has demonstrated that 
microRNAs involve in several mechanisms of the post-transcriptional 
regulation, including sequestering, transcript degradation and translational 
suppressing (Ambros, 2004, Bartel, 2004, Bartel and Chen, 2004, Zeng et al., 
2003). Thus, microRNAs are an essential part of transcription regulation 
system and can further involve into most biological developments and 
processes, such as cell cycle, proliferation, metabolism, development and 
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organogenesis (Brennecke et al., 2003, Cuellar and McManus, 2005, Poy et 
al., 2004).   
2) Small interfering RNAs (siRNAs), also termed as short interfering RNAs or 
silencing RNAs, are another set of post-transcriptional regulators, which are 
double-stranded RNA sequence in 20~25 nucleotides length (Hutvagner et al., 
2004, Zeng et al., 2003, Doench et al., 2003). siRNAs and their biological 
function in gene transcriptional regulation has been first found by Hamilton 
and Baulcombe in 1999. Their research revealed that siRNA could interfere 
with the transcription synthesize of specific genes containing complementary 
sequence. 
3) Long non-coding RNAs (lncRNAs) are usually defined as non-protein coding 
RNA sequences that longer than 200 bps (Mercer et al., 2009). During last 10 
years, it is found that the lncRNAs played many roles in gene transcription 
regulation (Rinn and Chang, 2012). At first, lncRNAs can impede the 
transcription factors binding to the targeted genes, resulting in inducing 
transcription initiation (Kwek et al., 2002) or repressing transcription 
elongation (Yang et al., 2001, Yik et al., 2003). In addition, lncRNAs also 
play multiple roles in post-transcriptional regulation. Similar to microRNAs 
and siRNAs, they can bind to the complementary mRNAs. The structure of 
RNA duplexes between lncRNAs and their complementary target RNA 
products are reported to shroud the essential regions in the mRNAs required 
to bind trans-acting transcription factors, potentially resulting in post-
transcriptional regulations (Chodroff et al., 2011). 
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3.3.3 Epigenetic regulation 
More recently, it has become a common consensus that there is a considerable influence 
of non-nucleotide-sequence change effects on gene expression, which are termed as 
‘epigenetic regulation’ (Attwood et al., 2002, Mattick et al., 2009, Kurokawa et al., 
2009, Jaenisch and Bird, 2003). The Human Epigenome Project has stated that 
‘Epigenetics is an emerging frontier of science of the study of changes in the regulation 
of gene activity and expression that are not dependent on gene sequence’ (The Human 
Epigenome Project, 2004). The epigenetics mainly contains two types of chemical 
markers: DNA methylation and histone modification. For many years, the DNA 
methylation has been considered to play a crucial role in epigenetic influencing gene 
expression and widely spread in most eukaryotic species, particular in vertebrates (He et 
al., 2011, Wu et al., 2011, Poetsch and Plass, 2011). But, the extent of function and 
mechanism of DNA methylation in gene expression is still unknown. To better uncover 
many of the unknown of DNA methylation, I comprehensively analyzed the distribution 
patterns and properties of DNA methylation system across several eukaryotic model 
species and multiple tissues, attempted to explore the roles of methylation in gene 
transcriptional regulation. The analyses are fully detailed in chapter IV. 
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Chapter IV: 
Comparative evolutionary epigenetic  
regulation of gene transcription 
4.1 Introduction to DNA methylation based transcriptional 
regulation 
In epigenetics, the post-replicative addition of methyl groups to the 5-position of the 
cytosine pyrimidine rings in the DNA sequences, termed as cytosine ‘DNA 
methylation’, has long been recognized as heritable chemical modification (Holliday 
and Pugh, 1975, Riggs, 1975, Day and Sweatt, 2010, Zhu and Reinberg, 2011, Parle-
Mcdermott and Harrison, 2011) (figure IV.1). The DNA methylation is highly 
conserved in most eukaryotic species, including protists, fungi, plants and animals, 
playing a fundamental role in modulating the biological processes, particularly 
regulation of transcription (He et al., 2011, Chen and Riggs, 2011, Jaenisch and Bird, 
2003, Patra et al., 2008). In previous studies, a prevalent view holds that DNA 
methylation regulates the gene transcription through two different ways (Geiman and 
Robertson, 2002, Herman and Baylin, 2003, Fahrner et al., 2002, Attwood et al., 2002, 
Li, 2002). On one hand, the methylated cytosine bases can physically disrupt the 
binding of RNA polymerases and transcription factors to the appropriate regions of 
target genes. On the other, the methylated DNA sequences may be wrapped by multiple 
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proteins, including methyl-CpG-binding domain proteins (MBDs), histone deacetylases 
and chromatin remodelling proteins, to form complex structures, which can inactivate 
the chromatin and hence silence the transcription of the genes coded in the 
corresponding chromosome region. 
 
Figure IV.1: Addition of a methyl group to the cytosine base in DNA sequence 
 
 
Although the DNA methylation has been widely accepted to play an essential role in 
regulating the gene transcriptions in many species, the distribution patterns and levels of 
DNA methylation appear to vary drastically among different species. Several well-
known eukaryotic model organisms, such as Saccharomyces cerevisiae (yeast) and 
Caenorhabditis elegans (C. elegans), do not encode any DNA methyltransferase-family 
genes and hence lack of DNA methylation in their genomes (Bird, 2002, Suzuki and 
Bird, 2008). Generally, the fungi, plants and invertebrate species, have moderately high 
methylation levels in many domains of the DNA sequences separated by domains of 
completely unmethylated genomic regions. This ‘mosaic’ methylation pattern has also 
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been discovered in a large number of species, including Neurospora crassa, 
Arabidopsis thaliana (Arabidopsis), Zea mays (corn), Oryza sativa (rice), Poplulus 
trichocarpa (poplar), Ciona intestinalis (sea squirt) and Drosophila melanogaster (fruit 
fly) (Chan et al., 2005, Gehring and Henikoff, 2007, Gowher et al., 2000, He et al., 2011, 
Henderson and Jacobsen, 2007, Zilberman et al., 2007, Montero, 1992, Palmer, 2003). 
In contrast, the vertebrate species, particularly mammals, typically exhibit ‘global’ 
DNA methylation patterns (Chen and Riggs, 2011, Robertson, 2005, Rollins, 2006). In 
vertebrates, the whole genome candidate methylation sites are completely methylated 
except those in the promoter regions. The methylation levels in promoter regions of 
vertebrates are highly varying among tissues and cells in different growth conditions 
and stages. The difference in methylation patterns among the eukaryotic organisms 
raises a question of whether it has a similar underlying mechanism at work, or whether 
the DNA methylation is co-opted to divergent biological functions and roles in different 
organisms. It has been found that the ‘mosaic’ methylation in plants and animals mainly 
targeted to the transposable regions is a crucial transcriptional silencing mechanism 
depending on the small interfering RNA (siRNA) modulation (Mette et al., 2000, Chan, 
2004, Chan et al., 2005). However, there is no evidence supporting such a similar 
mechanism in vertebrates. Over the last decades, many studies have been carried out to 
investigate the biological functions that the ‘global’ methylation patterns played in 
vertebrates. It has been speculated that the methylation status and the local density of 
CpG dinucleotides within the promoter regions may act to control the gene transcription 
in vertebrates (Boyes and Bird, 1992, Hsieh, 1994, Weber, 2007). However, this 
hypothesis was based on analyses of limited genes and might not be explicable in 
general situations. The regulated degree of DNA methylation underlies the divergence 
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of gene expression cross different cell lines (or tissues) in vertebrates remains unknown. 
Moreover, why are the promoter regions generally, but not always, unmethylated in 
vertebrates? What is the role or mechanism of the methylation states in promoter 
regions?  These questions are not well explored at present. 
Furthermore, the distributions of candidate methylation sites are also varying among 
eukaryotic species and even among different genome features from the same species. 
Generally speaking, the substrates for DNA methylation are mainly located at 
dinucleotide ‘CpG’ sites in plants and animals, although studies had revealed some cases 
where cytosine within ‘CpHpG’ and ‘CpHpH’ sites were also methylated in plants, 
where H represents any nucleotide expect guanine (Goll and Bestor, 2005). Noticeably, it 
was observed that the abundance of CpG sites in human genome was only a quarter of 
that expected based on the GC content fraction of the human genome sequence 
(Robinson et al., 2004). It has also been observed that there were many short 
chromosomal regions which contained more CpG dinucleotides than the rest of the 
genome, and hence appeared as CpG enriched regions or so-called the CpG islands (Bird, 
1986, Antequera and Bird, 1993, Gardiner-Gardner and Frommer, 1987, Glass, 2007). 
The CpG enriched regions are commonly overlapped with the promoters and many 
studies have shown that the presence of CpG dinucleotides enrichment in the promoter 
region is positively correlated with particular gene expression patterns (Ponger et al., 
2001, Weber, 2007). Based on the analysis by Saxonov et al. (Saxonov et al., 2006), 72% 
of the promoters in the human genome had contained CpG enriched regions. Other 
studies have also revealed that the promoters containing CpG enriched regions in human 
genome were more frequently associated with ‘house-keeping’ genes (Robinson et al., 
2004, Larsen et al., 1992). Although, so far, there are many significant achievements in 
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understanding the functional roles of the DNA methylation system in modulating gene 
transcription of vertebrates, the reason why CpG sites are enriched in promoters and how 
CpGs in promoters control the gene transcription still remain unanswered. In addition, 
most of our knowledge about the pattern of CpG sites distribution and the mechanism 
about the ‘global’ DNA methylation system involved in the regulation of gene 
transcription had been derived mainly from the studies of human species. What is the 
pattern of distribution of CpG sites in other vertebrates? Whether the distribution pattern 
is conserved across vertebrates? And, whether the regulatory mechanism of DNA 
methylation is conserved in vertebrates? All of these questions still remain unanswered. 
To understand the transcriptional regulatory roles  the DNA methylation system 
functioned in vertebrates’ genomes, I firstly examined the distributions and properties 
of ‘CpG’ dinucleotides in 10 diverse eukaryotic genomes, including Homo sapiens 
(Human), Mus musculus (Mouse), Rattus norvegicus (Rat), Bos taurus (Cow), Canis 
familiaris (Dog), Gallus gallus (Chicken), Danio rerio (Zebrafish), Drosophila 
melanogaster (Fruitfly), Caenorhabditis elegans (C. elegans), Arabidopsis thaliana 
(Arabidopsis). I found that the distribution pattern of CpG sites is quite similar in the 6 
higher vertebrates’ genomes. These conserved distribution patterns of CpG sites in 
vertebrates are an interesting starting point for studying the regulatory mechanisms of 
DNA methylation in vertebrates. I also analyzed and compared genome-wide 
transcription and DNA methylation profiles across multiple cell lines (or tissues) of 
human genome by microarray technology. The results revealed two distinct 
methylation patterns and regulatory mechanisms in human genomes. Finally, the results 
of GO analysis provided strong support for the propose that the primary role of the 
DNA methylation system to control gene transcription was highly conserved in 
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vertebrates and could be further divided into two distinct classes according to the 
distribution of CpGs in promoter regions. 
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4.2 Datasets and analytical methods 
With the development of whole genome sequencing technique and wide applications of 
microarray analysis, a large number of publicly available datasets described below were 
employed to investigate the DNA methylation mediated transcriptional regulation in 
vertebrate species. 
4.2.1 Whole genome sequence datasets and genomic features annotation 
information 
Whole genome sequence data for each of 10 eukaryotic model organisms was 
downloaded from the UCSC genome bioinformatics database 
(http://hgdownload.cse.ucsc.edu/downloads.html) (table IV.1). The genomic annotation 
information was obtained from the genome annotation database of UCSC GENOME 
BROWSER (http://genome-archive.cse.ucsc.edu/downloads), the Exon-Intron Database 
(EID, http://bpg.utoledo.edu/~afedorov/lab/eid.html), The Arabidopsis Information 
Resource (TAIR) (http://www.arabidopsis.org/tools/bulk/sequences/index.jsp) and 
Mammalian Promoter Database (MPromDb, http://mpromdb.wistar.upenn.edu/). A 
FORTRAN program was developed to parse these sequence data and identify the 
locations of CpG sites, the proportions of CpG dinucleotides, the fractions of GC 
content in different genomic features of each selected organisms. 
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Table IV.1: Data resources and information of 10 selected model species 
Species Classification 
Genome 
version 
Number of 
promoters 
Data resources 
Human Homo sapiens higher 
vertebrate hg18 34,257 
UCSCdb,EID, 
MPromDb 
Mouse Mus musculus higher 
vertebrate mm9 38,330 
UCSCdb,EID, 
MPromDb 
Rat Rattus 
norvegicus 
higher 
vertebrate rn4 12,721 
UCSCdb,EID, 
MPromDb 
Cow Bos taurus higher 
vertebrate bosTau6 10,739 UCSCdb,EID 
Dog Canis familiaris higher 
vertebrate canFam3 1,481 UCSCdb,EID 
Chicken Gallus gallus higher 
vertebrate galGal4 3,640 UCSCdb,EID 
Zebrafish Danio rerio lower 
vertebrate danRer7 12,189 UCSCdb,EID 
Fruitfly Drosophila 
melanogaster Insect dm3 16,983 UCSCdb,EID 
C.elegans Caenorhabditis 
elegans Nematode ce10 8,849 UCSCdb,EID 
Arabidopsis Arabidopsis 
thaliana Plant TAIR9 25,516 TAIR 
4.2.2 Distribution patterns of CpG sites in promoter regions 
In statistics, Poisson distribution is a discrete probability distribution that expresses the 
probability of a given number of events occurring in a fixed interval of space if these 
events independently occur with a known average rate. Thus, Poisson distribution can 
be used to test randomness in distribution of discrete random events. I inspected 
whether occurrence of CpG sites in promoter regions could be modelled as the expected 
Poisson distribution. In the human promoter regions, it had an average of 51 CpG sites 
for every 1000 bp length. Hence, I could estimate the expected probability of promoters 
with 0~25 CpG sites in a 1000 bp interval as: 
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where e is the base of the natural logarithm (e=2.718), k is the number of occurrences of 
CpGs in 1000 bp sequence, λ is the average number of CpGs in 1000 bp. In the same 
way, I also calculate the expected Poisson probabilities of promoters with 26~40, 41~50, 
51~60, 61~75 and >75 CpG sites in 1000 bp length. And then, I identified the observed 
proportions of promoters with 0~25, 26~40, 41~50, 51~60, 61~75 and >75 CpG sites in 
1000 bp length. Due to variation in length of promoters, I needed to normalize the 
promoters’ length into a fixed value of 1000bp. Pearson’s chi-squared test was used to 
assess the goodness of fit between observed frequency and expected probability: 
2 2Pearson's ( ) /O E Eχ = −∑      (IV-2.2) 
with degrees of freedom 6 2 4d f = − = . I implemented Poisson distribution 
analysis for each of the 10 selected model species under the studies. 
4.2.3 Identification of promoter classes 
According to distribution pattern of CpG dinucleotides in the promoter regions from 
each vertebrate species, the promoters could be grouped into two classes to distinguish 
High CpG density promoters (HCP) and Low CpG density Promoters (LCP). For every 
selected vertebrate, I calculated the GC fraction and the ration of observed /expected 
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(O/E) CpGs in the promoter region of each annotated genes. The O/E ratio was 
estimated as follows: 
 of 
 of /
 of  of  
number CpG
ratio Obs Exp N
number C number G
= ×
×
   (IV-2.3) 
where N is the length of the promoter. These two classes of promoters was defined 
using following criteria: the HCP category contains promoters with CpG 
observed/expected (O/E) ratio above 65% and GC fraction over 55%; the LCP group 
includes promoters with CpG O/E ratio < 65% and GC fraction < 45%; the rest 
unclassified promoters are considered as Intermediate CpG density Promoters (ICP) as 
proposed in (Weber, 2007, Saxonov et al., 2006). The analyse described above was 
performed through FORTRAN programs. 
4.2.4 Identification of homologous genes and interspecies conservation analysis 
The homologous genes across 6 higher vertebrate species were downloaded from the 
NCBI-HomoloGene Database (release 65, http://www.ncbi.nlm.nih.gov/homologene/) 
(table IV.2). The NCBI-HomoloGene is a comprehensive tool for detection of 
homologues across the annotated genes of all 6 completely sequenced vertebrate 
genomes which were recruited in the current analysis. It uses both DNA sequence and 
protein sequence data to calculate the similarities attributable to descent from a common 
ancestor, and then identify the homologous gene families. When a gene was confirmed 
homologue between two vertebrates, I checked whether their promoters were grouped 
into the same classification in the two species. If the promoter classifications were the 
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same, I considered the distribution of the CpG sites in the promoter of this homologous 
gene was conserved between the two species. 
Table IV.2: Datasets of the homologous genes for 6 higher vertebrate species 
Species Total number of 
genesa 
Number of 
Homologue genesb 
Human  19,565 18,631 
Mouse 22,566 16,841 
Rat 21,943 17,950 
Cow 21,121 17,472 
Dog 19,176 17,187 
Chicken 16,731 13,150 
a: the number of annotated genes used in homologue gene analysis 
b: the number of homologue genes identified with the other species 
4.2.5 Genome-wide DNA methylation data and gene expression data 
The methylation data was collected from 28 different human tissue or cell line samples. 
The genome-wide DNA methylation levels for each of these samples were extracted 
using the Illumina HumanMethylation27 BeadChip platform, which consists of 27,578 
probe units (representing 27,578 CpG sites and covering over 14,000 genes’ promoter 
regions). The methylation microarray raw data were downloaded from NCBI Gene 
Expression Omnibus (GEO) database under the series accession number GSE17769, 
GSE20872, GSE24087 and GSE28356 (http://www.ncbi.nlm.nih.gov/geo). The 
methylation levels for each CpG site and each sample were calculated by the standard 
Illumina procedure-Genome Bead Studio Software, which provides a quantitative 
measurement of DNA methylation. The methylation level varied from 0 to 1, reflecting 
to as completely unmethylated to methylated. 
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The gene expression data were obtained from 107 different human tissues (or cell lines). 
The mRNA from each sample was extracted, and then hybridized to Affymetrix U133 
human expression microarrays. The Affymetrix U133 human expression microarray 
GeneChip, which contained over 45,000 probe sets for representing approximately 
33,000 well annotated human genes, was an ideal tool to assess whole human genome 
expression. After RNA hybridization to microarray, raw signal intensities were acquired, 
and then analysed by the standard Affymetrix algorithm MAS5.0 and normalized by the 
global median scaling method. Here, all gene expression analyses were implemented by 
using R scripts. The raw microarray data from the 107 different human tissue or cell line 
samples was downloaded from NCBI Gene Expression Omnibus (GEO) database under 
the series accession number GSE7127, GSE17768, GSE24089 and GSE26133.  
4.2.6 GO annotation datasets and overrepresentation analysis 
The genome-wide GO annotation information for each of the 6 selected vertebrates was 
downloaded from Gene Ontology database (http://www.geneontology.org/) (table IV.3). 
To identify GO terms overrepresented in the HCP or LCP grouped genes, the binomial 
test was employed to compare the number of ORFs in a gene group associated with a 
GO term of interest to the number of genome-wide ORFs associated with that GO term. 
For each GO term, a Z statistic is computed as following: 
( )
(1 )
d G
G G
d
F FZ
F F
N
−
=
−
        (IV-2.4) 
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where 
dF was the fraction of the HCP (or LCP) promoter genes annotated into the 
specific GO term, 
GF was the fraction of all annotated genes in that term, and dN was the 
total number of genes with the HCP (or LCP) promoters. A GO term was determined to 
be significantly overrepresented in a group when Z>4.75 ( 61.0 10P −< × , after the 
Bonferroni correction for multiple tests). 
Table IV.3: Datasets from Gene Ontology database for 6 higher vertebrate species 
Species Number of annotated 
genesa 
Number of 
annotations 
Human  45,678 344,494 
Mouse 25,503 281,825 
Rat 25,106 260,633 
Cow 21,582 112,409 
Dog 19,891 106,432 
Chicken 16,832 96,743 
a: the number of genes which are characterized and annotated in GO database  
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4.3 Analysis and Result 
4.3.1 Overview of the genome-wide distributions of CpG sites and GC contents in 
several species  
To properly quantify the extent by which DNA methylation affects gene transcription, 
one needs knowledge of the distribution patterns of candidate methylation sites in the 
genome. In animals and plants, methylation primarily occurs at the CpG sites (Goll and 
Bestor, 2005). Thus, I first overviewed the distributions of the GC content fraction and 
the CpG concentration in different genome feature regions. Although the distribution of 
GC content and CpG density had been thoroughly analyzed for humans (Saxonov et al., 
2006), little is known about the relevant information in other species. With the fast 
development of DNA sequencing techniques, numerous species have been fully 
sequenced. Here, I carried out an investigation of distribution of the GC content and the 
CpG sites in different genome feature regions of 10 well-studied eukaryotic model 
species. In these 10 model species, 6 of them (human, mouse, rat, cow, dog and chicken) 
are higher vertebrates, while the rest species (zebrafish, D. melanogaster, C. elegans and 
Arabidopsis) are lower vertebrate, invertebrate or plant.  
Table IV.4 summarized the GC content fractions and the expected and observed 
proportions of CpG sites in different genome feature regions of the selected model 
species. The expected proportions of CpG sites were calculated based on random union 
of C and G nucleotides. Among the 6 higher vertebrate species, the whole genome and 
intron regions had the lowest fraction of GC contents (37.95~42.46%), followed by the 
exon regions which had GC content fractions of 48.88~51.57%. the promoter regions 
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had distinctly higher GC content (52.21~57.29%). Here, the observation was consistent 
with previous studies that the functional sequence had a higher GC content level than 
the entire genome or the non-functional region (Pozzoli et al., 2008). In contrast, for the 
lower vertebrate, invertebrates and plant I found that while the exon regions had higher 
GC contents compared with the entire genome or the intron regions, the promoter 
regions did not show enhanced GC content, but instead showed a similar make up to the 
entire genome or the intron regions. 
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Table IV.4: GC content and distribution of CpG sites in vertebrates, invertebrates and plant  
 
 Higher vertebrates Lower vertebrate, invertebrates and plant 
 GC % CpG %a CpG %b GC % CpG %a CpG %b 
Genome-wide 37.95~42.39 3.61~4.49 0.95~2.08 35.44~41.24 3.14~4.25 3.48~8.11 
Intron 40.37~42.46 4.07~4.50 1.75~2.21 32.14~39.91 2.58~3.98 2.65~7.35 
Exon 48.88~51.57 5.97~6.65 5.35~6.78 42.42~50.00 4.50~6.25 5.89~11.69 
Transcripts 48.47~51.72 5.87~6.69 4.94~6.82 42.59~50.10 4.54~6.27 5.93~11.71 
Promoter  52.21~57.29 6.81~8.21 7.66~11.98 32.42~41.55 2.63~4.32 4.19~9.08 
GC% is the proportion of GC content in different genome features. CpG %a is the expected fraction of CpG dinucleotides based 
on the GC content proportion. CpG %b is the observed fraction of CpGs for different genome features. I separately detect the 
proportions of GC content and CpG % for every model organism, and then summarize the fraction ranges in 6 higher vertebrates 
or 4 lower vertebrate, invertebrates and plant.  
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With regard to CpG sites, it was found that the CpG dinucleotides were consistently 
enriched in promoter regions in the 6 higher vertebrates, consistent with the fact that the 
promoters had higher level of GC contents in these species (Figure IV.2). However, it 
needs to be stressed that, in the 6 higher vertebrates, the observed CpG sites proportions 
were higher than expected in the promoters, but lower than expected in the entire 
genome. In contrast, it was observed a completely different pattern of CpG sites 
distribution in the other four model species (zebrafish, D. melanogaster, C. elegans and 
Arabidopsis), in which the observed proportion of CpGs always exceeding those 
expected and was similar between promoters and the entire genome (Figure IV.2). This 
discrepancy of CpG sites distribution patterns between higher vertebrates and the other 
4 species was significant under the Mann-whitney test (P-value < 0.05). 
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Figure IV.2: Expected and observed proportions of CpGs across the different genomic 
feature regions of 10 model species. 
 
  
144 
 
4.3.2 Analysis of the pattern of the distribution of CpG sites in the promoter 
regions  
To better understand the role of DNA methylation in regulating gene expression, I 
focused on the distribution of CpG sites in the promoter regions. The first question was 
to test whether the CpG sites were randomly distributed in the promoter regions. To 
address this question, I tested if the occurrence of CpG sites in the promoters followed a 
Poisson distribution with parameter λ (i.e. mean of the distribution) being the genome-
wide average number of CpG sites in a fixed promoter length, here 1000 base pairs 
(bps). The number of CpG sites occurring per 1000 bp of the promoter was counted and 
assigned into six categories according to the number of CpG sites: 0~25, 26~40, 41~50, 
51~60, 61~75 and >75 CpG sites. Pearson’s chi-square test was employed to test 
whether the observed fractions of CpG sites numbers classified in the six categories 
were consistent with the expectations based on the Poisson distribution. For the 6 higher 
vertebrate species, all of the Pearson’s chi-square P-values were smaller than 10-15, 
showing that the distribution of CpG sites in the 6 higher vertebrate genomes did not 
follow the Poisson distribution, and therefore were not randomly scattered in the 
promoter regions of these species. However, for the four lower vertebrate, invertebrate 
and plant species (zebrafish, D. melanogaster, C. elegans and Arabidopsis), the 
occurrence of CpG sites in the promoters did follow the Poisson distribution and hence 
they were randomly distributed (Pearson’s chi-square P-values all exceeded 5%).  
To further characterize the non-random distribution of CpGs in higher vertebrate 
promoters I looked at the occurrence of ‘CpG islands’, which are recognized as small 
dispersed regions of DNA sequence that contain highly dense clusters of CpG 
  
145 
 
dinucleotides relative to the whole genome. The widely accepted definition of a ‘CpG 
island’ is a genomic region with at least 200 bps in length, with the GC content fraction 
larger than 50% and the observed/expected CpG percentage ratio greater than 60% 
(Gardiner-Garden and Frommer, 1987). Out of the 34,257 annotated promoters of the 
human genome, I found 25,248 (74%) promoters containing ‘CpG islands’ while the 
rest 9,009 (26%) promoters have only few CpG dinucleotides. For the other 5 higher 
vertebrate species, CpG islands were detected in over half of their annotated promoters. 
The density of CpG sites in the promoters of all 6 higher vertebrates showed a bimodal 
distribution, which has been only found previously in human genome (Figure IV.3) 
(Saxonov et al., 2006). However, the CpG islands could not be found in the rest of 4 
lower vertebrate, invertebrate and plant genomes and the densities of CpG sites in the 
promoters showed a unimodal distribution in these species (Figure IV.3). Interestingly, 
a consistent unimodal distribution pattern of GC fraction in both vertebrate and 
invertebrate species (Figure IV.4). Hence, it is unlikely that the bimodal distribution of 
CpG proportion in promoters across all higher vertebrates is due to the GC content 
distribution. I proceeded to explore the functional roles of DNA methylation in 
regulating gene expression to explain the bimodal distribution pattern of CpGs in the 
promoters of higher vertebrates. 
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Figure IV.3: Histograms of the CpG sites proportions in the promoters of the 10 model 
species (The horizontal axis represents the CpG proportions in promoters, while the 
vertical axis represents the number of promoters for each model species) 
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Figure IV.4: Histograms of GC fractions in the promoters of the 10 model species (The 
horizontal axis represents the GC content fractions in promoters, while the vertical axis 
represents the number of promoters for each model species) 
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I classified gene promoters of the higher vertebrate species into two main groups 
previously defined for human genes (Weber, 2007) according to the GC fraction and 
observed to expected ratio of CpG sites (O/E). First, High CpG density Promoters (HCP) 
with GC fraction ≥55% and CpG O/E ≥65%; second, Low CpG density Promoters 
(LCP) with GC fraction <45% and CpG O/E <65%. The remaining genes were difficult 
to assign into either group and were grouped as Intermediate CpG density Promoters 
(ICP) (Weber, 2007, Saxonov et al., 2006). For each of the six higher vertebrates, there 
were approximately 50%, 25% and 25% of promoters classified as HCP, LCP or ICP 
respectively. In the following analyses, I focused on the two most divergent classes 
(HCP and LCP). A striking difference was observed between HCP and LCP promoters 
both for the GC content faction and the occurrence of CpG sites at varying distances 
from the transcription start site (TSS) (Figure IV.5 and Figure IV.6). For the HCP 
promoters in the higher vertebrates, both the proportion of CpG sites and the GC 
content fraction peaked consistently in the vicinity of the TSS and declined with 
increasing distance from the TSS. On the other hand, the proportions of CpG sites in 
LCP promoters were consistently close to zero, despite a peak for the GC content 
fraction around the TSS. These results indicated a high level of conservation of CpG 
site distribution among higher vertebrate species, suggestive of a possible link with 
important biological functions. For the zebrafish, a lower vertebrate, the patterns of GC 
content fraction and CpG site density at all promoters were similar to those of the HCP 
promoters of the higher vertebrates. The pattern was obviously different for the 
invertebrate species, with the GC content fraction and CpG density exhibiting a sharp 
peak immediately downstream of the TSS, but either a flat curve (Arabidopsis and C. 
elegans) or surprisingly a valley (D. melanogaster) upstream of the TSS.  
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Figure IV.5: Distributions of the CpG sites with respect to transcription start site (TSS) 
(The horizontal axis represents the distance from TSS, while the vertical axis represents 
average proportion of CpGs in that specific location for each model species) 
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Figure IV.6: Distributions of GC fractions with respect to transcription start site (TSS) 
(The horizontal axis represents the distance from TSS, while the vertical axis represents 
the GC fractions in that specific location for each model species) 
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4.3.3 Evolutionary conservation of promoters in higher vertebrates 
In the above analysis, I had observed that the patterns of the distribution of CpG sites in 
promoters were similar among the 6 higher vertebrate species, suggesting a possible 
link with biological implications. Here I would like to know whether the CpG sites in 
the promoters were evolutionarily conserved. For this purpose, I downloaded 
homologous gene list from the NCBI-HomoloGene database and tested if the promoters 
from homologous genes of different species were classified into the same promoter 
category of either the high (HCP) or low (LCP) density of CpG dinucleotides. In this 
analysis, I only considered the genes which have only one promoter. For a gene 
homologous between a pair of species among the 6 higher vertebrates, its promoter can 
be assigned to one of the different promoter classes in either species as described above. 
If the classifications were identical between a pair of species, I called the CpG sites 
distribution pattern in the corresponding promoter as being ‘conserved’.  
The analysis results were tabulated in Table IV.5. Each column of Table IV.5 represents 
the proportion of HCP or LCP promoters of homologous genes in the column species 
that were also classified as the same category in the row species. For example, there 
were 11,224 homologous genes between human and mouse. Among those homologous 
genes, 93.7%  of human genes having HCP promoters were also having HCP promoters 
in mouse. Meanwhile, 97.6% of the genes with HCP promoters in mouse were also 
classified as HCP promoters in homologous human genes.  
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Table IV.5: Conservation of two classes of promoters across higher vertebrates 
 
The diagonal cells show the number of genes with high (HCP) or low (HCP) CpG density promoters in each species. The upper and lower 
triangles show the percentage of genes in the column species also given the same classification for the row species. For example, for 93.7% 
of genes with HCP promoters in human also had HCP promoters in mouse, while, 97.6% of genes with HCP promoters in mouse also had 
HCP promoters in human. 
Proportions of conserved HCP promoters (%) Proportions of conserved LCP promoters (%)  
Human Mouse Rat Cow Dog Chicken Human Mouse Rat Cow Dog Chicken 
Human 7139 97.6 97.4 96.9 88.8 85.7 2895 86.7 87.3 79.5 89.8 42.1 
Mouse 93.7 8097 96.7 93.7 85.8 84.7 85.1 4365 89.9 83.2 87.4 48.2 
Rat 91.9 92.6 5634 90.4 83.4 89.7 85.0 94.6 2596 86.9 77.9 56.3 
Cow 93.6 94.1 95.2 1536 84.5 84.3 90.6 96.0 79.3 577 88.9 54.8 
Dog 82.2 80.5 84.9 86.3 435 80.6 81.1 90.6 87.2 97.1 187 40.0 
Chicken 89.6 87.0 89.7 84.4 82.5 913 47.3 53.6 51.6 53.7 33.3 251 
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Table IV.5 showed that the HCP promoters were highly conserved among the 6 higher 
vertebrate species. For each pair of vertebrate species, more than 80% of the HCP 
promoters of homologous genes in one species were also classified as HCP promoters in 
the other species. For LCP promoters of homologous genes, the conservation levels 
were found to be slightly lower than that of the HCP promoters in each pair of 
vertebrates, particularly in the pairs between chicken and the other 5 mammals. For 
example, for the homologous genes between dog and chicken, only 33.3% of the LCP 
promoters in dog were classified as LCP promoters in chicken. This variation may be 
expected due evolutionary changes that have occurred between bird and mammal 
lineages.  
It is interesting to note that the inter-species conservation of CpG sites in promoters 
could be used to infer the evolutionary relationships among species. By building a 
phylogenetic tree using the proportions of HCP/LCP promoters retained in the same 
category for a pair of species (Table IV.5) as an evolutionary divergence measure, I 
observed that the 5 mammals were closely linked each other while the chicken was in a 
separate cluster, which was remarkably similar to the phylogeny derived from DNA and 
protein sequence data (Hedges, 2002) (Figure IV.7). The only difference between the 
two phylogenetic trees is how the dog species is linked to the tree. In the tree based on 
promoter conservation, the dog species  diverged prior to all of the other mammals, 
while for the tree based on DNA and protein sequence data, the dog and cow diverged 
from the other three mammals around 92 million years ago, before the two separated 
around 83 million years ago. This discrepancy might be due to the limited number of 
promoters available for dog species. In fact, a total number of 13,410 genes were 
annotated for dog species, but only 1,481 promoters were identified.  
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Figure IV.7: Cluster analysis of higher vertebrate species 
 
(A): the phylogenetic relationships and times of divergence among vertebrates based on DNA and protein sequence data (Hedges, 2002) 
(B): the phylogeny of vertebrates constructed through the promoters’ conservation information 
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4.3.4 Distinct methylation patterns between HCP and LCP promoters across 28 
human tissues 
I analysed genome-wide DNA methylation profiles in 28 different human tissues (or 
cell lines) assayed by the Illumina HumanMethylation27 BeadChip platform (Bonazzi 
et al., 2011, Loudin et al., 2011, Chari et al., 2011). This BeadChip assessed 27,578 
CpG sites located within the promoter regions of 14,475 genes. On average, two CpG 
sites were interrogated per promoter region. Thus, the BeadChip assay provides an 
efficient solution for surveying the DNA methylation level in genome-wide promoter 
regions. Here, the analysis was consistent with previous findings that it had much lower 
methylation level in promoter region relative to genome-wide genome (Lister et al., 
2009). Figure IV.8 shows the distribution of the methylation levels of the CpG sites in 
the promoters across 28 different human tissues. The majority (72.7%) of the CpG sites 
in promoter regions were unmethylated (methylation level ≤ 0.1), while 18.5% were 
identified as semi-methylated (methylation level in 0.1~0.7) and only 8.8% of CpG sites 
were considered as methylated (methylation level ≥ 0.7). The distribution of 
methylation levels showed two distinct patterns for LCP compared with HCP promoters 
(Figure IV.8(B)). HCP promoters showed a unimodal distribution, with 77.1% 
unmethylated, 16.6% semi-methylated and 6.3% methylated CpG sites, while LCP 
promoters showed a bimodal distribution, with corresponding proportions of 25.8%, 
37.9% and 36.3%. I also investigated the CpG sites’ methylation levels with respect to 
the transcription start site (TSS) in all 28 human tissues. Illustrated in Figure IV.8 (C), 
each spot represented the average methylation level in an interval of 10 bp surrounding 
the TSS. I found that the CpG sites in both HCP and LCP promoters had the lowest 
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methylation levels in the core promoter regions at the vicinity of the TSS. The 
methylation level increased as their distance to the TSS increased. Furthermore, the 
CpG sites in the LCP promoters showed much higher methylation levels than those in 
the HCP promoters. 
The Illumina HumanMethylation27 BeadChip interrogated multiple CpG sites for a 
number of promoters, enabling us to examine whether the methylation levels between 
two CpG sites located in the same promoters were correlated. For a pair of CpG sites 
located in the same promoters, the Pearson’s correlation coefficient was calculated for 
their methylation levels across 28 tissues. And then, the average correlation coefficients 
in 10bps intervals with respect to the distance between these two CpG sites were shown 
in Figure IV.8 (D). The analysis showed that the methylation levels were positively 
correlated between CpGs located in the same promoter, particularly when the two CpG 
sites were close to each other.  As the distance between two CpG sites in the same 
promoter increased, the correlation of methylation levels decreased. Figure IV.8 (D) 
also shows that the CpG sites within the LCP promoters exhibited greater degrees of 
correlations in methylation levels than the CpG sites in the HCP promoters.  
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Figure IV.8: Distribution of methylation patterns across 28 different human tissues 
 
Methylation levels of CpG sites in all promoters (A), and in HCP and LCP promoters (B), across 28 different human tissues. The average 
methylation levels with respect to the transcription start site, with each point representing the average methylation level in an interval of 10 
bp (C). The correlation of methylation levels between all pairwise CpGs sites in the same promoter, with each point showing the average 
correlation in 10bp intervals according to the distance between CpG sites (D). 
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4.3.5 Distinct expression patterns between HCP and LCP promoters in 107 
human tissues 
I investigated the relationship between promoter DNA methylation and gene expression 
levels measured across 107 human tissues (including those 28 in the above methylation 
analysis) by the Affymetrix U133 human expression microarray (Johansson et al., 2007, 
Chari et al., 2011, Bell et al., 2011). I discovered a clear negative correlation (from -
0.05 to -0.18) between the gene expression level and methylation level of each profiled 
CpG site across the 28 tissues (Figure IV.9(A)). This correlation was confined to CpGs 
located in the core and proximal promoter regions (0 bp to 250 bp upstream of the TSS). 
For CpG sites located further upstream (>250bp) from the TSS, the strength of 
correlation decreased and no obvious relationship with gene expression level was 
apparent. No differences were observed between LCP and HCP promoters. Methylation 
of CpG sites in the core and proximal promoter regions must therefore play a crucial 
role in regulating gene expression levels.   
 
Next, I compared the number of tissues from which each gene was detectably expressed, 
from a total of 107 tissues (Figure IV.9(B)). The difference between LCP and HCP 
genes was striking. Genes with LCP promoters tended to be expressed in only a small 
number of tissues compared to genes with HCP promoters.  Over 35% of genes with 
LCP promoters were expressed in no more than 8 tissues, while only <5% were 
expressed in 99-107 tissues. On the other hand, genes with HCP promoters showed a 
reasonably uniform distribution for the number of tissues expressed from 0 to 107, and 
~15% of genes were expressed in 99-107 tissues. Genes with LCP promoters were 
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therefore more likely to be ‘tissue-specific’, while those with HCP promoters were 
more likely to be ‘housekeeping’ genes. In fact, among 885 housekeeping genes 
identified in the human genome (Zhu et al., 2008) that were also included in the present 
gene expression dataset, only 5.9% had LCP promoters, while 94.1% had HCP 
promoters. In particular, 376 (42.4%) of these housekeeping genes had HCP promoters 
and were expressed in almost all (99-107) tissues.  
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Figure IV.9: The correlation coefficients between methylation and gene expression level with increasing distance from the transcription 
start site (A). Distribution of the number of tissues in which HCP and LCP genes are expressed. Each bar is labelled with the corresponding 
number of house-keeping genes (B). 
 
 
  
161 
 
4.3.6 Distinct and conserved functions of genes with HCP and LCP promoters 
In previous gene ontology (GO) studies of human genome, it has been found that the 
promoters with ‘CpG Island’ were more likely associated with genes which had basic 
cellular functions, while the promoters without ‘CpG Island’ were likely associated with 
genes with tissues-specific functions (Larsen et al., 1992, Ponger et al., 2001, Saxonov 
et al., 2006). In this part, I attempted to explore if any GO term was disproportionately 
overrepresented in HCP or LCP promoter gene group in each of 6 higher vertebrate 
genomes. In addition, I examined whether the over-represented GO term(s) was shared 
among the higher vertebrates.  
To identify the overrepresentation of GO classes, I analyzed the number of genes in 
each GO class using the binomial test. A GO term was claimed to be significantly 
overrepresented when Z>4.75 (P < 10-6 after Bonferroni correction). For every higher 
vertebrate, the GO over-representation analysis identified about 100 GO terms 
significantly overrepresented in HCP or LCP promoter gene group respectively. Briefly, 
the HCP and the LCP promoter classes were predicted with different GO terms in all 6 
selected vertebrates: for LCP promoter genes, the GO terms were particularly presented 
in immunological function, response to stimulation, and functions characteristic of more 
differentiated or highly regulated cells, whereas GO terms detected for the HCP 
promoter genes were involved in the basic cellular processes, such as regulation of 
transcription, cell cycle, structure, and protein processing. 
For those overrepresented GO terms discovered, I tested whether they were shared 
among the higher vertebrate species. I called those GO terms shared by at least 4 
  
162 
 
vertebrate species as inter-species ‘conserved’ terms. Accordingly, 16 and 12 GO terms 
had been identified to be conserved in HCP and LCP promoter gene groups respectively 
(Table IV.6). As expected, the conserved GO terms were enriched in ‘tissue-specific’ 
functions for the LCP promoter group and enriched in ‘house-keeping’ functions for the 
HCP promoter genes.  
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Table IV.6: A list of conserved and overrepresented GO terms for HCP and LCP classes 
in the 6 higher vertebrates 
 
GO ID Conservationa Categoryb 
 GO term description 
Overrepresented in HCP class                             
0000122 4 BP regulation of transcription from RNA polymerase promoter 
0003676 4 MF nucleic acid binding 
0003677 4 MF DNA binding 
0003723 4 MF RNA binding 
0004672 4 MF protein kinase activity 
0004930 4 MF G-protein coupled receptor activity 
0005634 4 CC nucleus 
0005730 4 CC nucleolus 
0006915 4 BP apoptotic process 
0016021 4 CC integral to membrane 
0016301 4 MF kinase activity 
0043234 4 CC protein complex 
0043565 5 MF sequence-specific DNA binding 
0044212 4 MF transcription regulatory region DNA binding 
0045892 4 BP negative regulation of transcription, DNA-dependent 
0045893 4 BP positive regulation of transcription, DNA-dependent 
Overrepresented in LCP class                              
0004869 4 MF cysteine-type endopeptidase inhibitor activity 
0004984 4 MF olfactory receptor activity 
0006955 4 BP immune response 
0006958 5 BP complement activation, classical pathway 
0006974 4 BP response to DNA damage stimulus 
0007596 4 BP blood coagulation 
0007601 4 BP visual perception 
0008009 4 MF chemokine activity 
0008270 4 MF zinc ion binding 
0009897 4 CC external side of plasma membrane 
0015711 4 BP organic anion transport 
0032729 4 BP positive regulation of interferon-gamma production 
a: the number shown in ‘Conservation’ represents that the specific overrepresented GO 
term is conserved in how many vertebrates. 
b: the abbreviation shown in ‘Category’ stands for the three major subontologies 
comprising GO: CC for ‘cellular component’, BP for ‘biological process’, and MF for 
‘molecular function’. 
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4.4 Conclusion and Discussion 
DNA methylation has an essential role in the modulation of gene transcription in 
eukaryotic species, particularly in vertebrates (Suzuki and Bird, 2008, Antequera and 
Bird, 1993a, Attwood et al., 2002, Bennetzen et al., 1994, Zilberman and Henikoff, 
2007). While several studies have explored the relationship between regulation of gene 
transcription by DNA methylation and the CpG content  of gene promoters (Boyes and 
Bird, 1992, Robinson et al., 2004, Hsieh, 1994, Weber, 2007), they have all involved 
limited datasets or analysis only of the human genome. Moreover, the detailed 
biological roles of CgG dinucleotides in promoter regions and its impact degree on gene 
transcription are still unknown. The current study is the first comprehensive assessment 
of the DNA methylation system and its impact on gene transcription in 10 model 
eukaryotic (including both higher vertebrate, lower vertebrate, invertebrate and plant) 
species.   
These analyses revealed that the genome-wide distribution patterns of GC content and 
CpG dinucleotides vary dramatically between higher vertebrates and lower 
vertebrate/invertebrates/plant. In higher vertebrates, both the GC content and CpG 
dinucleotides were consistently enriched in functional regions of the genome, 
particularly in promoter regions, compared with putative 'non-functional' regions 
including introns and intergenic sequence. This pattern may be explained by the 
following two observations. First,  methylated have a higher probability than 
unmethylated cytosines to be converted to thymine over evolutionary time (Ehrlich et 
al., 1982, Kerry Lee, 2001). Second, nearly all CpG sites from non-functional 
sequences are completely methylated in vertebrate species. Functional constrains within 
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genic regions would limit the frequent of such mutations. However, I did not detect this 
pattern for lower vertebrate, invertebrate or plant species; instead, CpG dinucleotides 
were enriched across all regions of the genome, suggesting that there are similar levels 
of functional constraint in both 'functional' and putative 'non-functional' regions of the 
genome.  
Focussing on gene promoters I discovered that far from being randomly distributed in 
gene promoters, CpGs dinucleotides were consistently showed a bimodal distribution 
pattern in each higher vertebrate species. The previously defined 'CpG rich' promoters 
(HCP) and 'CpG poor' promoters (LCP) could be observed in all six higher vertebrate 
species, but not in lower vertebrates, invertebrates or plant. For both groups, CpGs were 
concentred in core and proximal promoter regions. Furthermore, the classification of 
genes into HCP or LCP groups was highly conserved among the homologous genes of 
the six higher vertebrate species. Indeed, the level of conservation of promoter 
sequences between species could be used to accurately reconstruct the evolutionary 
relationships between species. All of these observations led us to conclude that the 
DNA methylation system is highly conserved among higher vertebrate species and to 
further explore a role for the distribution of CpG dinucleotides within this system. 
DNA methylation of CpGs within both HCP and LCP promoters of the human genome 
is non-random; the level of methylation across the length of the promoter shows a u-
shaped distribution, with the lowest levels corresponding with the core promoter 
regions. This distribution is likely to facilitate transcription initiation, while the 
increased methylation level in the proximal and distal promoter regions could modulate 
transcription by impeding the binding of transcription factors. Methylation, specifically 
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in the core and proximal promoter regions, negatively regulated the gene expression 
level across multiple human cell lines and tissues. This could be explained by the 
physical distribution of protein binding sites in  promoter regions; the binding sites for 
RNA polymerase and most essential transcription factors are located in the core and 
proximal promoter regions, while only a few additional transcription factor binding 
sites are located in the distal promoter region (>250 bp upstream of the TSS).  
I discovered distinct characteristics of HCP and LCP promoters that ultimately relate to 
their underlying biological functions. The level of CpG methylation was consistently 
higher within LCP compared with HCP promoters. Methylation levels of CpGs within 
the same promoter were highly correlated among different cell types or tissues, 
particularly for two CpGs located in close proximity. However, methylation levels 
within HCP promoters displayed larger variation compared with the CpG sites within 
LCP promoters. These differences in the patterns of DNA methylation between the two 
classes of promoter were reflected in different patterns of gene expression. In particular, 
I discovered that 94% of annotated housekeeping genes in a comprehensive database 
contained HCP promoters, confirming previous reports of HCP promoters being more 
frequently associated with ‘housekeeping genes’ expressed in a large number of tissues 
and LCP promoters being associated with ‘tissue-specific' genes. For genes with HCP 
promoters, the DNA methylation system regulates the expression level in a number of 
tissues, while for genes with LCP promoters, the DNA methylation system provides a  
functional 'on-off' switch to determined whether the gene is expressed or not. 
Furthermore, I used genome-wide GO term functional annotations to confirm the 
functional distinctions between genes with HCP versus LCP promoters reported 
elsewhere (Ponger et al., 2001, Larsen et al., 1992, Saxonov et al., 2006, Weber, 2007), 
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but more importantly, I have shown that this relationship is conserved among all 6 
model vertebrate species. I can infer that these patterns are determined by the highly 
conserved regulatory mechanism of DNA methylation. 
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Part III 
Several cooperated researches of  
the linkage disequilibrium based association 
study and gene transcription regulation 
mechanism analysis 
This part presents several other research projects which I have involved during the last 4 
years. In these studies, I am a co-author and my contributions to the studies vary as 
reflected by my authorship. This chapter summarizes these projects and my contribution 
to them. 
1.  Inferring Linkage Disequilibrium (LD) in case-control samples 
1.1 Related publication 
Wang M, Jia T, Jiang N, Wang L, Hu X, Luo Z. (2010) Inferring linkage disequilibrium 
from non-random samples. BMC Genomics 11: 328-340. 
Please see Appendix IV for a copy of this article as it appeared in print. 
1.2  Summary 
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Fast advancement in DNA sequencing techniques has greatly facilitated a new tidal wave of 
genome wide association study (GWAS) to detect subtle genetic polymorphisms that 
underlie phenotypic variation of complex polygenic traits in humans, plants and animals. 
Obviously, adequate inference of the LD is the vital basis of efficient and reliable 
prediction of genetic association. Approaches widely implemented in LD estimations 
require samples to be randomly selected, which, however, are often ignored and thus 
raise the general question to the LD community of how the non-random collected 
samples affect statistical inference of the coefficient of Linkage Disequilibrium.  
We proposed a new likelihood-based method for estimating LD using a sample un-
randomly selected from the segregating population. Simulation study was conducted to 
mimic generation of samples with various degrees of non-randomness from the 
simulated populations. Our approach outperformed its rivals in adequately estimating 
the disequilibrium parameters in such sampling schemes. In analyzing a ‘case and 
control’ sample with β-thalassemia, this novel approach revealed robustness to non-
random sampling in contrast to two commonly used methods.  
Through a comprehensive simulation study and analysis of a real dataset, we have 
demonstrated the robustness of the proposed approach to non-randomness in sampling 
schemes and the significant improvement of the method to provide accurate estimates of 
the disequilibrium parameter. This approach provided a route to improve statistical 
reliability in association mapping. 
The author assisted with the FORTRAN computer program and data analysis. 
  
 173 
2. A powerful statistical method for genetic association studies 
using case-control samples 
2.1  Related publication 
This paper has been written up and submitted to BMC Genomics.  
2.2  Summary 
Genome wide association studies (GWAS) offer an unprecedented opportunity to detect 
genetic polymorphisms that underlie phenotypic variation of complex traits in humans, 
plants and animals. The theoretical basis of GWAS analyses is virtually estimation of 
linkage disequilibrium between any polymorphic locus and a putative trait locus. 
However, most methods widely implemented for such analyses are vulnerable to several 
key demographic factors and deliver a poor statistical power for testing for genuine 
associations but a high rate of false positives. 
In this project, we present a novel model to formulate genotypic distribution in terms of 
LD and other population genetic parameters in any non-random population based 
samples including cases and controls. A likelihood-based statistical approach is 
developed to infer these parameters from such samples. The method was explored 
thoroughly through intensive computer study and analysis of recently published large 
case and control datasets of Parkinson’s disease. The new method, to our best 
knowledge, is the first parametric statistical framework suitable to model and to infer 
LD between DNA marker and trait loci using the samples which are non-randomly 
collected from the segregating population under study. It provides adequate prediction 
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of LD and other model parameters, an ease integration of samples from multiple 
genetically divergent populations and the flexibility to incorporate various covariates 
into the analysis. 
Both real data analysis and intensive computer simulation study illuminate that the 
newly developed method confers significantly improved statistical power for detecting 
the associations and robustness to difficulties stemmed from non-randomly sampling 
and genetic structures when compared to the nonparametric trend tests. The new method 
detected 44 SNPs within 25 chromosomal regions of size < 1Mb in significant 
association with the disease trait but only 6 SNPs in two of these regions were detected 
by the trend tests. It discovered two additional SNPs located 1.18 Mb and 0.18 Mb from 
the PD candidates, FGF20 and PARK8, without invoking risk of false positive. 
The author assisted with the FORTRAN computer program and data analysis. 
3. Genetic dissection of agronomic and morphologic traits in highly 
structured populations of barley cultivars 
3.1  Related publication 
Wang M, Jiang N, Jia T, Leach L, Cockram J, Waugh R, Ramsay L, Thomas B, Luo Z. 
(2012) Genome-wide association mapping of agronomic and morphologic traits in 
highly structured populations of barley cultivars. TAG Theoretical and Applied Genetics, 
124, 233-246. 
Please see Appendix V for a copy of this article as it appeared in print. 
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3.2  Summary 
Whole genome association mapping has recently become a powerful strategy for 
exploring traits of agricultural importance in higher plants, especially crops. In this 
project, we implement a series of association studies for 32 morphologic and 10 
agronomic traits in a collection of 615 barley cultivars genotyped by genome-wide 
polymorphisms from a recently developed barley oligonucleotide pool assay. Strong 
population stratification effect related to mixed sampling based on seasonal growth 
habit and ear row number is present in this barley collection. Comparison of seven 
statistical methods in a genome-wide scan for significant associations with or without 
correction for confounding by population stratification, revealed that in reducing false 
positive rates while maintaining statistical power, a mixed linear model solution 
outperforms genomic control, structured association, stepwise regression control and 
principal components adjustment. Our analysis reports significant associations for 
sixteen morphologic and nine agronomic traits and demonstrates the power and 
feasibility of applying GWAS to explore complex traits in highly structured plant 
samples. 
The author assisted with the data analysis and presentation of the manuscript. 
4. Investigation of gene expression regulatory mechanisms in 
Saccharomyces cerevisiae (budding yeast) genome 
4.1 Related publication 
The paper based on this study has been written up and submitted to the journal of 
‘molecular biology and evolution’. In this project, the author analyzed both of the RNA-
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seq data and expression microarray data, and performed the statistical analyses. The 
author also contributed to write the manuscript. 
4.2 Summary 
Sense and anti-sense transcripts (S/AS) are the RNAs that are complementary each 
other to a various extent and can be either protein-coding or non-protein-coding. The 
presence of S/AS has been identified as one of common and key structure features in the 
genomes of both prokaryotes and eukaryotes such as human, mouse, Drosophila, C. 
elegans,  chicken, rat, cow, zebrafish, yeast, Arabidopsis, rice etc. According to their 
transcription orientation and extent of sequence overlap, S/AS can be classified into 
three major groups: convergent S/AS where the gene pairs overlap at the 3’ ends, 
divergent S/AS where the gene pairs overlap at the 5’ end, and consistent S/AS where 
the gene pairs overlap and transcript at the same direction. Distribution of these 
different types of S/AS shows the species specific, for example, the convergent S/AS is 
prevalent in Drosophila and C. elegans but not in Human and mouse.  
It has been widely supported that the structural characteristics of the S/AS gene pairs 
confers a natural and important mechanism of regulation of their expression.  In 2009, 
Guell et al. analyzed one of the smallest self-replicating organisms, Mycoplasma 
pneumonia, and found highly frequent antisense transcripts and clusters of operons into 
transcriptional units.  In 2006, Hongay et al. discovered that meiotic entry in 
Saccharomyces cerevisiae is controlled by antisense regulation of IME4, a gene 
required for initiating meiosis. The data reported reveals a transcription interference 
mechanism which is in sharp contrast to either RNAi in other eukaryotes and the 
interference between of the sense and antisense transcripts in this system acts only in cis 
  
 177 
but not in trans. By combining a global transcriptome analysis and expression profile 
analysis in mouse, Katayama et al. presented experimental evidence that RNAi 
mediated perturbation of an antisense RNA can alter the expression of sense messenger 
RNA in cis, in particular convergent pairs of S/AS show anti-regulation in expression in 
2005. Several models have been proposed to explain the interference in expression 
between S/AS RNAs. The most prominent is the collision model in which RNA 
synthesis from one DNA strand might clash with transcription from the other strand. 
According to this model, transcription occurs in only one direction at a given time, and 
active antisense transcription would suppress sense RNA transcription. This model was 
proposed using the atomic force microscopy data in E. coli and was tested on a pair of 
convergent genes in the budding yeast.  
All the studies aforementioned and reported so far on the S/AS transcriptional 
interference have been focused on only a few particular gene pairs and limited to their 
cis regulation. Recently popularizing RNA sequencing techniques enable to explore 
significance of the transcriptional interference at the genome scale. Several key 
questions remain unclear in regard to the structure dependent regulation of gene 
expression. For example, to what extent the transcriptional interference can be mediated 
in co-regulating expression of the S/AS pairs? What are the functional sequences that 
govern the co-transcriptional regulation? Whether the co-expression can be in trans in 
addition to cis?   
To tackle these questions, we focused here on the convergent gene pairs with 
overlapping 3’UTRs in the Saccharomyces cerevisiae genome to check the change 
pattern in cell-cycle and responds for different nutrient environments. All of the results 
confirmed the bioinformatics conclusion that the 3’UTR convergent overlapped genes 
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have a negative regulation in cis. Furthermore, we found overlapped 3’UTRs cause a 
noticeable negative effect from other locus. It proved that S. cerevisiae did conserve a 
regulation machine between convergent genes with overlapped 3’UTR and this machine 
could affect in both cis and trans, which was similar with the ancient RNA-depended 
regulation described in virus and bacteria. Comparing the transcriptome with other 
organisms, we further revealed the organisms had a trend to share more overlapping 
UTRs when they were more primeval. It indicated that UTR overlapping could take a 
regulation function rather than a strategy to narrow the genome. 
Upon the evidence above, we can suppose the regulation function in 3’ UTR overlapped 
units of yeast genes maybe an ancient regulation machine conserved from more ancient 
organisms, which was thought to be a vital and evolutionarily ancient component of 
genetic regulation as the early stage of small RNA molecule forms. 
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Chapter V: Final conclusion and summary of this 
project 
With the development of high-throughput technologies (such as microarray), the 
characterization and property of multi-levels ‘omics’ information has several important 
consequences in human and model organisms. First, microarray helps to accurately 
estimate gene transcription abundances by removing the influence of weak 
hybridization introduced by a mismatch between target and probe. Furthermore, it can 
also quickly and conveniently extract the genome-wide information in protein and DNA 
methylation levels for almost all model species. This is very valuable because it allows 
better interpretation of the fundamental, natural process through which organisms 
maintain their biological behaviours and life. Third, it enables one to investigate and 
identify the genetic variance among different samples. And, the genome-wide 
characterization of genetic diversity permits identification of many genetic markers that 
can be used in the physical mapping, linkage analysis and population studies. 
Additionally, analysis of genetic variability is of considerable significance for 
identification of genes in complex diseases, drug discovery and pharmacogenetics. 
Throughout the whole thesis, I comprehensively utilize the ‘omics’ information from 
different types of microarray; and mainly focus on the statistical methods for association 
analysis and the exploration of gene transcriptional regulation mechanism. I have 
divided this thesis into two independent parts: part I is a methodology research for 
genome-wide association analysis of complex traits; part II is to explore the DNA 
methylation mediated regulation of gene transcription in vertebrates. 
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The research in part I of this thesis introduces a linkage-disequilibrium based statistical 
algorithm for the genetic dissection of complex traits, particularly in structured 
populations. Currently, dissecting polygenic variation of complex traits at molecular 
level is one of the most challenging tasks in the era of functional genomics. The past 
two decades has witnessed a rapid development in both biological and computational 
technology, including genome sequences, high density marker maps, high-throughput 
genotyping methods and new statistical models, all of which greatly facilitate the 
progress of the reconstruction of genetic architecture for complex traits. Capitalizing on 
the achievements in both conventional experimental designs and the power of statistical 
methods, association study is capable of high precision and resolution for illuminating 
the complex pattern of relationship between genotypes and phenotypes and for 
understanding the role of complex genetics. However, a fundamental problem in 
association study is the existence of population structure because it can lead to 
‘spurious’ associations, even within relatively homogeneous populations. Thus, I 
develop a new approach (Method 1) to control the spurious associations from structured 
populations by incorporating a control marker into the linear regression model. This 
new approach (method 1) has been compared to the original linear regression model 
which was designed for association study (method 2) and multiple regression model 
(method 3). I have explored the different methods from several aspects in both 
simulation study and real data analysis. Both method 1 and method 3 can successfully 
remove the spurious LD and also maintain the statistical power to identify the real 
associations at a relatively high level. But, the performance of the multiple regression 
model (method 3) heavily depends on the accuracy of prediction of the population 
structure and on accurate allocation of individuals’ membership to the constituent 
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populations. Any bias in the structure prediction and uncertainty in the membership 
allocation can lead to severe consequences on its analytical efficiency. However, the 
new approach avoids the need for population structure prediction. Therefore, it is a 
convenient and powerful association analysis method for structured populations. 
Here, a number of possibilities still exist for extending the present LD based method of 
association analysis to increase its general applicability and dissection power. For 
example, this new method presented here is appropriate for dissecting association for no 
more than two admixed sub-populations. In the future, it will be useful to extend this 
method for the admixed population which involves more than two genetically divergent 
populations. But, this improvement requires the haplotype frequency information 
between test marker and control marker, which is not available right now. With the 
development of next-generation sequencing technology, the haplotype information will 
be available very soon and the present method will be extended at that time. 
In part II of my thesis, I utilize several levels of ‘omics’ information, included genomics, 
transcriptomics, genome-wide DNA methylation and annotation profiles, to explore the 
roles of methylation in gene transcriptional regulation, particularly in vertebrate species. 
DNA methylation in the genome plays a fundamental role in the regulation of gene 
expression levels and is widespread among eukaryotic species, particularly in 
vertebrates. Previous studies have revealed a consistent ‘global’ methylation pattern in 
higher vertebrate species, in which the CpG sites are completely methylated genome-
wide, except in promoter regions. Meanwhile, another striking feature of the CpG 
dinucleotides in the human genome is that the CpG dinucleotides are obviously depleted 
genome-wide, but relatively enriched in promoter regions. Thus, one of the key open 
  
 182 
questions in understanding the regulatory mechanisms of the DNA methylation system 
in vertebrates must be related to the distribution and roles of CpG sites in promoter 
regions and the variety of DNA methylation levels of CpGs in the promoters. In this 
work, I comprehensively examined and compared the distribution of CpG sites within 
10 well-studied eukaryotic model organisms. And then, I investigated the relationships 
between genome wide DNA methylation profiles and gene expression profiles across 
multiple human tissues. Third, I used the genome-wide gene ontology information to 
analyze the conserved association between GO terms and the CpG distribution in 
promoter regions among 6 higher vertebrates. The analysis revealed two distinct 
methylation patterns for human gene promoters, involving genes with distinct 
distributions of CpG dinucleotides within the promoter region. Comparative analysis 
with five other higher vertebrates revealed that the primary regulatory role of DNA 
methylation system is highly conserved in higher vertebrates. Ideally, the next step of 
this analysis would be to investigate the new strategy that how to efficiently integrate 
the multi-levels of ‘omics’ information together. All of these analyses will bring us 
closer to a comprehensive understanding of the mechanisms of gene transcription 
regulation, which is essential for both biological and medical research. 
Along with acquiring more comprehensive genetic knowledge through the above 
described research, I have gained plenty of sophisticated training and practice in both 
statistics and computational programming. In addition to using common statistical tools, 
e.g. minitab, SPSS and STATA, I am also professional in programming statistical 
methods and simulating statistical ideas in Fortran and R languages. These experiences 
strengthen my ability to develop new statistical methods and handle various kinds of 
data in real data analysis during my further career. 
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